Quarterlytics / Healthcare / Medical - Instruments & Supplies / Invacare

Invacare

ivc · ASX Healthcare
Claim this profile
Ticker ivc
Exchange ASX
Sector Healthcare
Industry Medical - Instruments & Supplies
Employees 1001-5000
← All annual reports
FY2020 Annual Report · Invacare
Sign in to download
Loading PDF…
2020 Annual Report

Resilient operating result 
in a challenging year

,,

  We’re here to support our clients,  
their families and friends, at a pivotal 
time in their lives. We do this by being 
compassionate, exceeding expectations 
and delivering outstanding service.

,,

About this report

InvoCare’s 2020 Annual Report is our primary statutory and regulatory 

reporting disclosure. It comprises information about our activities, strategy, 

our financial and non-financial performance, risk management, remuneration 

and our financial statements. The financial statements are structured to 

provide prominence to the disclosures that are considered most relevant to 

the user’s understanding of the operations, results and financial position.

Corporate reporting suite

InvoCare’s corporate reporting suite brings together the Group’s financial, 

non-financial, risk and sustainability performance for the financial year 

ended 31 December 2020, including:

Investor 

Presentation

Scan QR 

code on your 

smart device 

to download 

from the ASX

Sustainability 

Report

Scan QR 

code on your 

smart device 

to download 

from InvoCare 

website

Our corporate reporting documents are available for download on the 

InvoCare Investor Relations page:

www.invocare.com.au/investor-relations/

Resilient operating resultin a challenging year2020FullYearResults24 February 2021InvoCare FY20 Sustainability ReportNew dimension to sustainabilityContents

InvoCare Limited
ABN 42 096 437 393

Section 1 
Performance 
Overview

Performance highlights

Chairman’s message

Five year financials

Chief Executive Officer’s message

Executive Leadership Team

2020 Sustainability highlights

Managing the impact of COVID-19

Our community

Section 2 
Directors’ Report

Operating and financial review

Remuneration report – audited

Other statutory matters

Auditor’s Independence declaration

Section 3 
Financial Report 

Financial Report Introduction

Consolidated financial statements

Notes to the consolidated financial statements

Directors’ declaration

Independent auditor’s report

Section 4  
Other Information

Shareholders information

Glossary

Corporate directory

InvoCare            Annual Report 2020  | 3

4

6

9

10

12

13

14

16

21

36

60

66

68

69

75

125

126

132

134

135

P
e
r
f
o
r
m
a
n
c
e
R
e
v
e
w

i

D
i
r
e
c
t
o
r
s
’

R
e
p
o
r
t

i

F
n
a
n
c
a

i

l

R
e
p
o
r
t

O
t
h
e
r
I

n
f
o
r
m
a
t
i
o
n

1

2

3

4

 
 
 
 
Performance highlights

Remained focused on our mission and values of care and service

Financial a 
summary

Operating 
revenue b 
$476.2m 
↓  4.7% 

Operating 
EBITDA 
$102.6m 
↓  29%

Reported loss 
($9.2m) 
↓  114%

Operating EPS 
20.4¢
 ↓  61%

Capital  
management

Cash flow 
conversion
107%
↑ 25 ppts 

Leverage  
ratio
1.3x
 ↓  1.1x

 ROCE
8.6%
↓  8.5 ppts

Full year 
dividend
12.5¢
↓  70%

Operating 
EBITDA 
business 
lines

Operational 
and 
sustainability 
metrics

Funeral  
services
$80.1m
↓  26%

Memorial  
Parks
$57.6m
↓  8.7%

Pet  
cremations
$0.5m
 ↑ 141%

Funeral case 
volumes 
44,784
 ↓  3.0%

Funeral case 
average c 
$7,858 
↓  4.5%

Memorialisation 
revenue
+4.4%
 ↑ on PCP

NPS
+79
 ↑ 0.5

LTIFR
12.5
↓  1.6

N.B Variations noted above are versus the prior corresponding period 

a  For reconciliation of operating to statutory results, refer to page 33

b  Includes operating sales revenue and other revenue

c  Gross funeral case average, including disbursements

InvoCare            Annual Report 2020  | 4

Operating sales revenue  
$m

Operating EBITDA  
$m

2016

462.5

2017

2018

2019

2020

470.9

477.3

494.1

2016

2017

2018

2019

115.3

124.3

119.0

144.4

470.2

2020

102.6

450

460

470

480

490

500

90

100

110

120

130

140

150

Operating earnings after tax  
$m

(Loss)/profit after tax attributable to 
members $m

2016

2017

2018

2019

2020

27.5

57.4

63.5

49.5

59.2

2016

2017

2018

2019

2020

(9.2)

70.9

97.4

41.2

63.8

20

30

40

50

60

70

(10)

10

30

50

70

90

Operating earnings per share  
¢ per share

Ordinary dividend (full year)  
¢ per share

2016

2017

2018

2019

2020

20.4

52.4

57.9

45.2

51.7

2016

2017

2018

2019

2020

12.5

42.5

46.0

37.0

41.0

10

20

30

40

50

60

10

20

30

40

50

InvoCare            Annual Report 2020  | 5

Performance Review12Directors’ Report3Financial Report4Other InformationChairman’s message

Dear Shareholder,

On behalf of the Board, we would like to thank you for your support 

in what has been a year of unprecedented disruption.

The Board would also like to extend their thanks and gratitude to 

our employees. In 2020, our teams across our Funeral Services, 

Memorial Parks and Pet Cremations businesses, as well as our 

support office teams, stepped up to the significant challenge of 

the COVID-19 pandemic (COVID-19). They have committed to 

our purpose, serving families when they need us most, focusing 

on high standards of safety and service. They showed resilience, 

agility, and a readiness to do things differently to support families 

across Australia, New Zealand and Singapore. 

In 2020, our client families showed their satisfaction with these 

efforts with a very strong Net Promoter Score of +79, an 

exceptional result in difficult circumstances. We are proud and 

so grateful for everything our teams have achieved in such a 

demanding year.

2020 financial results

InvoCare reported statutory revenue of $477.7 million for the 

year, a decrease of 4.5% on the prior corresponding period 

(PCP). COVID-19 and the associated government restrictions 

had a significant impact on both InvoCare’s ability to deliver 

full-service funeral arrangements and on the mortality rate in 

the countries in which it operates.

The statutory net loss after tax attributed to shareholders 

was $9.2 million for the year. As disclosed to the market 

on 17 February 2021, this 2020 full year result includes the 

impact of net $26.5 million (pre-tax) of significant operating 

and non-operating items. 

The Group delivered an operating earnings per share 

(EPS) of 20.4 cents, 61% below the PCP, driven by the 

decline in operating earnings in the year and the dilutive 

impact of the increased number of shares on issue 

following the successful equity raising completed in 

April and May 2020.

               the Board remains confident 
about the long-term potential of 
the business, with future growth 
supported by both population growth 

,,
and ageing trends in its markets,,

InvoCare            Annual Report 2020  | 6

Impact of COVID-19

Embracing sustainability

The last year has clearly been challenging across the world and 

As Australia, Singapore and New Zealand’s leading operator in the 

the ongoing impact of COVID-19 is the backdrop to our financial 

funeral, cemetery and crematoria sector, InvoCare has a responsibility 

performance. While the strategies employed by various governments 

to both our shareholders and the communities we serve to lead the way 

in our part of the world to control the spread of COVID-19 have been 

in defining standards of excellence in the sustainability of our industry’s 

successful, they have led to softer market conditions in the Funeral 

environmental, social and governance (ESG) practices.

Services sector in particular.

2020 was the second year in our initial three-year plan, with a focus 

In 2020 our people were truly able to live our mission to support 

on developing the operational and reporting model ideal for our 

families at the most pivotal time of their lives. They have done so 

core sectors, and building on established and globally recognised 

by being compassionate, exceeding expectations and delivering 

frameworks such as the GRI Index. Further information is provided in 

outstanding service and by setting the highest standards in safety 

our separate Sustainability Report issued on 31 March 2021, which is 

and business practice. They were able to support families through 

available on our website.  

situations where they either couldn’t hold a funeral or were not able to 

attend in person because of government restrictions.

Despite the disrupted year hampering our ability to pursue some of 

their intended sustainability initiatives, the team’s response has been 

We implemented a detailed and comprehensive COVID-19 response 

to increase the focus on areas such as the health and safety of our 

plan. This involved additional measures in each business to protect 

employees and client families and expanding digital accessibility to 

the health and safety of our teams and customers, while supporting 

funeral events, which required the accelerated deployment of digital 

government efforts to limit the spread of the virus. These important 

capabilities at our funeral and memorial park locations. 

measures resulted in additional costs. I should note that our 

businesses in Australia did not benefit from JobKeeper assistance. 

There was also a measured approach to cost control in order to 

Leadership changes

maintain uncompromised service levels and this was a deliberate 

The InvoCare Board established and executed a leadership transition 

decision of the Board and Management given the important role our 

plan during the year. Adrian Gratwicke was appointed as InvoCare’s 

teams play in the community and in helping our client families farewell 

new Chief Financial Officer (CFO) from 3 August 2020. Adrian is 

their loved ones.

The impacts from COVID-19 have mostly been experienced in our 

core Funeral Services businesses where restrictions on gathering 

an experienced public company CFO, having worked across a 

broad range of sectors stretching into Oil & Gas, Mining, FMCG and 

Agriservices. 

limits impacted our ability to provide our full range of services. Rules 

Additionally, as announced on 19 November 2020, Olivier Chretien 

differed between geographies and states and changed multiple times 

joined the Company on 1 January 2021 as InvoCare’s new Managing 

Director and Chief Executive Officer (CEO). Olivier has a proven 

record of value creation, strategic design and execution, and he has 

pleasingly hit the ground running. Along with his refreshed Executive 

Leadership Team (see page 12), he has been working on the details of 

the InvoCare strategy for the next five years. 

over the year.  

A common trend seen across all markets has been an increase 

in direct cremations during the height of lockdowns as family and 

friends were unable to attend a ceremony in person. However, we 

have observed how important the ‘gathering’ element of a funeral 

arrangement to celebrate a loved one’s life was to client families. Even 

though the rise in digital solutions assisted families during lockdown, 

we have seen a progressive return to traditional arrangements when 

restrictions have lifted. Additionally, the breadth of our brand portfolio, 

particularly in Australia, has helped the business manage the shift to 

direct cremation and back to traditional services. Either way, digital 

solutions will continue to be needed and we have ensured our funeral 

homes and memorial park chapels have the appropriate technology.

InvoCare            Annual Report 2020  | 7

Performance Review12Directors’ Report3Financial Report4Other InformationChairman’s message

continued

Remuneration activities

Capital management

Robyn Stubbs resigned as an independent Non-Executive Director 

In response to the uncertain impact of COVID-19 and to ensure 

effective 1 February 2021. Robyn has been a valued member of the 

the continued positive momentum of growth initiatives through 

Board since her appointment in 2017, especially in her role as Chair 

an environment of temporary restrictions on the funeral industry, 

of the People, Culture & Remuneration Committee (Committee). 

InvoCare successfully completed a $274 million capital raise in April 

On behalf of the Board we thank her for her commitment and 

and May 2020 via an institutional placement and share purchase plan. 

contributions to the business.

We are delighted with the strong support shown by participants in the 

Our 2020 Remuneration Report is contained in this Annual Report. 

raise, which positioned the Group to maintain momentum to deliver 

Led by Robyn, the main activities of the Committee during the year 

long-term value for its shareholders and I thank our shareholders on 

were highly influenced by COVID-19, which provided a back drop for 

behalf of the Board for their continued support.

its assessments of both the STI and LTI outcomes for the year but also 

in assessments of base salary and director fees. Key remuneration 

outcomes in the year included: 

• •  The financial performance in 2020 did not meet the agreed financial 

targets, and as a result the full financial portion (50%) of STI has 

been forfeited by the Executive Key Management Personnel (KMP). 

The average STI outcome for 2020 for Executive KMP was 27% 

based on their balanced scorecard

• •  The Return on Invested Capital (ROIC) gateway was not met for 

the 2017 and 2018 LTI grants that were tested in the year. None of 

these awards therefore vested in 2020 in accordance with the plan 

rules

The net proceeds of the capital raise have been used to reduce 

net debt, increase liquidity, and provide balance sheet flexibility for 

acquisitions and ongoing capital investment. Management also 

successfully re-negotiated an extension of the undrawn $200 million 

debt tranche due to mature in February 2021. This funding line, 

along with the additional capital is expected to provide InvoCare with 

increased flexibility to further strengthen its balance sheet, accelerate 

the roll out of Enhance and Growth projects in the NBO program, and 

in taking advantage of new growth opportunities that may arise.

Notwithstanding the earnings reduction, the Group was able to 

maintain strong cash conversion and that in turn has enabled the 

Board to determine a final fully franked dividend of 7 cents per share, 

• •  From 1 August to 30 November 2020, the Non-Executive Directors 

which brings the full year dividend to 12.5 cents per share. The 

took a 25% base fee reduction (COVID-19 related)

reduction in dividend payout ratio to 61% reflects an appropriately 

The Committee also undertook a review of the LTI arrangements in 

place and a new LTI plan was introduced during the year for the 2020 

grant with a particular focus on its ability to attract and retain senior 

management to ensure they are focused on delivering sustainable 

long term growth. Key features of the 2020 LTI plan include:

• •  Introduction of two performance hurdle measures weighted 50% 

on compound annual growth of EPS and 50% on average ROIC 

over the three-year performance period with no ROIC gateway and 

the testing point for vesting being at the end of this performance 

period only

• •   Participants are able to choose a mix of options and performance 

rights based on their personal risk profile

• •   Vested options or performance rights are subject to a further  

12- month restriction period

• •   The performance rights are entitled to dividends, if determined, 

prudent approach to capital management given ongoing short-term 

outlook uncertainty and another year of heightened capital spend as 

the Group seeks to complement its commitment to the NBO program 

of works with other growth initiatives.

Outlook

Short-term market conditions are still being impacted by COVID-19 

restrictions and the timing and extent of the unwind of related 

impacts remains hard to predict. Notwithstanding this, the Board 

remains confident about the long-term potential of the business, 

with future growth supported by both population growth and 

ageing trends in its markets. The refreshed Executive Leadership 

Team and the appointment of Olivier as CEO sets the Company up 

for its next phase in meeting the evolving needs of client families.

paid in the form of shares but no voting rights attach to the options 

Bart Vogel  Chairman

or performance rights awarded

               The Board would also like to extend their thanks and gratitude to our 
employees... They have committed to our purpose, serving families when they 
need us most, focusing on high standards of safety and service. They showed 

,,
resilience, agility, and a readiness to do things differently to support families,,

InvoCare            Annual Report 2020  | 8

Five year financials 

$’000 

Operating sales revenue a  

Operating EBITDA  

Operating EBITDA margin  

Operating earnings after tax b 

Operating earnings per share (cents) 

(Loss)/profit after tax attributable to members  

Earnings per share (cents) 

Dividend paid in respect of the financial year (cents) 

2020

2019

2018

 2017 

 2016 

 470,232 

 494,112 

 477,337 

 470,852 

 462,476 

 102,565 

 144,433 

 118,998 

 124,316 

 115,344 

22%

29%

25%

26%

25%

 27,478 

 59,202 

 49,496 

 63,526 

 57,417 

 20.4 

 (9,242)

(6.9)

 12.5 

 51.7 

 45.2 

 57.9 

 52.4 

 63,752 

 41,224 

 97,439 

 70,949 

 55.8 

 41.0

 37.8 

 37.0

 88.8 

 46.0

 64.7 

 42.5 

Ungeared, tax free operating cash flow 

 109,324 

 118,776 

 104,222 

 116,891 

 105,007 

Proportion of EBITDA converted to cash  

107%

82%

88%

94%

91%

Actual capital expenditure 

 68,136 

 65,289 

 84,120 

 47,471 

 30,321 

Net debt  

 137,468 

 349,968 

 393,469 

 227,547 

 222,927 

Operating EBITDA/Net interest (times) 

Net debt/EBITDA (times) 

Funeral homes (number) 

Memorial Parks (number) 

 8.3 

 1.3 

 278 

 17 

 10.1 

 2.4 

 280 

 17 

 9.6 

 3.3 

 255 

 16 

 13.8 

 1.8 

 228 

 16 

 11.0

 1.9 

 233 

 16 

a  Operating sales revenue excludes other revenue including rent and sundry revenue

b   Operating earnings after tax excludes the net gain/(loss) on pre-paid contracts, costs associated with the administration of pre-paid contracts, 

commissions received,  gain/(loss) on sale, disposal or impairment of non-current assets and non-controlling interests  

Le Pine Funerals / White Lady Funerals, Kew Victoria

InvoCare            Annual Report 2020  | 9

Performance Review12Directors’ Report3Financial Report4Other Information 
Chief Executive Officer’s message

Dear Shareholder,

I have only been here a short time but from the site visits I’ve 

done and employees I have met with, I am impressed and proud 

of their professionalism, flexibility, and work ethic. Echoing the 

Chairman’s message, I would like to thank all our employees in 

Australia, New Zealand and Singapore for their tireless efforts this 

last year to support each other and our client families to ensure 

they were provided with the best care and service at all times, 

notwithstanding the very difficult conditions they faced.  

During the past year, we completed 63 NBO projects across Australia 

and New Zealand. We also welcomed to our Group the team of 

Galaxy Funerals in NSW and two well-established Pet Cremations 

businesses in Australia, Family Pet Care and Pets in Peace, providing 

strong platforms for growth.

We delivered full year operating revenue of  

$476.2 million and an operating EBITDA of 

$109.6 million after excluding the impact of 

some significant items captured in our results, 

which was in line with market expectations. 

This is pleasing in what was a very difficult 

year where all our businesses faced 

significant operating constraints, changes 

in consumer behaviours and demand, as well 

as increased price competition, especially at the 

height of the lockdowns. But that was the past and 

we need to focus on the future. 

We are still living with a level of uncertainty and ever-changing 

restrictions across our three countries. This simply means that we 

need to continue to adapt and be nimble. I am delighted to have joined 

a team who is extremely passionate about what they do every day. 

With drive, expertise and commitment, there is so much more we can 

do for our client families in the year ahead.

Refreshed Executive Leadership Team

We recently announced a leadership restructure of the business 

where I confirmed several recent executive promotions and made 

additions and changes to accountabilities to align with our strategic 

focus areas and my strong commitment to diversity. 

This new ‘leaner’, flat structure will enable me as CEO to have direct 

oversight of our operations and I am pleased to have the leadership 

accountabilities in place to deliver on our strategic plan for the next five 

years. In addition, my Executive Leadership Team and I are committed 

to doing all we can to ensure that over the coming years we 

build an even safer, inclusive and rewarding place to 

work, so that all our employees can be proud to 

work here.

InvoCare            Annual Report 2020  | 10

InvoCare 2025

As the Chairman touched on, my team and I are in the process of 

Leveraging stronger foundations, we can then really grow our market 

evaluating some elements of our five-year strategic plan.

share in value – several avenues for growth exist across pre, at and 

The guiding principle for this next stage of our strategy is to leverage our 

core assets and recent investments in our properties (the NBO program) 

and IT systems, and to optimise their potential to meet the evolving 

needs of our client families through an expanding value proposition.

Our key focus will be on enhancing the experience we provide to both 

our client families and teams to position our business for success today 

and for sustainable growth in the future. Our purpose is to honour life 

and celebrate memories for generations. This means considering our 

lifetime customer journey, where we can really leverage our pre, at and 

post-need offerings, through our Pre-paid Funerals, Funeral Services, 

Memorial Parks and Crematoria, as well as Pet Cremations services. 

We will also focus on expanding our service offering for targeted 

customer segments – rather than taking a generic approach to market 

share in case volume. This will require a progressive shift in our business 

post-need including expanding our provision of value-add services to 

customers. We will also continue to seek to expand our addressable 

market. This includes further growth in our Pet Cremation business, 

expanding digital channels and being a partner of choice. Work is also 

underway to assess and prioritise other growth opportunities. 

Last but not least, I believe we can and have a duty to extend our 

industry leadership across a number of dimensions – our commitment 

to service excellence; our safety standards and performance; 

developing talent; our sustainability commitments; digital, data and 

innovation investments; as well as our community support and a 

more proactive stakeholder engagement, including with our industry 

associations.

Outlook

focus with a greater emphasis on innovation, flexibility, and diversity. 

I am energised by the quality of our teams, services, brands and 

First and foremost – we are a service business, so the core foundation 

of the strategy will be a relentless focus on our client families and our 

teams to meet and exceed customer needs. This includes a focus on 

our service excellence and customer metrics, and ensuring we provide 

a safe, inclusive, and rewarding workplace.

assets across Australia, New Zealand and Singapore. In the years 

ahead, I really look forward to providing an increased quality of care 

and excellence in service to our client families and communities;  

a safe, inclusive and rewarding workplace to our employees; 

industry stewardship, notably through our commitments to 

sustainability, innovation and proactive stakeholder engagement; 

To succeed, we need to simplify our approach. We need to put our 

and delivering value to our shareholders through a relentless 

attention on what matters by empowering our local leaders and 

commitment to profitable growth and satisfactory returns on 

supporting our frontline teams to do the best they can. My commitment 

capital employed. 

as CEO is that we will remain focused on achieving better experiences 

for our teams and client families.

We have already initiated a review of our operating model and will look 

for opportunities to variabilise more of our cost base over the long term. 

Finally, I too would like to thank all our shareholders for their 

ongoing support.

Some areas of focus here will include our funeral network performance 

Olivier Chretien Managing Director & Chief Executive Officer

and strategy; the value propositions of our leading brands; our capital 

deployment; as well as more efficient support services.

,,

            ...we will also focus 
on expanding our service 
offering for targeted 
customer segments... 
this will require a 
progressive shift in our 
business focus with a 
greater emphasis on 
innovation, flexibility, and 

diversity ,,

Beth Shan Funerals, Taradale New Zealand

InvoCare            Annual Report 2020  | 11

Performance Review12Directors’ Report3Financial Report4Other InformationExecutive Leadership Team

Chief Executive Officer

Chief Financial Officer

Olivier Chretien

Adrian Gratwicke

Executive General Manager 
 – Australian Funerals

Lynne Gallucci

Executive General Manager 
 – Cemeteries & Crematoria

Executive General Manager 
– Customer

Executive General Manager  
– Stakeholder Engagement

Steve Nobbs 

Victoria Doidge

Fergus Kelly

Executive General Manager 
– Health, Safety and Sustainability

Executive General Manager  
– Human Resources

Grace Westdorp

Amanda Tober

Company Secretary

Heidi Aldred

InvoCare            Annual Report 2020  | 12

2020 Sustainability highlights

Health & Safety

InvoCare was very pleased to have remained 

operational throughout the 2020 COVID-19 

Local empowerment and rewards

A significant component of 2020’s COVID-19 

driven cost control was to substantially reduce the 

lockdowns without any recorded cases of workplace-

level of centrally located operational management, 

acquired infections.

delegating more authority and responsibility to local 

Heightened awareness of safety, backed by increased 

leaders and teams. 

resources around safety risk evaluation and best 

The quarterly Net Promoter Score incentives for 

practices were realised through online safety training 

our customer-facing employees were deferred 

and incentive initiatives. These initiatives contributed to 

during 2020. However in recognition of the critical 

a 11.6% reduction in Lost Time Injury Frequency Rates 

roles they had in maintaining excellent client service 

(LTIFR) from 2019 to 2020, which was ahead of our 

and satisfaction, an end of year incentive was paid in 

proposed target (10.0%). 

December 2020.

Digital accessibility

Another key achievement in 2020 was to provide our 

client families and others much greater online access 

to our employees, product and service information and 

live events. 

Accelerated due to COVID-19 lockdowns, digital 

platform innovations were a key outcome of the 

increased focus on positive customer engagement. 

More accessible and transparent information was 

provided which  contributed to positive Net Promoter 

Score outcomes.

Modern slavery statement

A significant milestone at the end of the 2020 year was 

the development of our Modern Slavery Statement, 

which sets out our process to identify, prevent, mitigate 

and address modern slavery risks in our supply chain. 

The Statement reflects our commitment to 

understanding and addressing the social and ethical 

challenges associated with our business and to 

promoting high standards of ethics and integrity.

Building on the success of the ongoing Aspire 

Leadership program, these initiatives have supported 

the maintenance of very high Net Promoter Score 

levels (+79) despite the frustrations and uncertainties 

associated with COVID-19 lockdown regulations.

Gender-balanced senior  
leadership team

At the end of 2020 our Executive Leadership Team, 

including the CEO, was equally gender balanced 

with four females and four males. Normally reported 

without the CEO (who is counted with the Board) this 

is a significant improvement on last year.

Diversity and inclusion leadership

In 2020, InvoCare was included as one of only nine 

Australian listed corporations in the world’s top 100 

companies by the Refinitiv Diversity and Inclusion 

Index. 

As one of the top 100 international organisations from 

over 9,000 assessed globally, that places InvoCare 

in the top 1% of the world’s listed organisations on 

Diversity and Inclusion.

Download the full 2020 
Sustainability Report

Scan this QR code on your smart 

device to access the full report

InvoCare            Annual Report 2020  | 13

InvoCare FY20 Sustainability ReportNew dimension to sustainabilityPerformance Review12Directors’ Report3Financial Report4Other InformationManaging the impact of COVID-19

The Company’s response to the  
COVID-19 pandemic revolved around  
four key principles:

• •  Safety  

of our staff, suppliers and client families

• •  Retention of key talent   

measured approach to cost control, retaining frontline 

field staff expertise to ensure uninterrupted support to 

client families

The operation and financial performance of all InvoCare business units 

was substantially impacted by the COVID-19 pandemic, due both to 

a decline in the number of deaths in the communities we serve, and to 

the restrictions placed on our ability to host funeral gatherings.

Preliminary indications of partial data from the ABS for doctor certified 

deaths in Australia covering the 52 weeks ending 31 December 2020 

are that social isolation, social distancing, face masks and hygiene 

awareness has contributed to the number of deaths reducing by 

around 2.3% relative to the comparable period in 2019. In New 

Zealand, full-year data shows that the number of deaths has declined 

• •  Maintain customer service standards   

by 4.8% year on year.

innovative and digitally focused solutions allowed 

families to continue to arrange a service which 

honoured their loved ones

• •  Strong balance sheet   

The decline in the number of deaths is reflected in both funeral 

and cremation case volumes, which were down 3% and 3.8% 

respectively. During the winter flu season, which is normally the 

busiest time of the year (Q2/3), the Group’s funeral case volumes were 

capital raise and extension of debt maturity allowed 

down by 6%.

the Group to deleverage the balance sheet and 

maintain the momentum of its growth initiatives. 

The nature and impact of government restrictions varied from time to 

time and place to place, as circumstances changed. The overall result 

was a substantial shift towards simpler funeral ceremonies and an 

increase in cremations and direct cremations in all three countries.

InvoCare            Annual Report 2020  | 14

The financial impact on our funeral businesses was relatively greater 

government cost relief to cover the cost of PPE and it did not qualify 

in Singapore, where full-service offerings on farewells which normally 

for JobKeeper. Wage subsidies were received in the New Zealand and 

last from three to seven days were severely affected by prolonged 

Singaporean businesses contributing $2.3 million to other income in 

government restrictions and ongoing bans on catered indoor wakes 

the year.

and gatherings. New Zealand, where traditionally most people are 

embalmed, was also badly impacted. In Australia, we were able 

to leverage our Simplicity and Value Cremations brands to meet 

the market demand for affordable arrangements that combined a 

memorial event with a cremation, reducing the relative severity of the 

financial impact.

On the positive side, InvoCare was able to sustain its very high NPS 

(+79) over the course of the year, in part due to our ability to provide 

online video access to funeral ceremonies, which was offered to 

clients free of charge. We were also able to manage the relatively high 

risks of COVID-19 infections associated with serving many families 

affected by the disease, with no recorded cases of work-related 

Social distancing measures also impacted on the performance 

infections amongst staff or customers throughout the year.

of our Memorial Parks business, albeit to a lesser extent. Chapels 

had reduced capacities due to the two and four-square metre rules 

restricting our full range of services. Offsetting an initial reduction 

in revenue during March and April due to reduced attendance at 

our parks, we have seen strong revenue performance from the 

Memorial Parks business in the second half of the year, particularly 

The majority of our staff voluntarily chose to take one day a week leave 

for several weeks during the first wave of lockdowns in April and May, 

a testament to the One Team culture embedded within the business. 

The Non-Executive Directors also chose to reduce their fees by 25% 

for a period of four months this financial year. 

in memorialisation sales. Also, digital investment was accelerated 

The extraordinary challenges and stresses placed on our staff by 

to ensure our parks had the appropriate AV technology to be able to 

the need to manage COVID-19 restrictions and remain operational 

conduct live streamed funeral services.

With the easing of COVID-19 related restrictions all markets have seen 

a return to more typical patterns of demand for face-to-face services 

and larger funeral gatherings.

despite risks of exposure to the disease have been acknowledged 

and addressed via a heightened focus on mental wellbeing and social 

support. An important challenge for the coming year will be to mitigate 

the cumulative effects of these human impacts while ensuring that we 

sustain high levels of service quality and continue to reduce voluntary 

Operating expenses for the Group included $1.9 million of incremental 

turnover rates.

costs associated with live streaming, cleaning, and personal 

protection equipment (PPE). The ability to travel remains volatile and 

specific safety measures remain necessary. In addition, the funeral 

services industry in Australia was not considered to be an ‘essential 

service’ and therefore the business did not receive any Australian 

Photographs courtesy of Billy Foster Photography

InvoCare            Annual Report 2020  | 15

Performance Review12Directors’ Report3Financial Report4Other InformationOur community

The Queen of Nurses  
Louise Thomson, 1960 – 2021

Our ladies were honoured to farewell an incredible woman, Louise 

Thomson, who dedicated her life to bettering the nursing community. 

Working in consultation with her husband Steve Thomson, White 

Lady Funerals in Melbourne ensured that Louise was farewelled in 

the grandeur befitting her larger-than-life personality and her long and 

accomplished career.

Louise, or Louy as she was affectionately known, left an enduring 

mark on our communities through her work to empower women 

to progress their careers or enrich their personal lives. She was 

farewelled in style in a sea of her favourite colours – hot pink and red – 

with eight adorned horses leading the procession and guard  

of honour.

The Queen of Queensland 
Mabel Crosby, 1909 – 2021

The team at George Hartnett Metropolitan Funerals were 

honoured to host a celebration of the life of Mabel Crosby, 

Australia’s oldest resident, who passed following a brief 

illness at the age of 111.

Mabel’s own desire was for a simple service with just one 

hymn and a single red rose for her coffin, requesting that 

people should honour her passing with donations to 

Vision Australia rather than flowers. 

Farewelled by her three surviving children, 10 

grandchildren, 20 great grandchildren and 9 great, great 

grandchildren, Mabel’s long life was a testament to 

the tough and pioneering spirit that has 

been so important to the development of 

Australia as we know it today.

InvoCare            Annual Report 2020  | 16

Making it personal 
Life Art

An area of focus is to increase the variety of ways in which customers 

might choose to memorialise a life; Life Art is a business that offers 

personalised artwork on coffins that reflect the special character or 

passion of the loved one whose life is being celebrated.

LifeArt predesigned  
or customised coffins

Making it personal  
Luteru Reupena

A personal passion for honouring the 

end of life is part of the vocation that calls 

people of all ages and cultures to work in our 

industry. From a Samoan heritage and trained 

as a carpenter, Luteru first learned his carving 

skills working with a professional Samoan carver 

to carving the lecterns, pulpits and icons for his 

church.

In 2017, more than a decade after Luteru chose 

to become a mortician, his skills were called 

upon to carve the coffin of a fellow church 

member. Since then, Luteru has accepted many 

requests for personalised carvings of coffins and 

grave markers. 

                Combining the roles of contemporary funeral professional, traditional 
cultural craftsman and dedicated local community member, Luteru epitomises 

,,
the personal passion that we share for celebrating the end of life.,,

InvoCare            Annual Report 2020  | 17

Performance Review12Directors’ Report3Financial Report4Other InformationInvoCare            Annual Report 2020  | 18

Directors’ Report

InvoCare            Annual Report 2020  | 19

Directors’ Report

Your directors present their report, together with the consolidated financial report 
of InvoCare Limited (the Company) and its subsidiaries (together referred to as 
InvoCare or the Group) for the financial year ended 31 December 2020, along with 
the independent audit report.

The flow of the information in the Directors’ report is outlined in the table below.

Information is only being included in the 2020 Annual 

PAGE 

INFORMATION

Operating and financial review

Report to the extent it has been considered material 

and relevant to the understanding of the financial 

performance and financial position of the Group.

21 

21 

21 

21 

21 

25 

25 

27 

28 

30 

31 

33 

34 

36 

60 

60 

60 

61 

64 

64 

64 

65 

65 

65 

65 

65 

65 

65 

66 

Company overview and principal activities

A disclosure is considered material and relevant if,  

for example:

• •  The dollar amount is significant in size (quantitative 

factor)

• •  The dollar amount is significant by nature 

(qualitative factor)

• •  The Group’s results cannot be understood without 

the specific disclosure (qualitative factor)

• •  It is critical to allow a user to understand the impact 

of significant changes in the Group’s business 

during the period such as business acquisitions 

(qualitative factor)

• •  It relates to an aspect of the Group’s operations 

that is important to its future performance

Review of financial performance

Generating long term shareholder returns 

Profit performance

Portfolio management

Balance sheet

Cash flow

InvoCare business strategy update

2021 outlook

Risks

Reconciliation of financial information

Glossary for operating and financial review

Remuneration report – audited

Other statutory matters

Directors

Directorships of other listed companies

Directors’ profiles 

Meetings of directors

Company secretary

Significant changes in the state of affairs

Dividends

Subsequent events

Indemnification and insurance of officers

Environmental regulation and performance

Corporate governance

Non-audit services

Rounding of amounts

Auditor’s independence declaration

InvoCare            Annual Report 2020  | 20

Directors’ Report

Operating and financial review

Company overview and principal activities

Profit performance

InvoCare Limited (listed on the Australian Securities Exchange, 

The year ended 31 December 2020 has been a year of unprecedented 

ASX:IVC), headquartered in Sydney, is a leading provider of  

disruption. Whilst the success that countries like Australia, New 

at-need and pre-need funeral services in Australia, New Zealand 

Zealand and Singapore have had in controlling COVID-19 has kept 

and Singapore operating a portfolio of national and local brands in its 

their populations safe, the travel restrictions and social distancing 

network of over 278 locations. It also owns and operates 17 private 

initiatives combined with government imposed funeral attendee limits, 

memorial parks providing burial, memorialisation and cremation 

have led to a softening of the funeral services sector.

services respectively. Following acquisitions in 2020, InvoCare is now 

also a leading provider of Pet Cremation services in Australia.

Review of financial performance

To grow earnings per share and total shareholder returns, we seek 

to complement operational execution of our strategy with financial 

discipline, strong portfolio management, balance sheet strength and 

cash flow generation. Set out below is a description of these areas and 

the financial tools we use to measure success:

The Group delivered Operating net profit after tax of $27.3 million 

for the year, a 54% decline on the PCP driven both by a decrease 

in funeral case volume and case average in Australia, New Zealand 

and Singapore and an $18.5 million increase in operating costs. The 

latter includes $5.3 million of significant items arising from reviews of 

carrying values undertaken at the year-end of aged debtors and slow 

moving inventory and $1.7 million of costs associated with the change 

in senior leadership that was announced in the second half. It also 

reflects increased costs of working such as COVID-19 driven PPE 

and live streaming costs and EBA award increases to wages that were 

• •  Financial discipline – Focus on cost control and efficiency to drive 

unavoidable.

positive operating leverage

• •  Balance sheet strength – Maintain funding flexibility and disciplined 

capital management to support growth aspirations

Reported loss for the year attributable to shareholders of $9.2 million 

reflects the impact of $25.5 million of impairments recognised 

with respect to the Group’s goodwill arising from its New Zealand 

• •  Portfolio management – Acting decisively on the allocation of 

operations and of capitalised IT development costs relating to certain 

capital and managing returns from investments

• •  Cash flow generation – Pursue working capital efficiency and 

realisation of profits into cash to reinvest in the business

The Group’s performance in these areas during the financial year ended 

31 December 2020 (2020) is set out on the following pages. The prior 

corresponding period (PCP) is the year ended 31 December 2019. 

Generating long term shareholder returns 

InvoCare seeks to optimise shareholder’s returns through earnings 

per share (EPS) and dividend growth which, if delivered, should 

support share price performance. The Board determined a fully 

franked final dividend of 7.0 cents per share for 2020, taking the 

full year ordinary dividend to 12.5 cents per share (fully franked), 

representing a dividend payout ratio of 61% of Operating EPS. 

The final dividend is payable on 22 April 2021 to shareholders who 

were on the Company’s register as at 4 March 2021, the record date 

for the final dividend. The Dividend Reinvestment Plan continues to 

operate in respect of the final dividend.

2020 
cents

2019 
cents

Movement 
%

Basic earnings per share 
(EPS)

Operating EPS

Final dividend

Total dividend for the 
financial year

Dividend payout ratio (%)

(6.9)

20.4

7.0

12.5

61%

55.8

51.7

23.5

41.0

79%

(112)

(61)

(70)

(70)

modules of the Oracle Enterprise Resource Planning (ERP) system 

rolled out in the PCP. The impairment of goodwill related to the New 

Zealand operations (which represents less than 10% of Group 

Operating EBITDA) reflects the disruption caused by COVID-19 

and the subsequent restrictions imposed by the New Zealand 

government that hampered the Group’s ability to operate as planned. 

New Zealand’s financial performance was significantly impacted 

as a consequence and this has been reflected in long term financial 

projections used to support carrying value testing. The $6.2 million 

partial impairment of certain modules of the Oracle ERP system 

reflects significant remediation in 2020 and the replacement of certain 

functionality that has rendered some elements of the IT platform 

obsolete.

Partially offsetting the impact of these impairments, an assessment 

of carrying values of our memorial parks and crematoria during the 

year has identified an impairment reversal of $6 million with respect 

to Allambe Memorial Park following remediation works undertaken 

over the last two years enabling a gradual return to successful sales 

performance.

Also reflected in the reported loss for the year is a $16.6 million loss 

arising from the mark-to-market accounting for pre-paid funeral 

contracts with a $3.7 million gain on the revaluation of pre-paid funds 

under management (FUM) offset by a $20.3 million increase in the 

associated provision for pre-paid contract liabilities. It should be 

noted that the provision for pre-paid contract liabilities has increased 

in line with expected change in costs to fulfil the contracts. The 

corresponding value of the (independently controlled) funds under 

management reflects the gradual recovery in equities and asset values 

(18 ppts)

over the year from the significant equity market volatility experienced 

in the first half of 2020. This net movement compares unfavourably 

InvoCare            Annual Report 2020  | 21

Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report

Operating and financial review continued

to the PCP where a large $45.6 million net gain on the revaluation of 

Despite such a challenging year, the resilient nature of the funeral 

pre-paid FUM assets was recognised driven by strong returns from 

services industry is reflected in the operating revenue results, with a 

the equities market and property investment revaluations. Importantly, 

stronger Q4 in funeral case volume and case averages stemming the 

the headroom between pre-paid contract FUM assets and pre-paid 

full year operating revenue decline to 4.7%.

contract liabilities remains healthy at $71.8 million at 31 December 2020.

Operating results for 2020

InvoCare considers Operating earnings before interest, tax, 

depreciation and amortisation and business acquisition costs 

(Operating EBITDA) and Operating earnings before interest and tax 

(Operating EBIT) as key performance measures.

Operating EBITDA, EBIT and net profit after tax exclude the following 

items:

• •  The financial impacts of the pre-paid funerals business

A high proportion of our sales are driven through referrals and 

therefore maintaining the quality of our service standards is critical. 

It was a deliberate management decision to maintain full service 

levels at a time of heightened anxiety amongst our client families. 

With employee costs a large proportion of OPEX this meant that 

fluctuations in revenue had a consequential impact on Operating 

EBITDA, which reduced 29% on the PCP and is reflected in the  

7.1 ppts increase in OPEX to sales % metric to 54%.

Cost savings achieved in employee expenses from leave initiatives, 

reduction in temporary labour and restructuring activities undertaken 

in response to COVID-19 have been offset by a number of additional 

• •  Other non-operating activities, including asset sale gains/losses, 

expenses including contractual wage increases of c.3%, $5.3 million 

impairment losses and restructuring costs as relevant

• •  Net finance costs associated with the pre-paid funerals business

• •  The tax effect of the above items

A reconciliation of operating to statutory financial results is included on 

page 33.

Set out in the table below is the operating result and key performance 

metrics:

Revenue

Expenses

EBITDA

Depreciation and 
amortisation

2020 
$’000

2019 
$’000

Movement 
%

476,249

499,665

(373,684)

(355,232)

102,565

144,433

(44,280)

(36,973)

Business acquisition costs

(1,918)

(2,021)

EBIT

56,367

105,439

Net finance costs

(20,484)

(23,213)

Profit before income tax

35,883

82,226

Income tax expense

(8,405)

(23,024)

Non-controlling interest

(167)

(136)

Operating net profit after 
income tax

27,311

59,066

(4.7)

(5.2)

(29)

(20)

5.1

(47)

12

(56)

63

(23)

(54)

of costs arising from the increases in provisions for aged debtors and 

slow moving inventory and $1.7 million of costs associated with the 

change in senior leadership announced in the second half.

Depreciation and amortisation expense increased $7.3 million or 

20% on the PCP driven by increased depreciation of leasehold 

improvements arising from completed Network and Brand 

Optimisation (NBO) projects and amortisation of captialised IT 

costs relating to the implementation of the Oracle ERP system. The 

impairment of the latter as previously disclosed, has been recognised 

within non-operating expenses.

Net finance costs have declined $2.7 million reflecting the benefit of 

repaying $111.8 million of borrowings following the successful capital 

raising in April and May 2020.

Operating revenue by region

By regions

Australia

New Zealand

Singapore

Total

2020 
$’000

2019 
$’000

Movement 
%

404,855

421,863

51,990

56,579

19,404

21,223

476,249

499,665

(4.0)

(8.1)

(8.6)

(4.7)

OPEX to sales %*

EBITDA margin (%)

EBIT margin (%)

Operating EPS (cents per 
share)

53%

22%

12%

46%

29%

21%

(7.1 ppts)

(7.4 ppts)

(9.3 ppts)

20.4

51.7

(61)

*    OPEX excludes finished goods, consumables and funeral 

disbursements.

InvoCare            Annual Report 2020  | 22

Operating EBITDA and EBIT by region

By regions

Australia

New Zealand

Singapore

Total

Operating results by revenue type

2020

Case volumes (number)

Revenue

EBITDA

EBITDA margin (%)

EBIT

2019

Case volumes (number)

Revenue

EBITDA

EBITDA margin (%)

EBIT

Australia

Funeral services

The Australian funeral services business experienced challenging 

market conditions, notably in Q2 and Q3. It finished the year with 

a 7.2% decrease in revenue overall attributed primarily to a 4.5% 

reduction in funeral case average and to a lesser extent a reduction in 

volume, which had recovered in most states by the end of the year and 

grew 3% on the PCP in Q4.

Despite decreases in revenue earned from professional service 

fees and items such as catering and transport services, which were 

unable to be provided in a lot of instances in line with social restriction 

requirements, the business also observed changes in category spend 

by client families, with the inability to hold in-person farewells driving 

an increase in coffin and floral arrangement spend, particularly at the 

height of lock downs.

The trend observed in the first half of an increase in demand for simpler 

funerals and direct cremations continued into Q3 as travel restrictions 

and attendee limits hampered the ability for client families to conduct 

full service farewells, but, as restrictions eased demand for full service 

offerings has slowly recovered.

Operating EBITDA

Operating EBIT

2020 
$’000

2019 
$’000

Movement 
%

2020 
$’000

2019 
$’000

Movement 
%

84,395

121,627

8,778

9,392

12,889

9,917

102,565

144,433

(31)

(32)

(5.3)

(29)

44,746

88,868

3,416

8,205

7,855

8,716

56,367

105,439

Funeral  
services 
$’000

44,784

349,297

80,035

23%

49,673

46,171

377,525

107,853

29%

81,813

Memorial  
Parks 
$’000

Pet  
cremations 
$’000

Support  
office 
$’000

122,310

57,632

47%

51,661

121,324

63,150

52%

57,275

4,642

502

11%

(301)

816

(1,239)

(152%)

(1,580)

-

(35,604)

-

(44,666)

-

(25,331)

-

(50)

(57)

(5.9)

(47)

Total 
$’000

44,784

476,249

102,565

22%

56,367

46,171

499,665

144,433

29%

(32,069)

105,439

The business was also able to respond to this change in market 

demand notably with our Simplicity brand, which offers client families 

an arrangement that combines a memorial event and cremation 

at an affordable price. In addition, despite a weaker April and May, 

packages put together in our White Lady and traditional brand 

locations meant we could still provide client families with higher 

service arrangements that were meaningful farewells but just of a 

smaller size. Live streaming was also provided to client families at no 

additional charge. This continuation of high-quality service has been 

reflected in the business’ NPS score of +79 for the year.

Overall funeral case volume in Australia declined 2.5% compared to 

the PCP with a strong second half in both New South Wales and West 

Australian businesses partially offsetting declines experienced in 

Victoria and Queensland. Victoria notably was hard hit by lockdowns 

in Q3 compared to other states.

As noted previously, the focus on maintaining client service 

throughout the pandemic and the fixed cost nature of the funeral 

services business has meant that the revenue decline has been 

transmitted directly to Operating EBITDA, which has decreased by 

27%, and EBITDA margin has dropped 5.5 ppts. Despite actions 

taken during the year to reorganise the business on a regional basis 

InvoCare            Annual Report 2020  | 23

Performance Review12Directors’ Report3Financial Report4Other Information 
Directors’ Report

Operating and financial review continued

and to remove layers of middle management that resulted in second 

half employee cost savings, increased marketing costs in the first 

half to protect volumes in a market where we couldn’t offer our usual 

product and services, the increase in facilities costs arising from NBO 

locations, the impact of incremental COVID-19 driven costs and the 

increase to provisions for aged debtors noted previously, have driven 

a 5.8% increase in operating expenses for the year.

Pre-paid funerals

The recognition of a reported loss for the year partly reflects the 

impact of non-cash movements in our pre-paid funerals business’ 

funds under management (FUM). Reported profit of $63.8 million in 

the PCP included a net $45.6 million mark-to-market (MTM) gain on 

the revaluation of undelivered pre-paid FUM and contract liabilities. 

New Zealand

Total revenue for the New Zealand business declined 8.1% on the 

PCP driven primarily from a 6.7% decline in case average and to a 

lesser extent volume decline.

The restrictions placed on funeral services in New Zealand were more 

extreme than in Australia with no funerals or tangihanga permitted 

in late March into April (direct cremation or burials only). This led to a 

25% decline in Q2 funeral case averages alone in this business.

Similar trends to Australia were observed in revenue drivers of case 

average decline with a reduction in professional service fees the main 

contributor but reduced catering services have had a greater impact 

on case average than in Australia, as attendee limits reduced demand 

Market volatility (particularly in equity markets) in 2020 arising from 

for this service significantly.

COVID-19 uncertainty has held asset valuations relatively flat, 

resulting in a net $17 million MTM loss for 2020 (which reflects a 

material improvement on the $39.5 million half year net loss recorded 

at 30 June 2020). It is primarily for this reason that the Company has 

historically distinguished its results on an operating versus non-

Despite restrictions on the level of service that was able to be provided 

to client families, the hard work and dedication of our employees to 

support our client families through these difficult periods was reflected 

in growth in the business’ NPS score by 2 ppts to +86.

operating basis to exclude the impact of such material, non-cash 

Overall, the New Zealand funeral case volume declined 4.9% 

movements. Importantly, FUM asset headroom (defined as pre-paid 

compared to the PCP driven primarily by a weaker Q2 and Q3 with the 

contract assets less liabilities) at 31 December 2020 remains strong at 

country experiencing a benign winter flu season (like Australia), but 

approximately $72 million.

Memorial Parks

COVID-19 led to reduced patronage at the parks with the cancellation 

of many community events, particularly in the first half of the reporting 

period. Despite this, the Memorial Parks business recorded strong 

growth in memorialisation sales in the second half of the year, 

notably from sales from deepening relationships with local religious 

communities at some of our largest parks. This growth, together 

with a favourable release of revenue deferred on transition to  

AASB 15 Revenue from Contracts with Customers as instalment 

payers completed their plans, drove an overall increase in revenue of 

1% against the PCP.

Operating EBITDA was down 8.7% on the PCP as operating costs 

increased with the shift to live streaming of memorial services, 

increased cleaning to protect client families and employees, and 

increased grounds maintenance costs. An additional provision for 

slow moving inventory of $2.5 million has also been recognised 

following a review of slow-moving inventory items. The provision mainly 

relates to single-site niche walls and specific memorial developments 

that have not achieved expected sales since construction.

Pet cremations

The pet cremations business in Australia continued to grow and was 

largely untouched by COVID-19. The greenfield development on the 

existing NSW Lakeside Memorial Park continued to ramp up and 

the second greenfield development on the NSW Central Coast had 

reached practical completion in June.

In November, the Group acquired two pet cremations businesses, 

Family Pet Care and Pets in Peace, representing a strategic expansion 

of the Group’s existing pet cremations business. Both of these 

businesses contributed only one month of trading results in the year.

volumes have slowly recovered over Q4.

The New Zealand funeral services market remains fragmented across 

regional areas and competition, particularly on price, has been 

increasing along with an observed increase in client family preference 

for simpler funerals and cremations for their loved ones. COVID-19 

has accelerated this change, with government restrictions on the 

number of funeral attendees and economic pressure on household 

incomes. This trend has a greater impact in New Zealand, where 

traditionally most people are embalmed, and the business does not 

currently have the breadth of brand portfolio in every local market 

to the extent we do in Australia, to quickly meet such changes in 

consumer demand. As a result, a review of the assumptions used 

in the long-term modelling to support the carrying value of the New 

Zealand group of cash generating units (CGUs) was made at the 

balance date and an impairment of $19.3 million of the goodwill 

allocated to this group of CGUs was recognised.

Singapore

Total revenue for the Singaporean business declined 8.6% with the 

funerals market negatively impacted by prolonged funeral attendance 

restrictions, a ban on catering and a general economic downturn 

in the country all of which has heightened price competition and 

reduced discretionary spend attached to higher service offerings. 

Declines in revenue have been driven both by funeral case average 

and volume declines.

InvoCare            Annual Report 2020  | 24

Funeral case average has declined 6.5% for the year with an 

increase in consumer preference for direct cremations as higher 

service, catered wakes and gatherings not permitted by government 

authorities. Similarly, funeral case volume has declined 5.3% on the 

PCP with an increase in competition observed in the market due to the 

low barriers of entry to the lower service, and direct cremation.

Disciplined cost control in the Singaporean business has held OPEX 

as a % of sales to 32% and improved EBITDA margin 3 ppts to 51% in 

the year despite a decline in Operating EBITDA to $9.4 million.

Balance sheet

InvoCare successfully deleveraged its balance sheet during the 

year via a successful $274 million institutional placement and share 

purchase plan and continues to maintain a strong balance sheet with 

a disciplined focus on working capital management. The Group’s capital 

employed excluding net debt items is comprised of the following.

Total capital employed as at 31 December

2020 
$’000

2019 
$’000

Movement 
%

Support office

InvoCare’s support office includes the centralised costs of 

Procurement as well as Information and Technology (IT), Finance, 

Marketing, Safety, Sustainability, Human Resources and the costs 

Trade and other receivables

82,582

82,794

Inventories

44,117

45,117

Trade and other payables

(60,514)

(60,810)

associated with the CEO, Company Secretary and Board. The 

Net working capital

66,185

67,101

increase in support office costs is attributed to a step up in IT related 

software license costs incurred by the Group following system 

investments in the current and prior year and $1.7 million of  

one-off transition costs incurred as a result of the appointment of  

new executive leadership during the year.

Portfolio management

Decisive action to invest, restructure or divest non-core operations 

while fulfilling the Company’s investment and strategic priorities is vital 

to managing InvoCare’s portfolio of operations.

Acquisitions

In July, the Group acquired Galaxy Funerals for $5.9 million,  

$5.3 million of which is deferred as it is contingent on achieving 

earnings targets over the next two years. Galaxy Funerals is a Sydney 

based funeral business with two locations that specialise in serving 

the Asian community. The acquisition represents an investment in the 

strategic priority of growing presence in the inclusive funerals market.

In November, the Group acquired two pet cremation businesses as 

noted previously for $49.8 million, $11.9 million of which was deferred 

and is contingent on achieving earnings targets over the next two 

years. These acquisitions represent a strategic expansion of the 

Group’s existing pet cremation businesses in NSW, positioning the 

Company to be Australia’s leading provider of pet cremation services 

in a growing industry.

Disposals

As part of the NBO project, sites that have been identified as non-core 

(0.3)

(2.2)

0.5

(1.4)

8.7

16

24

5.5

37

(73)

1.1

3.2

Property, plant and 
equipment

464,277

426,955

Intangibles

243,515

210,724

Net pre-paid funds under 
management/contract 
liabilities

71,822

94,006

Deferred selling costs

37,712

39,928

Deferred contract assets

4,066

6,449

Net right of use asset and 
lease liabilities a

(11,346)

(6,561)

Deferred revenue

(137,718)

(139,300)

Net tax items

Other items b

(34,513)

(35,639)

(34,632)

(16,716)

(107)

Total capital employed

669,368

646,947

Net debt

Net assets

(137,468)

(349,968)

531,900

296,979

3.5

61

79

Average working capital % 
of sales c

ROCE % d

14%

8.6%

10%

17%

4.0 ppts

(8.5 ppts)

a    Excludes certain finance leases which are considered ‘debt-like’ and 

included in net debt balance.

b    Includes assets held for sale, other financial assets, derivative financial 

instruments, provisions for employee entitlements and deferred 
consideration.

c    Represents the average working capital for the reporting period 

(average of opening and closing) divided by revenue for the same 
period.

are sold to realise their value. During the year the Group disposed of 

d    ROCE = Operating EBIT/(Average total equity + Average net debt).

six locations, four in Australia and two in New Zealand for combined 

proceeds of $11.9 million giving rise to a gain on disposal recognised 

through non-operating profit of $7.4 million.

Disciplined working capital management and the $5.3 million impact 

from the review of trade receivable and inventory carrying values at 

year end held working capital relatively steady on the PCP. Despite 

this, average working capital as a % of sales has increased 4 ppts in 

the year as the nature of inventory balances (primarily memorialisation 

items like crypts) do not fluctuate materially in response to revenue.

InvoCare            Annual Report 2020  | 25

Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report

Operating and financial review continued

Total capital employed has increased by 3.5% reflecting the continued 

After accounting for borrowings, capitalised loan establishment costs, 

capital investment in property, plant and equipment arising primarily 

finance leases and a cash position of $118.8 million the Group’s net 

from the NBO program, an increase in intangibles arising from the 

debt as at 31 December 2020 was $137.5 million, a 61% decrease on 

acquisitions and continued capitalisation of IT development costs.

the PCP.

ROCE has deteriorated, reducing 8.5 ppts to 8.6%. This reflects 

InvoCare successfully deleveraged its balance sheet during the year 

reduced Operating EBIT in the year (as explained above) and an 

and undertook two key initiatives:

enlarged capital base driven by the equity raise. The $274 million of 

funds raised from the institutional placement and share purchase plan 

in April/May has been used to continue the roll out of NBO, shared 

service centres and IT projects and fund the acquisitions conducted 

during the year.

Included in the increase of property, plant and equipment is  

$39.5 million associated with the continuation of the NBO project as 

well as IT development costs. It was also impacted by the $6 million 

increase in the value of cemetery land reflecting a reversal of a portion 

of the previous impairment at Allambe Memorial Park (refer to  

Note 11 Non-current operating assets).

The net $32.8 million increase in intangible assets is net of the 

$52 million impact of acquisitions in the year and the $25.5 million 

impairment of the goodwill relating to the New Zealand business and 

of capitalised IT development costs previously referred to in this report 

(refer to Note 12 Intangibles).

The decrease in net pre-paid funds under management/contract 

liabilities of $22.2 million is driven by higher redemptions following 

service delivery and an increase in the provision for pre-paid contract 

liabilities of $20.3 million (2019: $20.3 million) reflecting the financing 

charge recognised on the liability. The 2019 net pre-paid funds 

under management of $94 million reflected a net $45.6 million gain 

on the revaluation of these balance sheet items. Equity market 

volatility, particularly in the first half due to uncertainties regarding 

COVID-19, have stabilised in the second half resulting in a significantly 

lower gain of $3.7 million from the mark-to-market revaluation 

of these independently controlled funds at 31 December 2020. 

Notwithstanding this impact in 2020, significant headroom  

between the asset and liability remains healthy at $71.8 million at  

31 December 2020.

Net debt as at 31 December

2020 
$’000

2019 
$’000

Movement 
%

Cash and cash equivalents

118,781

19,560

Borrowings

(246,039)

(357,189)

Net right of use asset and 
lease liabilities

(10,210)

(12,339)

Net debt

(137,468)

(349,968)

Total shareholders’ equity

531,900

296,979

507

31

17

61

79

Gearing ratio (spot) %

Leverage ratio (times)

Interest cover ratio (times)

21%

1.3

8.3

54%

2.4

10.1

(34 ppts)

1.1

1.8

• •  Conducted a well-supported institutional placement and share 

purchase plan that raised $274 million of capital in April/May with a 

small discount to prevailing share price ($270.9 million net of raise 

costs)

• •  On 19 June 2020, the Group successfully renegotiated its three 

year $200 million revolving debt facility, extending its maturity 

to February 2023, as it was due to expire in February 2021. This 

facility remains undrawn

Both these measures provide the Group with balance sheet flexibility 

to support the business during the period of economic uncertainty 

and to fund growth initiatives, and also allowed repayment of  

$111 million of borrowings during the year.

The Group has access to $452.5 million of loan facilities at  

31 December 2020 as follows:

• •  10 year $100 million Note Purchase Agreement with Metlife,  

fully drawn at 31 December 2020 and due for repayment in 

February 2028

• •  5 year Syndicated Facility Agreement supported by ANZ, HSBC, 

Westpac, Mizuho and SMBC providing $152.5 million (fully drawn) 

and $200 million (undrawn) due for repayment in February 2023. 

The facilities are multi-currency with NZ$50 million drawn with 

respect to New Zealand and SG$35 million drawn with respect to 

Singapore

The foreign currency drawings naturally hedge InvoCare’s 

investments in the Singapore and New Zealand markets.

The financial covenant ratios included on the debt facilities differ from 

the calculations included in the table above as they are calculated on 

an adjusted Operating EBITDA basis (primarily to include the proforma 

earnings contributions from acquisitions and to adjust for costs arising 

from restructuring initiatives). The covenant target ratios are as follows:

• •  Leverage ratio (being net debt to adjusted Operating EBITDA) must 

be no greater than 3.5x

• •  Interest cover ratio (being adjusted Operating EBITDA to net 

interest adjusted to remove interest related to AASB 16 lease 

accounting) must be greater than 3.0x

The above ratios continued to be met as at 31 December 2020, being 

1.3x and 8.3x, respectively (2019: 2.4x and 10.1x, respectively).

To maintain certainty over cash flows, the Group also has financial risk 

management policies limiting exposure to interest rate fluctuations. In 

accordance with InvoCare’s policy, at 31 December 2020, 58% (2019: 

94%) of the debt principal was at fixed interest rates through using 

either floating to fixed interest rate swaps or fixed rate debt (notably 

the $100 million Note Purchase Agreement).

InvoCare            Annual Report 2020  | 26

Due to the level of stability of Singaporean interest rates and its 

The Group ended the period with cash on hand of $118.8 million and 

quantum, Singapore dollar debt is not covered by interest rate swaps. 

improved its cash conversion to 107% (2019: 82%).

Additionally, due to low volatility of interest rates the Group’s policy has 

been amended and no new interest rate swaps will be taken out whilst 

low interest rates continue. Existing swaps in place will be allowed to 

expire.

Despite a reduction in business activity during the year, a disciplined 

focus on current year cash collections and a reduction in tax and 

finance costs paid has led to growth in operating cash flows of 7.6%. 

This has also led to improved cash conversion and realisation ratios as 

While there is the ability to pay down an additional, material amount 

more earnings were converted into cash.

of debt, the fixed term nature of these drawn facilities means that 

repayment would result in retirement of such debt. A review will 

be undertaken in the first half of 2021 to determine an appropriate 

structure and tenure of the Group’s debt facilities.

Cash flow

Investing cash flows for the year of $84 million includes $38.5 million 

for the purchase of the two pet cremation businesses and the Galaxy 

Funerals business (excluding the amounts deferred as previously 

noted) and proceeds of $11.9 million from the disposal of certain 

properties as part of our ongoing portfolio management activities.

Capital expenditure (CAPEX) of $68.1 million in the year included 

InvoCare aims to use cash generated from operations to pay down 

$39.5 million of NBO related expenditure and $16.2 million of 

borrowings, fund capital expenditure and bolt-on acquisitions and 

IT related projects. The remainder relates primarily to annual 

return dividends to shareholders.

maintenance CAPEX of the Group’s facilities.

Net financing cash flows includes the impact of the $270.9 million 

capital raise net of raise costs, the subsequent $111.8 million 

repayment of debt and $3.1 million of payments made to exit related 

interest rate swaps early following repayment of a debt as noted 

previously. In addition, the deferred 2019 final dividend was paid in 

October 2020.

Cash conversion % calculation

Operating cash flows

2020 
$’000

2019 
$’000

63,568

59,070

Add back: Net finance costs paid

17,046

20,803

Add back: Tax paid

14,424

20,631

Net funds from pre-paid contracts

12,857

15,866

Other cash flows related to pre-paid 
contracts

1,429

2,406

Ungeared, tax free operating cash flows

109,324

118,776

Operating EBITDA

Cash conversion %

102,565

144,433

107%

82%

The conversion ratio calculation and the line items as shown in the 

table above are all non-IFRS information, however, all financial data is 

based on the information disclosed in the audited financial statements 

and notes to the financial statements and follow the recognition 

requirements of Australian Accounting Standards.

Abridged cash flow for the year ended 31 December
Movement 
%

2020 
$’000

2019 
$’000

Operating EBITDA

102,565

144,433

Net change in working 
capital

(7,527)

(43,929)

Net finance costs paid

(17,046)

(20,803)

Tax paid

(14,424)

(20,631)

Operating cash flows

63,568

59,070

Acquisitions

(40,581)

(15,187)

Divestments/sale of assets

11,908

6,550

Capital expenditure

(68,136)

(65,289)

Net funds from pre-paid 
contracts

12,857

15,866

Investing cash flows

(83,952)

(58,060)

Dividends paid

(29,514)

(32,863)

(29)

(83)

18

30

7.6

(167)

82

(4.4)

(19)

(45)

10

Equity raise (net of raise 
costs)

270,875

85,787

216

Net draw down/repayment 
of borrowings

(106,761)

(53,103)

Net lease payments

(11,599)

3,625

Other

(3,184)

258

Financing cash flows

Change in cash held

Cash conversion %a

Cash realisation %b

119,817

99,433

107%

89%

3,704

4,714

82%

62%

(101)

420

(1,334)

(3,135)

2,009

25 ppts

27 ppts

a  Cash conversion % calculated as per table below.

b    Cash realisation % means Operating cash flows as a % of operating 

profit after income tax for the period adjusted to remove depreciation 
and amortisation expense.

InvoCare            Annual Report 2020  | 27

Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report

Operating and financial review continued

InvoCare business strategy update

In 2016 the InvoCare Board recognised that acquisitions alone  

could not continue to drive EPS growth at the same level as  

historically achieved. Regulatory limits on further acquisitions in 

Australian metropolitan markets imposed by the ACCC and the 

growing demand for personalised funeral celebrations in modern,  

non-religious surroundings led to a shift in focus to updating existing 

facilities, products and service capabilities to meet contemporary 

expectations.

During 2016 and 2017, comprehensive plans were developed for 

a major transformation of the Group’s physical network to ensure 

that the Group’s facilities and product offerings were appropriate 

to drive organic growth into the future. The rollout of this Protect & 

share decline, increasing revenue by providing increased product 

offerings to meet the changing needs of client families and creating 

opportunities to drive operational efficiencies. The rollout of this 

strategy continued in 2020.

Network and brand optimisation (NBO)

A core focus of the Protect & Grow strategy has been the NBO 

program which is transforming InvoCare’s unrenovated, out-of-date 

and underperforming funeral homes into modern, contemporary 

locations with new capabilities that allow for additional service levels 

that are in-tune with client families’ needs and preferences. The 

following tables provide a summary of the completed projects since 

the commencement of the project in 2017 and the projects planned 

Grow strategy was started in 2017, with a focus on reversing market 

for completion in 2021.

Year completed/due

2017

2018

2019

2020

Refresh

Enhance

Growth

Total

CAPEX ($m)

Acquired properties ($m)

Sites sold (Number)

Proceeds ($m)

26

-

4

30

(21.0)

(8.3)

2

6.1

32

7

16

55

(39.2)

(1.2)

1

0.7

15

2

4

21

54

7

2

63

Total

127

16

26

169

(26.5)

(39.5)

(126.2)

-

3

3.1

-

6

12.0

(9.5)

12

21.9

2021 
estimate

40-50*

~2

*  Number of projects is approximate and subject to change

The total amount of capital deployed for NBO sites is $126.2 million 

As noted at half year, the restrictions and social distancing have had 

by the end of the four years to date. Offsetting this is $21.9 million of 

a greater impact on the renovated locations than the unrenovated 

proceeds from the sale of identified non-core sites as a result of this 

locations due to the low attendance at funerals negatively impacting 

program.

As part of the Group’s response to COVID-19 earlier in the year, 

CAPEX was delayed or deferred until such time as the full impact on 

the business was known. Despite a resumption of NBO activity in 

the second half, some projects have been delayed and are due to be 

the locations that are able to provide a wider range of services. 

Therefore, when assessing performance of NBO locations, 2020 

provides an abnormal trading year for comparison. It also makes it 

difficult to ascertain the drag on earnings that may have come from 

closed sites due to renovation and construction.

completed in early 2021. Notwithstanding the COVID-19 driven delay, 

The first cohort of 48 sites that were completed between June 2017 

a total of 63 projects were completed during the year. A further 40-50 

and July 2018 have now had two years of post completion trading for 

sites are planned for works in 2021, subject to business case and DA 

comparability purposes. Projects completed post that date have the 

approval.

abnormal 2020 trading conditions to cycle in their post completion 

returns assessments. 

It should be noted that there are around 50 to 60 locations remaining 

that do not form part of the NBO program of works. These are 

locations that either do not require renovation or are intended to be 

sold. Additionally, future Refresh renovation type activity will form part 

of the annual maintenance CAPEX budgets of the network from 2021.

Work will continue Enhance and Grow projects, to be categorised as 

Growth CAPEX and subject to disciplined capital approval processes.

InvoCare            Annual Report 2020  | 28

When comparing the growth in net sales of this cohort and growth in EBITDA margin (both pre NBO to now), those sites that were Enhance 

or Growth locations continue to outperform other locations both in volumes and sales. This is shown in the graph below.

Positive

EBITDA 
margin

(2016 – 
2020) 
versus 
Average

Average

Enhance/Growth 

location (first cohort)

Refresh location  

(first cohort)

Unrenovated 

location (as of 

December 2020)

Negative

Negative

Average

Positive

Net sales  (2016 – 2020) versus Average

How to read the above graph:

Operational efficiencies

• •  Locations plotted include unrenovated sites (as of December 

2020) and the 48 Refresh and Enhance/Grow NBO sites that were 

completed in the first cohort (2017 to July 2018)

As noted at half year, the roll out of the Oracle ERP system for the 

funeral services businesses in Australia and New Zealand is now 

complete (except for acquisitions and the Memorial Parks business, 

• •  Bubble size reflects NBO CAPEX spend per location

which is a focus in 2021). Initial implementation issues are being 

• •  Average is the average of all funerals locations in Australia and New 

Zealand including those that have been renovated after July 2018 

and those identified as not requiring NBO investment

• •  The horizontal axis is the growth in revenue (excluding 

disbursements) for a location relative to the average

• •  The vertical axis is the change in EBITDA margin of that location 

over the same period relative to the average

• •  The closer a bubble appears towards the top right of the chart, the 

better it has performed relative to the average for the same period.

addressed and the current year remediation activities undertaken 

is what has driven the $6.2 million of impairment of capitalised IT 

development costs.

In addition, four shared service centre projects were completed in 

the year with a further six to eight planned for 2021. A summary of the 

amount spent on IT investment and shared service centre projects 

from 2017 to 2020 is included in the table below.

CAPEX spend

Information technology ($m)

Shared service centres ($m)

2017

(6.7)

-

2018

(12.4)

(2.2)

2019

(7.6)

(7.9)

2020

(8.6)

(1.2)

Total

(35.3)

(11.3)

2021 
estimate

6-8 sites*

*  Number of projects is approximate and subject to change

InvoCare            Annual Report 2020  | 29

Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report

Operating and financial review continued

People & Culture

2021 outlook

InvoCare is acutely aware of the additional pressures our employees 

InvoCare remains cautious in its outlook with short term market 

faced throughout the COVID-19 crisis. Working with grieving families 

conditions still being impacted by COVID-19 restrictions and the 

is highly emotional and demanding. In a COVID-19 impacted world, 

timing and extent of the unwind of related impacts remains hard to 

our team have strived to meet and exceed government guidelines to 

predict.

ensure the safety of themselves and their client families and friends. 

Those guidelines impact many aspects of the way funerals are 

planned and managed including restrictions on the attendance at 

funerals.

The Group remains nevertheless confident about the long term 

potential of this business with future growth underpinned by 

population and ageing trends in its markets, and management 

have initiated an operating model and cost efficiency review to 

NPS is a our key measure of customer satisfaction and the fact that 

further strengthen the business foundations. With an experienced 

the Group overall (excluding Singapore, which is not measured by 

team, strong national and local brands, a modernised asset base 

this metric) has been able to maintain or grow their NPS scores during 

and leading market position, the Company’s management see 

the year is a testament to the quality of the service that our employees 

many opportunities to leverage and optimise the foundations 

provide. The NPS result of +79 in 2020 also compares favourably to 

of the business to meet the evolving needs of client families and 

the NPS achieved at the beginning of the Protect & Grow strategy 

communities with an expanding value proposition. The Company will 

in 2017 of +74, a 5 point increase over the three years. This reflects 

also look to extend its industry leadership through increased focus 

the investment in leadership and management training alongside 

on talent, safety, sustainability, innovation, and proactive stakeholder 

the Group’s cultural and community engagement initiatives and the 

management.

positive impact these are having on both employee and client family 

experiences.

Ensuring the health and safety of our employees and client families 

is our highest priority. At the onset of the COVID-19 pandemic, 

InvoCare created a COVID-19 Taskforce focused on creating safe 

work practices, including infection control procedures, adequate 

personal protective equipment (PPE) availability and usage, cleaning 

guidelines, supporting remote working practices and general 

principles of COVID-19 safety.

Lost time injury frequency rate (LTIFR) is a key metric to measure the 

safety performance of the Group. The LTIFR in 2020 was 12.5, which 

reflects a 1.6 ppts improvement since the renewed strategic focus 

began in 2017. The recent appointment of a new EGM of Health, 

Safety and Sustainability in early 2021 reflects the continued focus on 

safety in our organisation.

Additionally, InvoCare took a proactive approach to the 

implementation of a paid pandemic leave policy in March 2020. We 

have also worked hard to support the new ways of working that have 

come with COVID-19, not only how we engage with each other, 

but also how we engage with our client families. In response, the 

Learning & Development team have delivered many training initiatives 

to employees via virtual platforms this year in order to upskill their 

capabilities in this changing environment.

The focus in 2019 shifted towards training our field team to become 

strong local leaders with a focus on providing the leadership required 

to elicit high levels of discretionary effort which is essential to delivering 

the highest levels of customer service. While this training has been 

put on hold in 2020 due to budgetary and travel constraints imposed 

by COVID-19, it is our intention to resume this program in 2021 as 

high performing, empowered local leaders are an essential part of our 

service proposition.

InvoCare            Annual Report 2020  | 30

Risks

The Company has in place an Enterprise Risk Management Framework. As part of the framework the Group maintains an extensive risk register. 

The most significant risk for annual financial performance is the number of deaths occurring in the markets in which we operate.

The key areas of identified risks are summarised below.

Risk

Description

Risk management mitigation

Number of deaths

• •  Change in mortality rates 

• •  BDM data monitoring and analysis

• •  Relocation of population to areas 

• •  Workforce flexibility

outside InvoCare business operating 

• •  Geographic footprint

regions

• •  Service offerings

• •  Data analytics

Strategic risk

• •  The risk that the Company’s 

• •  Experienced executive team

strategies and growth initiatives 

are not successfully executed or 

integrated or deliver the expected 

returns

• •  Board and CEO sign-off of individual business cases with process in place to 

monitor performance post execution

Competitive risk

• •  Risk from existing and new market 

• •  Focus on client satisfaction via continuous improvements in delivery of 

entrants

customer required products and services

• •  Competitors may offer/develop 

• •  Leveraging existing brands in local markets with strategies to expand market 

superior products/services

share locally

• •  Delivery of superior products/services to exceed customer expectations and 

competitors’ products/services offerings in same operating regions

• •  Focus on local community engagement and relationship to maintain or 

improve competitive advantage

Loss of key brand 

• •  Failure to maintain brand reputation 

• •  Continued investment in customer research to sustain market leading 

reputation/customer 

in market

position

relationships

• •  Failure to react to changes in 

• •  Customer feedback surveys and complaints monitoring

customers’ needs/trends

• •  Products and/or services do not 

keep pace with developments in 

market needs or technological 

advancements

• •  Customers/media complaints

• •  Net promoter score reporting or tracking

• •  Close monitoring of market developments

• •  NBO renovations and transformations of locations and facilities to exceed 

customer expectations

Regulatory risk

• •  Environmental regulations risks

• •  Sustainability plan and commitments

• •  Perpetual care

• •  Consumer Act training for employees

• •  Australian Competition and  

• •  Aligned accountabilities at executive level

Customer Act 2010 (Consumer Act) 

and other related legislations

Safety risk

• •  Occupational, health and safety risks

• •  Behavioural-based safety programmes

• •  Lost Time Injury Frequency Rate metrics reported monthly by business

People risk

• •  Loss of key executives

• •  Appropriate incentives and career development opportunities for key 

• •  Loss of key individuals in operating 

executives and senior management

businesses with consequential 

• •  Identification and management of high potential employees

material business interruption

InvoCare            Annual Report 2020  | 31

Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report

Operating and financial review continued

Risk

Description

Risk management mitigation

Information 

• •  Risk of targeted cyber-attack against 

• •  Cyber-security training

technology (IT) risk – 

Company assets

• •  Dedicated internal resources to monitor and address cyber and information 

cyber risk, privacy  

and data sovereignty

• •  Unauthorised access to or loss of 

risks

customer data including personally 

identifiable data

• •  Risk of data loss/fraud, system 

breakdown

• •  ERP implementation risk

• •  Monitoring and prevention of unauthorised access to IT assets

• •  Code of Conduct is set up and relevant employee training is conducted

• •  Disaster Recovery Plan

• •  Penetration Testing

Reliance on single 

• •  Unable to supply products to deliver 

• •  Dedicated internal resources to monitor supply agreement contracts

point of failure in 

services for families

supply chain

• •  Commercial tendering processes to identify alternative suppliers

• •  Inventory management

Working capital

• •  The risk that the Company cannot 

• •  Six monthly reporting to funding providers on covenant compliance

meet its financial obligations

• •  Quarterly reforecasting and annual budget requiring Board sign off

• •  Regular monitoring and reporting on debtors

Investment risk –  

• •  Potential escalation in service/

• •  Control our cost of service at below 4% inflation factor applied to liability 

pre-paid funeral 

product costs

revaluation annually

contracts

• •  Volatility of investment returns on 

• •  Maintain Board representation in the Over Fifty Guardian Friendly Society, the 

pre-paid funds under management 

main investment portfolio for over 85% of the pre-paid funeral contracts

fluctuation

• •  Ensure the pre-paid funeral contracts are invested in diversified asset classes 

to maximise returns without exceeding risk levels as specified in accordance 

with the Fund investment policy and guidelines

Investment risk – 

• •  Deficiencies in due diligence

• •  Balance sheet management

acquisitions

• •  Potentially unknown or contingent 

• •  Investment Committee scrutinises investment proposals and provides 

liabilities

recommendations to the Board on acquisition decisions

• •  Reliance on previous owners 

• •  Post-acquisition reviews conducted to ensure performance in line with 

performing satisfactorily

expectation

• •  No guarantee of continued 

successful performance of acquired 

businesses

Financing risk

• •  Insufficient funding to capitalise on 

• •  Monthly reporting of financial metrics to the Board and Executive Leadership 

opportunities

Team

• •  Business unit performance reviews and monitoring against budget and 

forecasts

• •  Monitoring of debt covenants and monthly cashflow statements

Lease arrangements

• •  The risk that existing lease 

• •  Monthly reporting to executive on leases due for renewal

agreements are not renewed or not 

renewed at satisfactory levels

• •  Legal review for all lease contracts

A crisis occurs 

• •  A pandemic

• •   Pandemic and Epidemic Diseases Plan in place

threatening the 

Company, our 

stakeholders or the 

general public

• •  Natural disaster occurs such as 

• •  Infectious Disease procedure in place

fire, floods impacting significant 

operations

• •  IT system breakdown

• •  Emergency Management Plans, developed locally with clear escalation 

guidelines to Corporate Emergency Management Plan (EMP)

• •  Disaster Recovery Plan (DRP) in place to manage IT risks

• •  Above plans linked to Business Continuity Plan (BCP) with identified 

processes, roles and responsibilities to mitigate disruption to the business 

and community

InvoCare            Annual Report 2020  | 32

Reconciliation of financial information

The Company results are reported under Australian Accounting 

Standards (AASB). This report and associated market releases 

include certain non-IFRS measures including reference to operating/

non-operating measures of profitability and associated performance 

measures that are used internally to assess the performance of the 

business.

The Company considers Operating EBITDA and Operating profit 

after income tax as key performance measures. These measures 

are considered to provide more useful indications of the Group’s 

recurring earnings base and exclude the impact of significant items 

such as material impairments, asset sales gains/losses and costs 

of restructuring operations. Operating measures also exclude the 

impact of accounting for the Group’s funds under management and 

pre-paid funerals business which requires net gains and losses from 

undelivered pre-paid contracts to be included in reported profit. These 

gains and losses are non-cash and do not impact on the Company’s 

business operations.

The table below presents a reconciliation of statutory results as 

disclosed in the consolidated statement of comprehensive income 

and operating results in Note 1 Operating segments.

Year ended 31 December

Revenue

Expenses

EBITDA

Depreciation and amortisation

Business acquisition costs

Net gain/(loss) on pre-paid contracts

Asset sales gain/(loss)

Impairment loss on intangibles

EBIT

Net finance costs

Tax

Non-controlling interest

2020

Non-
operating 
results 
$’000

Operating 
results 
$’000

Statutory 
results 
$’000

Operating  
results 
$’000

2019

Non-
operating 
results 
$’000

Statutory 
results 
$’000

476,249

1,403

477,652

499,665

683

500,348

(373,684)

(6,350)

(380,034)

(355,232)

(8,026)

(363,258)

102,565

(4,947)

97,618

144,433

(7,343)

137,090

(44,280)

(1,918)

(12)

(44,292)

-

(1,918)

(36,973)

(2,021)

(13)

(36,986)

-

(2,021)

-

-

-

(16,618)

(16,618)

7,383

7,383

(19,500)

(19,500)

-

-

-

45,550

45,550

2,404

2,404

(24,404)

(24,404)

56,367

(33,694)

22,673

105,439

16,194

121,633

(20,484)

(3,386)

(23,870)

(23,213)

(1,247)

(24,460)

(8,405)

(167)

527

-

(7,878)

(167)

(23,024)

(10,261)

(33,285)

(136)

-

(136)

Net profit/(loss) after income tax attributable to 
equity holders of InvoCare Limited

EPS (cents per share)

OPEX to sales %

EBITDA margin (%)

EBIT margin (%)

27,311

(36,553)

(9,242)

59,066

4,686

63,752

20.4

53%

22%

12%

(27.3)

(6.9)

54%

20%

4.7%

51.7

46%

29%

21%

4.1

55.8

48%

27%

24%

The table above summarises the key reconciling items between 

The Directors also consider that the presentation of all activities 

net profit after tax attributable to the Company’s equity holders 

related to the mark-to-market fair value movements in the 

and operating EBITDA and EBIT. The operating EBITDA and EBIT 

independently controlled funds under management and pre-paid 

information included in the table above has not been subject to any 

contract liabilities as non-operating in nature and therefore these are 

specific audit or review procedures by the auditor but has been 

also excluded from Operating EBIT and Operating profit after income 

extracted from the accompanying financial report.

tax. This is considered to provide a better reflection of the Company’s 

As well as impairments and gains or losses arising from disposals 

of assets, items included in the non-operating column include the 

financial consequences of all activities related to the administration and 

financial impacts of the pre-paid funerals business. This has resulted in 

normalisation adjustments to revenue and operating expenses to reflect 

the exclusion of the financial impact of the business.

core business performance and results. It also removes volatility from 

the reported profit and loss that arises from the fair value activities 

required by accounting standards on these pre-paid funerals business 

related assets and liabilities.

InvoCare            Annual Report 2020  | 33

Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report

Operating and financial review continued

Glossary for operating and financial review

Term

AV

Description

Term

Description

Audio visual equipment including technology to 

Interest cover 

Calculated as Operating EBITDA/Net finance 

facilitate live streaming of funeral services

ratio

costs. Interest cover calculation used for bank 

Average capital 

Average of opening and closing capital 

employed

employed

Average working 

Average of opening and closing working capital

capital

Average working 

Average working capital divided by Operating 

capital % of 

Revenue for a 12 month period

sales

B2B/B2C

Business to business/Business to consumer

Compound annual growth rate

Capital expenditure

CAGR

CAPEX

Capital  

employed

covenant testing purposes uses an Adjusted 

EBITDA measure (primarily adjusted to include 

proforma earnings from acquisitions and 

costs arising from restructuring initiatives) and 

adjusted net finance costs to exclude interest 

arising from AASB 16 lease accounting

Leverage ratio

Calculated for disclosure purposes as Net debt/

Operating EBITDA. Leverage calculation used 

for bank covenant testing purposes uses an 

Adjusted EBITDA measure (primarily adjusted to 

include proforma earnings from acquisitions and 

costs arising from restructuring initiatives)

As used in ROCE % calculation. Calculated as 

LTIFR

Lost time injury frequency rate

Total equity + Net debt

Maintenance 

Recurring annual CAPEX required to maintain 

Cash conversion 

Ungeared, tax free operating cash flows divided 

CAPEX

facilities

%

by Operating EBITDA

Memorialisation 

Revenue earned from the sale of memorials, 

Cash realisation 

Calculated as Operating cash flow/ (Operating 

revenue

plaques, burial plots etc. in the Memorial Parks 

%

NPAT + Depreciation and amortisation expense)

COVID-19

COVID-19 pandemic

Dividend payout 

Dividend per share/Operating EPS

MTM

NBO

ratio

business

Mark-to-market

Network & Brand Optimisation program of 

projects as part of Protect & Grow Strategy

EBITDA margin

Operating EBITDA/ Operating revenue

Net debt

Cash and cash equivalents + Borrowings + 

EGM

EPS

Executive General Manager

Earnings per share, calculated as Reported 

profit/(loss)/ weighted average number of 

shares

ERP

Enterprise Resource Planning, the main Oracle 

general ledger financial system used by the 

business

Funeral case 

Calculated as funeral gross revenue (including 

average

disbursements)/funeral case volume

Funeral case 

Number of funeral services undertaken

volume

FUM

Funds under management in the pre-paid 

funerals business

Gearing ratio

Calculated as Net debt / (Net debt + Total 

shareholder’s equity)

Growth CAPEX

CAPEX undertaken to expand existing 

operations or further growth prospects

Finance leases

NPS

Net Promoter Score, calculated based 

on customer feedback with Group score 

representative of Australia and New Zealand 

only

Operating 

Reported profit excluding non-operating items 

earnings after 

and associated tax

tax

Operating 

EBITDA

Operating earnings before business acquisition 

costs, interest, tax, depreciation and 

amortisation

Operating EBIT

Operating earnings before interest and tax

Operating EPS

Operating net profit after tax/weighted average 

number of shares

Operating 

leverage

Means the percentage growth in Operating 

EBITDA divided by the percentage growth in 

Operating revenue

Operating 

revenue

Revenue for the Group excluding revenue 

earned from pre-paid funerals business

OPEX % sales

Operating expenses / Operating revenue

InvoCare            Annual Report 2020  | 34

Term

PCP

PPE

Pet case 

average

Description

Prior corresponding period

Personal protective equipment

Pet cremation revenue/pet cremation volume

Pet cremation 

The number of pets cremated

volumes

Reported profit/

Net profit/(loss) attributed to shareholders of 

(loss)

InvoCare Limited

ROCE %

Calculated as Operating EBIT/Average capital 

employed

Ungeared, tax 

Calculated as operating cash flow excluding 

free cash flows

net finance costs paid and tax paid adjusted by 

net funds from pre-paid contracts (Payments 

to funds under management for pre-paid 

contract sales and receipts from funds under 

management for pre-paid contracts performed) 

sourced from investing cash flows and other 

cash flows related to pre-paid contracts

WFH

Work from home

Working capital

Inventories + Trade and other receivables + 

Trade and other payables

InvoCare            Annual Report 2020  | 35

Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report

Remuneration report – audited

The Board presents the 2020 Remuneration Report for InvoCare in accordance with 
the Corporations Act 2001 and its regulations. This report outlines the key remuneration 
policies and practices for the year ended 31 December 2020. It highlights the link between 
remuneration and corporate performance and provides detailed information on the 
remuneration for Key Management Personnel (KMP).

The Remuneration Report is set out under the following main headings:

PAGE 

SECTION  WHAT IT COVERS 

36 

A 

Who is covered by the report –  

Key Management Personnel 

A.  Who is covered by the report –  
Key Management Personnel

For the purposes of this report, the Key Management Personnel 

37  

39  

41  

47  

57  

59  

B 

C 

D 

E 

F 

G 

Remuneration snapshot 2020 

(KMP) are those persons who have the authority and responsibility 

2020: How did we perform? 

Remuneration governance and framework

Executive KMP remuneration 

Non-Executive Director remuneration 

Additional information 

for planning, directing and controlling the activities of the Group or a 

major operation within the Group as listed in Tables 1 and 2 below.

Table 1 – Independent Non-Executive Directors (NED)

Name

Role

Date  
appointed

Date  
resigned

Bart Vogel

Chairman  

1 October 

N/A

of the Board

2017

Richard Davis

Non-Executive 

21 February 

N/A

Director

2012

Jackie McArthur

Non-Executive 

1 October 

N/A

Director

2018

Megan Quinn

Non-Executive 

1 October 

N/A

Director

2018

Keith Skinner

Non-Executive 

1 September 

N/A

Director

2018

Robyn Stubbs

Non-Executive 

1 January  

1 February 

Director

2017

 2021

Table 2 - Executive Key Management Personnel (Executive KMP)

Name

Role

Martin Earp

Damien MacRae

Managing 
Director and 
Chief Executive 
Officer (MD and 
CEO)

Deputy Chief 
Executive 
Officer (Deputy 
CEO)

Date  
appointed  
as KMP

Date  
ceasing  
as KMP

1 May  
2015

31 December 
2020

5 February  
2018

31 December 
2020

Adrian Gratwicke

Chief Financial 
Officer (CFO)

3 August  
2020

N/A

Josée Lemoine

Former CFO

8 September 
2016

3 August  
2020

InvoCare            Annual Report 2020  | 36

 
 
Management of the Group is delegated to the Executive Leadership 

Team (ELT) comprising Martin Earp’s direct reports. The Board has 

determined that not all members of the ELT are considered Executive 

KMP other than those listed in Table 2 above, as they do not have 

B. Remuneration snapshot 2020
Total fixed 
remuneration 
(TFR)

STI outcome

LTI outcome

NED 
remuneration

responsibility for planning, directing and controlling a substantial part 

The CEO 

The average 

2015 –  

The NEDs 

of the operations of the Company. Periodically, changes are made to 

and the COO 

STI outcome 

100% vested 

received a 3% 

the ELT to reflect the evolving strategy and structure of the Group.

Changes to Executive KMP

During 2020, the Company had the following Executive KMP 

changes:

• •  Martin Earp – Mr Earp determined not to seek re-appointment 

upon conclusion of his six year contract on 31 March 2021.  

On 19 November 2020, the Company announced the appointment 

of Olivier Chretien, as the new Managing Director and Chief 

Executive Officer (MD and CEO) effective 1 January 2021. Mr Earp 

stepped down to support Mr Chretien’s transition into his role from  

1 January 2021. Therefore, Mr Earp ceased as Executive KMP from 

31 December 2020.

• •  Damien MacRae – In support of succession planning for the CEO, 

Mr MacRae was appointed to the role of Deputy CEO on  

1 July 2020, previously from the role of Chief Operations Officer 

(COO). Following the appointment of Mr Chretien, the role of 

Deputy CEO ceased from 1 January 2021. Therefore, Mr MacRae 

ceased as Executive KMP from 31 December 2020.

received a 3% 

for the 2020 

increase to  

year for 

TFR effective  

Executive 

2016 –  

100% vested 

increase to the 

Board base fee 

effective  

1 January 2020

KMP was 

2017 –  

1 January 2020 

27% based on 

0% vested 

their balanced 

scorecard

2018 –  

0% vested

From 1 August 

to 30 November 

2020, the NEDs 

took a 25% 

Board base 

fee reduction 

(COVID-19 

related)

I. 2020 Target pay mix

CEO – Target pay mix

• •  Josée Lemoine – Ms Lemoine resigned from her position of  

36%

Chief Financial Officer and stepped down to assist with the 

transition of her responsibilities to Mr Gratwicke from  

3 August 2020. Ms Lemoine ceased as Executive KMP from  

3 August 2020.

Fixed
remuneration

42%

STI – Cash

STI – Restricted
shares

LTI

8%

14%

Other Executive KMP – Target pay mix

29%

10%

19%

42%

Fixed
remuneration

STI – Cash

STI – Restricted
shares

LTI

InvoCare            Annual Report 2020  | 37

Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report

Remuneration report – audited continued

II. 2020 Remuneration outcome vs financial performance

Element

Purpose

Link to performance

2020 changes and outcome

FIXED REMUNERATION

Total fixed 

TFR (base salary plus fixed cost 

TFR is benchmarked to be competitive to 

There was a 3% TFR increase to the CEO 

remuneration 

benefits) is targeted at the median of 

attract and retain experienced individuals 

and COO (effective 1 January). 

(TFR)

the market for expected performance 

to drive the Company’s strategy. 

with the opportunity to earn above 

median remuneration for exceptional 

performance.

AT RISK REMUNERATION

Promotion of the COO to Deputy CEO 

Changes to TFR are linked to a 

(Effective 1 July) resulted in a 22.7% 

combination of rewarding high 

increase to TFR. For further details, see 

performance, and the capacity to pay.

Section E. II. 

Short term 

STI is awarded for achievement of pre-

The following factors are among those 

Promotion of the COO to Deputy CEO 

incentive (STI)

determined financial and non-financial 

considered by the People, Culture 

(effective 1 July) resulted in an increased 

objectives. This element of remuneration 

& Remuneration Committee (PCR 

STI from 45% to 70% of TFR. For further 

constitutes part of a market competitive 

Committee) in making its assessment on 

details see Section E. III.

total remuneration package and aims 

the achievement of the STI opportunity: 

to provide an incentive for eligible roles 

to deliver annual business plans that will 

lead to sustainable superior returns for 

shareholders. 

STI for Executive KMP is delivered 

through cash with a potential portion that 

can be deferred to be settled in the form 

of restricted shares. 

A deferral STI was introduced to the 

Executive KMP and ELT with the purpose 

to aid retention and align to market 

practices.

For 2020 Executive KMP outcome was 

• •  Financial performance

27% of target. 

There were no deferrals for 2020 as 

total STI payments did not exceed the 

threshold of $150,000. 

For further details of 2020 STI outcome 

refer to Table 6 in Section E.III.

• •  Our customers

• •  Our people

• •  Our safety 

The STI is measured over a one year 

performance period and paid in cash 

with a potential portion subject to deferral 

paid in the form of restricted shares. The 

shares will be held in trust for 12 months. 

Refer to Section D. IV. Remuneration 

framework for further information.

Long term 

The LTI plan is aimed at attracting, 

The Company utilises incentives to align 

Promotion of the COO to Deputy CEO 

incentive (LTI)

rewarding and retaining high performing 

the long-term interests of Executive KMP 

(effective 1 July) resulted in an increased 

Executive KMP, ELT and other nominated 

with those of equity holders and to ensure 

target LTI from 45% to 70% of TFR. 

participants who contribute to the overall 

that the participants are rewarded in line 

medium and long term success of the 

with the economic value created. 

A new LTI plan was introduced for 

2020. For further details of the changes 

Company.

LTI granted are in the form of a 

introduced refer to Section D. IV. 

combination of options and performance 

rights. 

Introduction of two performance 

hurdles – earnings per share (EPS) with 

Participants can choose the mix of 

a weighting reduced to 50% of the LTI 

vehicles that has most appeal to them. 

and the introduction of return on invested 

The value of LTI awards offered in 2020 

was up to a maximum of 85% of TFR for 

capital (ROIC) as a measure rather than a 

gate with a weighting of 50% of the LTI. 

the CEO and up to a maximum of 70% for 

For further details on LTI vesting outcome 

other Executive KMP.

for 2020 refer to 2020 LTI outcome below 

and Table 10 in Section E.VI.c.

InvoCare            Annual Report 2020  | 38

a. 2020 STI outcome

C. 2020: How did we perform?

In the second half of 2020 the PCR Committee reviewed the impact 

that COVID-19 was having on both the short term and long term 

incentives. This required careful and diligent consideration to ensure 

the plans continued to engage and drive performance. As such, the 

decision was made to adjust our financial focus for the remainder of 

2020 and set separate financial STI targets for the second half of the 

year.

All non-financial components of the STI remained unchanged, and 

therefore applied across the full year.

In what has been a year of unprecedented disruption, the Company 

has reported a net loss after income tax attributed to equity holders 

of $9,242,000 for 2020. COVID-19 and the associated government 

restrictions had a significant impact on both the Company’s ability to 

deliver full-service funeral arrangements and on the mortality rate in 

the countries in which its businesses operate.

The Group delivered an Operating EPS of 20.4 cents, 61% below 

the prior year, driven by the decline in operating earnings in the year 

and the dilutive impact of the increased number of shares on issue 

Despite this, business performance in 2020 did not meet agreed 

following the equity raising completed in April 2020.

Further details of the analysis of our financial performance for 2020  

are provided in the Operating and financial review section.

97.4

57.9

70.9

52.4

63.8

51.7

45.2

41.2

54.5

54.8

45.1

42.2

20.4

2020

(9.2)

2014

2015

2016

2017

2018

2019

Reported profit after income tax ($m)

Operating earnings per share (cents)

financial targets and as a result, the full financial portion of STI has 

been forfeited by the Executive KMP.

In the table below, financial targets are set with reference to the annual 

budget for the financial year. Refer to Table 6 in Section E.III for details 

of STI outcome for each Executive KMP.

Component

Financial 
performance

Our  
customer

Our  
people

Our  
safety

2020 
performance 
targets

Group EBIT

Net Promoter 
Score (NPS)

Market share 
growth – year on 
year

Employee 
turnover < 12 
month tenure

Lost time injury 
frequency rate 
(LTIFR)

Weight

50%

10% 

2020 
performance 
outcome

Target was not 
met

Target was 
partially met 

10%

Target was not 
met

10%

Target was not 
met

20% Target was met

b. 2020 LTI outcome

Grant year

2015

2016

2017

2018

Performance 
measure

7-10%  
CAGR in EPS

7-12%  
CAGR in EPS

Result

Proportion of 
award vested

10.3%

100%a

12.3%

100%a

7-12%  
CAGR in EPS

ROIC gateway 
not met

8-12%  
CAGR in EPS

ROIC gateway 
not met

0%b

0%b

a   CAGR is above the top end of performance measure from the grant 

year to the 2019 annual financial results. The vesting tests took place 
after the ASX announcement of the 2019 annual results.

b    Based on the plan rules, no grants can be vested if return on invested 
capital (ROIC) for the year does not exceed the weighted average 
cost of capital in the year of testing.

InvoCare            Annual Report 2020  | 39

Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report

Remuneration report – audited continued

Relationship between remuneration and the Company’s performance

The overall level of Executive KMP reward considers the performance of the Group over several years, with at risk remuneration linked to that 

performance. The remuneration approach, elements and mix have delivered an annualised 15% shareholders’ return (being the sum of cash dividends 

and share price growth) between listing in December 2003 and the end of 2020.

Table 3 outlines the Group’s performance delivered over the last five years. It provides details of the key financial performance indicators which are used 

to determine the STI and LTI outcome over the last five years. This table also shows the STI payout percentage to the CEO and the average payout 

percentage to the other Executive KMP.

Table 3 – Key financial performance indicators

Net (loss)/profit after income tax attributable  
to equity holders of InvoCare Limited ($’000)

Operating EBITDA ($’000)

Operating EBIT * ($’000)

Operating net profit after income tax ($’000)

Basic EPS (cents)

Operating EPS (cents)

Full year dividend per share (cents)

Share price at 31 December ($)

Payout % of Cash STI to CEO

Average payout % Cash STI to other Executive KMP

2020

2019

2018

2017

2016

(9,242)

63,752

41,224

97,439

70,949

102,565

144,433

118,998

124,316

115,344

56,367

27,478

(6.9)

20.4

12.5

11.45

27%

27%

105,439

59,202

55.8

51.7

41.0

13.19

62%

57%

89,366

49,496

37.8

45.2

37.0

10.30

32%

35%

N/A

N/A

63,526

57,417

88.8

57.9

46.0

16.10

69%

67%

64.7

52.4

42.5

13.87

91%

80%

*    Operating EBIT was a financial performance indicator only reported from 2018 onwards, no comparatives are provided for the financial years prior to 

2018.

InvoCare            Annual Report 2020  | 40

 
D. Remuneration governance and framework

I. Guiding remuneration principles

The guiding remuneration principle underlying the executive remuneration philosophy is to ensure the Company rewards and recognises the delivery 

of the Group’s strategy, promoting long term sustainable success, aligning management and stakeholder interests and encouraging behaviours 

reflective of the One InvoCare culture. The Company’s remuneration policy follows six guiding principles:

1    Key performance indicators should balance the near-term focus on current year results to drive value creation and the need for sustainable 

outcomes

2    Performance for incentive plan purposes is measured at the level which best aligns with driving accountability for the delivery of the business 

objectives

3    All variable pay should align reward with the stakeholders and encourage a long-term view

4    It should enable the Company to compete effectively to attract and retain talent

5    Reward must be aligned with, and promote the achievement of the Company’s purpose and consistently demonstrate and promote its Values

6    The KMP and ELT total remuneration is benchmarked to comparable positions in comparably sized companies (taking into account sales revenue, 

market capitalisation and industry), with the value of the incentives included in total remuneration based on amounts that can be achieved when 

overall Group performance targets are met

II. The Company’s remuneration governance framework

Board of Directors

People, Culture & Remuneration Committee*

Management

Ensuring the Group’s remuneration 

Approving the Group’s overall remuneration policy 

Implementing of remuneration policies and 

framework is aligned with the Group’s 

and process.

practices.

purpose, core values, strategic 

objectives and risk appetite.

Reporting to the Board on corporate culture within 

Providing information relevant to remuneration 

the Group and making recommendations to the 

decisions and making recommendations to the 

Determining Non-Executive Directors 

Board regarding corporate governance policies to 

PCR Committee with respect to remuneration 

and Executive KMP remuneration. 

support a strong corporate culture.

arrangements.

Monitoring Executive KMP and the 

Reviewing and recommending to the Chair 

Making recommendations to the PCR Committee 

ELT performance and implementation 

arrangements for the Executive KMP and the ELT in 

in relation to the design and implementation of the 

of the Group’s objectives against 

relation to their terms of employment, remuneration 

remuneration strategy and structure.

measurable and qualitative indicators.

and participation in the Group’s incentive programs 

(including performance targets).

Reviewing and recommending to the Board the 

remuneration arrangements for the Chair and  

Non-Executive Directors of the Board, including 

fees, travel and other benefits.

*    The full charter for the PCR Committee is displayed on the Company’s website

III. Use of remuneration advisors

From time to time, the PCR Committee engages external remuneration consultants to provide independent benchmarking data and information 

on best practice and community expectations. This ensures the Company continually reviews, assesses and adapts the remuneration governance 

functions to assist the Board and the PCR Committee in making informed decisions.

During 2020, the PCR Committee commissioned an external consultancy group to provide the following information:

• •  Executive remuneration alternatives in response to COVID-19

• •  Further work on the new LTI plan

No remuneration recommendations as defined by the Corporations Act 2001 were provided by the external consultancy group.

InvoCare            Annual Report 2020  | 41

Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report

Remuneration report – audited continued

IV. Remuneration framework

TOTAL FIXED REMUNERATION

What is total fixed remuneration 

Base salary, superannuation and any other benefits e.g. motor vehicle.

(TFR)?

How is TFR determined?

TFR (base salary plus fixed cost benefits) is targeted at the median of the market for expected performance 

with the opportunity to earn above median remuneration for exceptional performance. 

TFR is benchmarked to be competitive to attract and retain experienced individuals to drive the Company’s 

strategy. 

Changes to TFR are linked to a combination of rewarding high performance, and market equity.

SHORT TERM INCENTIVE

What is the purpose of the short 

STI aims to provide an incentive for the Executive KMP and the ELT to deliver annual business plans that will 

term incentive (STI) plan?

lead to sustainable superior returns for shareholders. Target based STIs are intended to modulate the cost to 

the Group of employing senior executives, so that risk is shared with the senior executives themselves and the 

cost to the Company is reduced in periods of poor performance. 

This year we have introduced a deferral to the Executive KMP and ELT STI plan with the purpose to aid 

retention and align to market practices. 

The STI plan has been developed to reinforce the Company’s values and behaviours, while supporting a 

commercial mindset and alignment to business objectives.

What is the performance period?

The Group’s financial year from 1 January to 31 December.

What is the award opportunity?

In 2020 target STI as a percentage of TFR was 51.4% for the CEO and 70% for the other Executive KMP.

What key performance  

STI outcome is directly linked to both individual and Group performance against KPIs. The Board has focused 

indicators (KPIs) are measured  

the Executive KMP on four main areas:

for STI to be paid?

• •  Financial performance

• •  Our customers

• •  Our people

• •  Our safety

STI attainment is determined excluding the impact of changes in accounting standards. For further details of 

2020 STI outcomes refer to Table 6 in Section E.III.

What is the relationship between 

performance scales and 

outcomes?

Performance scales

STI outcome

Below threshold

0% paid

Between threshold and target – for the 

50% earned on achievement of threshold level performance, 

financial components, threshold is 95%.

increasing on a straight-line basis to 100% for target level 

Target

performance.

100% paid

Maximum – for financial  

100% earned at target level performance, increasing on a straight-

components only

line basis to 150% earned on achievement of maximum level 

performance.

Is over achievement applicable  

No. Over achievement is only available on the financial components of the STI and this is capped at 150%.

for all the components of the STI?

Is there a gate to  

over achievement?

Yes. Access to over achievement for all financial components is dependent on the Group achieving  

EBITDA target.

Are non-financial components 

Yes. Non-financial components are capped at 100% payment.

capped?

InvoCare            Annual Report 2020  | 42

What are the plan features  

50% of any STI award that exceeds $150,000 will be subject to deferral and will be paid in the form of 

of the deferral?

restricted shares. The shares will be held in trust for 12 months.

What is the deferral period?

There is a one-year deferral period from grant.

How is the number of shares 

The number of shares to be granted will be calculated by dividing the deferred STI amount by the volume 

determined?

weighted average price (VWAP) of shares transacted for the first ten days of the trading window immediately 

after the announcement of the Company’s ASX annual financial results for the STI performance year.

Will participants have access 

Yes. The restricted shares held in trust are entitled to dividends.

to dividends during the deferral 

period?

Is there Board discretion on the 

Yes. The deferred STI will be paid in InvoCare shares, but the Board retains the discretion to deliver the 

payment vehicle used?

deferred STI in cash.

When is STI paid?

Cash STI is payable in the first quarter of each year after the announcement of the Company’s ASX annual 

financial results for the previous year ended 31 December. 

For deferred STI, restricted shares will be allocated in the first quarter of each year after the VWAP price is 

available for the previous year ended 31 December.

Are there any disqualification 

All financial performance data relating to the plan is subject to external audit. 

provisions?

Potential participants may be disqualified from all or part of the plan if their annual performance is determined 

to be below the “on track” rating category in the performance management practices. Should a dispute arise 

regarding a potential disqualification, eligibility will be at the discretion of the CEO, or the Board for the CEO. 

The Company reserves the right to suspend or alter STI payments to any participant due to any action which 

has caused the Group loss or reputational damage. This includes any deferral STI (in the form of restricted 

shares) in the event of fraud, malfeasance, dismissal for cause, or other misconduct.

How is STI treated on cessation of 

In the event of cessation of employment due to resignation or dismissal for cause, all entitlements in relation to 

employment?

the performance period are forfeited. Where an Executive KMP’s employment is terminated by the Company 

LONG TERM INCENTIVE

for any reason other than cause, the relevant executive may receive a pro-rated portion of their STI opportunity 

based on the portion of the performance year served and the STI paid or payable in respect of the immediately 

preceding financial year.

Deferred STI will not vest if the individual resigns or is terminated for cause during the deferral period. The 

Board retains the discretion to allow deferred STI to remain on foot and vested in the normal course for 

approved good leavers. A good leaver will generally be determined by the Board (or its delegate) at the time of 

cessation of employment having regard for the facts and circumstances prevailing at that time.

The Company’s long term incentive (LTI) plan seeks to closely align the interests of the senior executive 

participants with those of investors to ensure participants are rewarded in line with economic value created. 

The following graphic provides a detailed timeline of the key activities of the new 2020 LTI throughout its 

lifecycle. Further details comparing the features of 2020 and 2019 and prior terms and conditions of the LTI 

plan are provided in the question and answer table below.

2019 Initial 
performance 
period  
Baseline

Grant of
performance rights 
and/or options
March 2020

Vesting and 
commencement
of restriction period
March 2023

Performance rights 
and/or options 
exercisable
March 2024

Performance period

Restriction period

2019

2020

2021

2022

2023

2024

Jan Mar

Dec

Jan Mar

Dec

Jan

Mar

Dec

Jan

Mar

Dec

Jan Mar

Dec

Jan Mar

Dec

What is the purpose of the long 

The LTI plan is aimed at attracting, retaining and rewarding high performing executives who contribute to the 

term incentive (LTI) plan?

overall medium and long-term success of the Company.

InvoCare            Annual Report 2020  | 43

Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report

Remuneration report – audited continued

Who participates in the LTI plan?

Participation is limited to Executive KMP and selected senior management positions by invitation and as 

approved by the Board.

What size of award is granted?

The 2020 LTI target opportunity was 85% of TFR for the CEO and 70% for the other Executive KMP.

How are the grants calculated?

The number of options is calculated based upon the value of LTI to be awarded in options divided by the option 

valuation at the award date. The option value is determined using a Black-Scholes valuation methodology. The 

valuation for allocation excludes dividends and does not incorporate any discount relating to the performance 

and tenure conditions.

The number of performance rights is calculated at the date of issue by dividing the value of LTI to be awarded 

in the form of performance rights by the face value of an InvoCare share. The face value is based on the 

ten-day VWAP for InvoCare shares starting from the first day of the trading window immediately following the 

announcement of the annual financial result.

CHANGES TO THE LTI PLAN

2019

2020

Plan features

The LTI awards are in the form of options and 

Participants are able to choose a mix of options and 

performance rights subject to vesting conditions.  

performance rights but are limited to the following 

The ratio of options and performance rights are  

combinations:

at 75% and 25% for participants.

• •  100% of either options or performance rights

• •  50% each of options and performance rights

• •  25% of one, and 75% of the other

What are the performance  

The performance hurdles for the  

The performance hurdles for the 2020 LTI plan:

hurdles?

2016-2019 LTI plans:

• •  Continued employment condition and

• •  Compound annual growth (CAGR) in normalised 

EPS over the vesting period

EPS is calculated based on “normalised earnings” 

meaning reported profit as adjusted:

• •  To remove the impacts of any gains or losses  

arising from the sale, disposal or impairment  

of non-current assets

• •  To maintain consistency in accounting policies 

across the respective vesting periods for each grant

• •  For LTI awards from February 2018:

•  To reflect constant currency

•  To remove impacts of pre-paid contracts and 

associated funds under management

• •  Continued employment condition and

• •  Two performance hurdles:

•  50% weighting on EPS

•  50% weighting on ROIC

EPS is calculated based on the Operating EPS 

adjusted to reflect constant currency.

ROIC in each year is calculated based on Operating 

EBIT divided by the average invested capital.

Is there a gateway before  

A ‘gateway’ condition must be met before any LTI 

Removal of gateway.

any LTI awards can vest?

awards can vest. The gateway requires a minimum 

level of return on invested capital (ROIC) greater than 

the weight average cost of capital (WACC).

ROIC is a performance hurdle in addition to  

CAGR in EPS.

What are the performance  

Performance is measured over four years:

Performance is measured over three years.

and vesting periods?

• •  Tranche One – 50% vest in year three

• •  Tranche Two – 50% vest in year four

Vesting of the options and performance rights are 

tested on the third and fourth anniversary of their 

grant. Unvested awards at the fourth anniversary of 

the grant are automatically forfeited.

Vesting of the options and performance rights are 

tested at the end of this three year period, subject to a 

further 12 months restriction period.

It also permits for malus in the event of governance 

concerns with Board discretion to be applied 

if performance is impacted by events outside 

management’s control.

InvoCare            Annual Report 2020  | 44

Do we allow for re-testing?

If performance measures are not met on the third 

Re-testing has been removed.

anniversary they are again tested on the fourth 

anniversary.

What are the performance 

Subject to the ROIC gateway condition,  

50% on EPS

conditions?

the EPS performance conditions applying for  

LTI awards are as follows:

For 2018 and 2019:

• •  8% to 12% CAGR in EPS results in  

30% to 100% of LTI vested

For 2016 and 2017:

• •  7% to 12% CAGR in EPS results in  

30% to 100% of LTI vested

• •  6% to 10% CAGR in EPS results in  

30% to 100% of LTI vested

50% on ROIC

• •  10% to 12% average ROIC over the three-year 

period results in 30% to 100% of LTI vested

Are there dividends  

or voting rights?

There are no dividends or voting rights attached to 

There are no voting rights attached to the options and 

the options and performance rights awarded. It is 

performance rights awarded.

only if the options and performance rights vested and 

exercised that there will be any entitlement.

Performance rights are entitled to dividends, if 

determined. Dividends will only be paid, in the form 

of shares, if the performance rights vested and 

exercised.

Why were these  

measures chosen?

CAGR of normalised EPS was selected as the most suitable and reliable measure of organisational performance, 

based on independent advice and analysis by the Board. The reasons for this conclusion include:

• •  The Company is a unique and relatively stable business

• •  EPS growth is aligned with the Company’s strategic objectives and is intended to underwrite appropriate 

dividend returns to shareholders

ROIC was selected as the second performance measure as it is intended to ensure effective capital 

deployment and maintenance of balance sheet strength.

What happens on ceasing 

For the options and performance rights to vest, the employee must be employed at the date of vesting unless 

employment?

the termination of employment has been determined to be a good leaver.

For good leavers, providing a participant has at least three years’ employment with the Company and has 

not engaged in proscribed conduct (meaning serious and wilful misconduct, wilful disobedience, gross 

negligence or incompetence, disqualification under the Corporations Act or serious breaches of contract 

of employment), the Board may at its discretion allow unvested LTI grants to continue to be on foot and 

vest subject to the original terms and performance conditions attached to the relevant grants, regardless of 

whether or not the participant is employed by the Company at the relevant vesting time.

If no determination is made by the Board, all unvested LTI held by the participant will lapse upon termination of 

employment.

The Board has the discretion to determine that any LTI benefit payable in the above termination circumstances 

can be settled in cash.

What happens if a change 

In the event of a change in control or other circumstances where the Board determines it is not practical or 

 of control occurs?

appropriate for the unvested LTI to continue on foot, the Board has the discretion to determine the extent to 

which all or part of any unvested LTI may vest and the specific performance testing to be applied.

Is there a clawback policy 

Payments or vesting related to performance conditions associated with an LTI are subject to a clawback 

included?

policy. The Group will seek to recover all or part of an executive’s incentives that have already been paid to 

ensure the executive has not been inappropriately awarded in circumstances including:

• •  A material misstatement or omission in the Group’s financial statements

• •  Actions or inactions seriously damaging the Group’s reputation or putting the Group at significant risk and/or

• •  A material abnormal occurrence resulting in an unintended increase in the award

InvoCare            Annual Report 2020  | 45

Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report

Remuneration report – audited continued

When would Board discretion  

Board discretion may be applied to either operating earnings or capital employed in the calculation of EPS or 

be considered?

ROIC. The guiding principle will be to ensure fairness in assessing LTI vesting outcome and alignment with 

shareholder interests.

Any Board discretion applied will be disclosed at the latest when vesting occurs.

InvoCare Share Trading Policy

In accordance with InvoCare’s Share Trading Policy, senior managers are prohibited from trading in 

the Company’s shares other than during specified trading windows, or with approval in exceptional 

circumstances, provided they do not possess inside information. In addition, senior managers are not 

permitted to enter into transactions with their shareholding in the Company which operate to limit the 

economic risk of their shareholding (e.g. margin loans, hedging or cap and collar arrangements), including 

limiting the economic risk of holdings of unvested entitlements associated with LTI securities.

InvoCare            Annual Report 2020  | 46

Directors’ Report

Remuneration report – audited  
Executive KMP remuneration

E. Executive KMP remuneration

I. CEO 2020 remuneration details

a. What was target and actual remuneration in 2020?

The target remuneration for the CEO is set to place a considerable portion of remuneration at risk to align remuneration with both the 

Group’s performance and the individual’s personal influence and contribution to the Group’s performance. The total maximum, target and 

actual remuneration for the CEO for the full year are summarised in the graph below.

Maximum remuneration represents total potential remuneration of TFR, STI and LTI. For STI, the amount includes the 150% achievement for 

financial targets as prescribed by the STI performance targets conditions.

Target remuneration represents total potential remuneration of TFR, STI (achieved at 100% for both financial and non-financial targets and 

reflected through cash and restricted shares) and LTI awarded (at 100% subject to performance and employment conditions to be met).

2020 CEO maximum, target and actual take home

Maximum

Target

Actual take
home*

40.1%

42.3%

38.6%

16.2%

9.6%

34.1%

$2,283,644

14.3%

7.4%

36.0%

$2,165,911

5.4%

56.0%

$2,377,067

0

400,000

800,000

1,200,000

1,600,000

2,000,000

2,400,000

Fixed remuneration

STI - cash

STI - restricted shares

LTI

Total remuneration in $

*    Inclusive of LTI award in 2020 related to 2015 and 2016 grants vested when performance hurdles were tested post 2019 annual results announcement. 

Refer to Table 5 below for further detail.

b. 2020 CEO remuneration breakdown

Total fixed remuneration (TFR)

TFR of $916,206 per annum.

Short term incentive (STI)

Target STI of $470,930 (51.4% of TFR).

The balanced scorecard was based on the following:

• •  Financials 50%

• •  Our customer 20%

• •  Our people 10%

• •  Our safety 20%

The CEO received 27% of target STI for 2020.

100% of this was received in cash.

For further detail on 2020 STI outcome refer to Table 6 below.

Long term incentive (LTI)

Target LTI of $778,775 (85% of TFR).

Of the maximum LTI award, 75% is in options and 25% in performance rights.

For all the grants which were up for performance hurdle testing during 2020, 2015 Tranche Three, 2016 

Tranches Two and Three were 100% vested and 2017 grant hurdles were not met.

For further details on LTI vesting outcomes for 2020 refer to Table 10 in Section E.VI.c below.

InvoCare            Annual Report 2020  | 47

Performance Review12Directors’ Report3Financial Report4Other Information 
Directors’ Report

Remuneration report – audited 
Executive KMP remuneration continued

II. Executive KMP remuneration details – actual received

This section provides details of the cash and value of other benefits 

STI paid in cash and vested LTI exercised or exercisable.  

actually received by the Executive KMP. This is a voluntary disclosure 

Refer to table notes below for further details on how these  

to provide shareholders with increased clarity and transparency in 

amounts were determined.

relation to Executive KMP remuneration.

Director’s discretion was considered in the determination of both the 

Actual pay in Table 5 below represents the pre-tax take home amounts 

2020 STI and 2020 LTI awards. For the Executive KMP who were in 

by each Executive KMP for the financial years ended 31 December 

their roles for the full financial year, the 2020 LTI calculations of EPS 

2020 and 2019. This consists of cash salary, non-monetary benefits, 

and ROIC will be adjusted to take account of the impairment of the  

NZ business and Compass ERP system.

Table 5 - Executive KMP remuneration details – actual pre-tax received

Short-term employee benefits

Post-employment 
benefits

Long-term 
benefits

Share 
 based 
payments

Total

Cash  
salary 1 
$

Short term 
incentive-  
cash 2, a 
$

Non-
monetary 
benefits 1 
$

Super-
annuation 1 
$

Termination 
payments 
$

Long  
service 
leave 
accruals 
$

Shares, 
options and 
perform-
ance  
rights 3 
$

$

Martin Earp

Damien MacRae,  
Deputy CEO commenced  
1 July 2020 (formerly COO) b

Adrian Gratwicke,  
appointed 3 August 2020 c

2020

818,809

126,880

77,075

25,000

2019

794,270

283,776

77,127

25,000

2020

595,750

104,571

4,678

25,000

2019

525,000

127,653

4,730

25,000

2020

272,211

63,652

1,949

10,847

Former Executive KMP ceased during the financial year

Josée Lemoine, resigned 
and ceased as Executive KMP 
effective 3 August 2020

2020

290,148

50,000

3,119

15,925

2019

430,008

120,251

4,730

25,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,329,303

2,377,067

-

-

-

-

1,180,173

729,999

682,383

348,659

130,869

490,061

-

579,989

Footnotes to Table 5

Table notes to Table 5

a   Based on performance in 2020, the PCR Committee determined the 
Executive KMP forfeited an average of 73%, achieving an average of 
27% of their target STI opportunity. Refer to Table 6 below for further 
details.

1    Cash salary, non monetary benefits and superannuation represents 

actual amounts received during the financial year. Cash salary 
excludes the movement of annual leave accruals.

2    STI awarded based on 2020 and 2019 achievement of performance 

b   Damien MacRae was promoted to Deputy CEO on 1 July 2020. 

targets and payable in cash.

His remuneration package was increased accordingly to reflect the 
increased scope of the role and external market positioning.

c   Adrian Gratwicke commenced in the role of CFO on 3 August 2020. 
His remuneration package was commensurate with his skills and 
extensive experience combined with the external market positioning.

 For 2020, 50% of the STI awarded that exceeded $150,000 would 
be subject to deferral and paid in the form of restricted shares. The 
shares would be held in trust for 12 months. Therefore, any deferred 
portion of the 2020 STI is not included as take home pay for 2020.

3    For 2020, LTI awarded related to 2015 and 2016 grants vested 

when performance hurdles were tested post 2019 annual results 
announcement. The vested and exercised/exercisable performance 
rights and options were converted or convertible to InvoCare shares 
during 2020. The value in Table 5 above represents the variable 
weighted average price (VWAP) of InvoCare shares for the financial 
year ended 31 December 2020 times the number of vested and 
exercised/exercisable performance rights and options. The VWAP 
over the period was $11.10.

 For 2019, no LTI vested when performance hurdles were tested post 
2018 annual results announcement.

InvoCare            Annual Report 2020  | 48

 
 
 
III. Executive KMP 2020 STI outcomes

Table 6 below provided details of each Executive KMP’s balance scorecard and the achievements and the financial outcomes during the financial year 

ended 31 December 2020.

Table 6 – Executive KMP 2020 STI outcomes

Executive KMP 

Performance 
target 

Achievement 
%

Target STI  
potential 
$

Actual STI 
awarded  
as a % of  
target  
STI potential 
%

Actual STI  
awarded 
$

STI forfeited as 
a % of target STI 
potential 
%

Financial

Customer

People

Safety

Financial

Customer

People

Safety

Financial

Customer

People

Safety

Martin Earp

Damien MacRae a

Adrian Gratwicke b

Footnotes to Table 6

-

35

-

100

-

35

-

100

-

35

-

100

470,930

27

126,880

73

388,125

27

104,571

73

236,250

27

63,652

73

a    Damien MacRae was promoted to Deputy CEO on 1 July 2020. His target STI potential reflects 45% of current TFR from the 1 January to 30 June 2020 

and 70% of current TFR from 1 July to 31 December 2020, or 57.5% of TFR for the financial year ended 31 December 2020.

b   Adrian Gratwicke’s target STI potential reflects 70% of TFR which was pro-rated to six months in 2020.

InvoCare            Annual Report 2020  | 49

Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report

Remuneration report – audited 
Executive KMP remuneration continued

IV. Executive KMP remuneration details – statutory basis

Table 7 below discloses the remuneration for Executive KMP calculated in accordance with statutory requirements and Accounting Standards. Refer 

to table notes underneath Table 7 for the relevant statutory and accounting requirements.

Table 7 – Total Executive KMP remuneration – statutory basis

Short-term employee benefits

Post-employment 
benefits

Long-term 
benefits

Cash  
salary 1 
$

Short term 
incentive-  
cash 2 
$

Non-
monetary 
benefits 3 
$

Super-
annuation 4 
$

Termination 
payments 
$

Long 
service 
leave 
accruals 5 
$

Share 
 based 
payments

Shares, 
options and 
perform-
ance  
rights 6 
$

Total

$

Martin Earp a

Damien MacRae,  
Deputy CEO commenced  
1 July 2020 (formerly COO) a

Adrian Gratwicke,  
appointed 3 August 2020 a

2020

875,719

126,880

77,075

25,000

2019

842,702

283,776

77,127

25,000

-

-

(62,453)

101,709

1,143,930

13,097

(232,563)

1,009,139

2020

568,607

104,571

4,678

25,000

428,909

(16,675)

80,951

1,196,041

2019

527,017

127,653

4,730

25,000

2020

297,365

63,652

1,949

10,847

Former Executive KMP ceased during the financial year

Josée Lemoine, resigned 
and ceased as Executive KMP 
effective 3 August 2020 a,b

2020

308,888

50,000

3,119

15,925

2019

431,676

120,251

4,730

25,000

-

-

-

-

8,749

(68,779)

624,370

1,499

137,018

512,330

(24,301)

812

354,443

7,262

(154,260)

434,659

Footnotes to Table 7

Table notes to Table 7

a    The remuneration mix for the Executive KMP based on the 

1  The total cost of cash salary and leave accruals, including annual 

remuneration details in Table 7 above are:

•    Martin Earp: 80% fixed and 20% at-risk  

(2019: 96% fixed and 4% at-risk)

•    Damien MacRae: 84% fixed and 16% at-risk  

(2019: 91% fixed and 9% at-risk)

•   Adrian Gratwicke: 61% fixed and 39% at-risk

•    Josée Lemoine: 86% fixed and 14% at-risk  

(2019: 100% fixed and 0% at-risk)

 2019 remuneration mix had a higher fixed remuneration compared 
to 2020. This was impacted by the negative value of share based 
payments value in 2019. The share based payments value in 2019 
was lower than 2020 due to the performance hurdle forecast being 
partially met at a lower rate in 2019 for all options and performance 
rights whilst in 2018 it was forecast to be met at a higher rate.

b    Josée Lemoine resigned during 2020. No STI was awarded, 

however, in recognition of Ms Lemoine’s contribution to the Company 
during her service and transition support to the incoming CFO, 
a special bonus of $50,000 was paid to her for her assistance in 
completion of all handover duties as agreed.

 Ms Lemoine’s unvested performance rights and options granted 
under the 2017, 2018 and 2019 LTI plans will remain on foot and will 
be subject to the relevant performance hurdles before any vesting 
occurs. No performance rights or options under the 2020 LTI plan 
were granted to Ms Lemoine.

 No termination benefits have been provided to Ms Lemoine on 
cessation of her employment.

leave taken and the increase or decrease in the annual leave provision 
applicable as determined in accordance with the Accounting 
Standard, AASB 119 Employee Benefits.

2  The amount to be settled in cash relating to performance of the  
Group and the individual for the financial year from 1 January to  
31 December. The proportions of STI bonuses awarded and forfeited 
are set out in Table 6 in Section E.III of this Remuneration Report.

3  Non-monetary benefits represent the costs to the Group, including 
any fringe benefits tax, for the provision of fully maintained cars, free 
car parking and other items.

4  Superannuation contributions are paid in line with legislative 

requirements.

5  Long service leave accruals are determined in accordance with 

Accounting Standard, AASB 119 Employee Benefits.

6  The share based payments value in Table 7 above represents the 
amount of sign-on incentive, deferred STI and LTI (in the form of 
unvested shares, options and performance rights) grants made 
in the current and past financial years. They are accounted for in 
accordance with AASB 2 Share-based Payments. Subject to 
meeting the vesting conditions of the grants, the shares, options or 
performance rights will vest, or be forfeited, in future financial years. 
Table 8 below provides the breakdown of share based payments.

InvoCare            Annual Report 2020  | 50

 
 
 
 
Table 8 – Breakdown of share based payments

Deferred STI 
in the form of 
shares 
$

Sign-on 
incentive in 
the form of 
shares 
$

LTI in the  
form of 
shares 
$

LTI in the  
form of 
options 
$

LTI in the  
form of 
performance 
rights 
$

Total share 
based 
payments 
$

Martin Earp

Damien MacRae,  
Deputy CEO commenced  
1 July 2020 (formerly COO)

Adrian Gratwicke,  
appointed 3 August 2020 a,b

2020

2019

2020

2019

2020

Former Executive KMP ceased during the financial year

Josée Lemoine,  
resigned and ceased as Executive 
KMP effective 3 August 2020 b

2020

2019

Footnotes to Table 8

-

-

-

-

-

-

-

-

-

-

-

108,008

-

-

2,275

54,631

44,803

101,709

236,939

(384,191)

(85,311)

(232,563)

-

-

-

-

-

-

80,951

80,951

(51,584)

(17,195)

(68,779)

-

29,010

137,018

406

406

812

(126,305)

(27,955)

(154,260)

a    Adrian Gratwicke received a sign-on incentive in the form of shares held in trust. One third each of the total number of shares granted will be vested on  

1 July 2021, 2022 and 2023 respectively provided that Mr Gratwicke meets the employment condition at the date of vesting.

b    The share based payments for both Adrian Gratwicke and Josée Lemoine are only recognised for the period from the date commenced as or up to the 

date ceasing as Executive KMP.

V. Executive KMP employment terms

The total remuneration package is reviewed annually and the key terms are summarised below.

Role

Martin Earp

Term of 
agreement

Notice period 
(by company or 
by employee)

Post 
employment 
restraints

Termination benefits

1 April 2018 –  

31 March 2021

Six months

12 months

No redundancy payment entitlements. If there are any 

termination entitlements to be paid, they will be limited by 

the current Corporations Act 2001 (Cth) or the ASX Listing 

Rules or both.

Damien MacRae

No expiry date

Six months

12 months

Any payment required under the Fair Work Act 2009 (Cth)

Adrian Gratwicke

No expiry date

Six months

12 months

Any payment required under the Fair Work Act 2009 (Cth)

InvoCare            Annual Report 2020  | 51

Performance Review12Directors’ Report3Financial Report4Other Information 
Directors’ Report

Remuneration report – audited 
Executive KMP remuneration continued

VI. Share based payments

a.  2020 Deferred Employee Share Plan’s grant

As part of the CFO appointment during 2020, Adrian Gratwicke received a one-off sign-on incentive in the form of 30,000 InvoCare shares, which will 

be held in trust within the InvoCare Deferred Employee Share Plan (DESP). The shares will vest in three equal tranches on 1 July 2021, 1 July 2022 and 

1 July 2023, respectively, provided that he is still employed by InvoCare at those dates and the applicable vesting conditions are met as described in 

the DESP rules. Table 9 below provides details of the fair value and maximum value for the sign-on incentive granted.

Table 9 – Fair value and maximum value for sign-on incentive

Grant 

Executive KMP 

Grant date 

Fair value per  
sign-on incentive 
$

Number of  
shares granted 

Performance  
period 

Maximum value to 
be recognised from 
grant date 
$

Adrian Gratwicke

15/06/2020

11.1

30,000

15 June 2020  
to 1 July 2023

333,000

Shares granted 
under DESP

b. LTI plan

The Executive KMP were granted LTI in the form of a combination of options and performance rights (under the Performance Long-term Incentive  

Plan (LTIP)) and shares (under the Deferred Employee Share Plan (DESP), which was replaced by the Performance Long-term Incentive Plan from  

2016 onwards).

The key terms and conditions of the LTI granted are disclosed in Note 20 Share-based remuneration Section B and C.

Refer to Section E.VI.c below for the performance to date of all LTI grants impacting the value of Executive KMP remuneration.

InvoCare            Annual Report 2020  | 52

c.  Performance to date of LTI grants

i.  Performance Long-term Incentive Plan’s grants

Table 10 below summarises the performance to date for the LTI grants under the LTIP since 2016 which impact remuneration in the current or a future 

financial year.

Table 10 – Performance of outstanding LTI granted under LTIP

Grant

Tranche

Performance hurdles a

Tranche One

30% vesting at 7% CAGR 

100% vesting at 12% CAGR

Tranche Two

Pro-rata vesting in between 7% and 12%

February 2019

Tranche Three

0% vesting if less than 7% CAGR

February 2020

Tranche One

30% vesting at 7% CAGR

February 2019

2016 grant  
– three equal 
tranches

2017 grant  
– three equal 
tranches

2018 grant 
– two equal 
tranches

2019 grant 
– two equal 
tranches

Tranche Two

Tranche Three

Tranche One

Tranche Two

Tranche One

Tranche Two

2020 grant  
– one 
tranche, two 
performance 
hurdles

50% of  
2020 grant

50% of  
2020 grant

Footnotes to Table 10

100% vesting at 12% CAGR

Pro-rata vesting in between 7% and 12%

0% vesting if less than 7% CAGR

30% vesting at 8% CAGR

100% vesting at 12% CAGR

Pro-rata vesting in between 8% and 12%

0% vesting if less than 8% CAGR

30% vesting at 8% CAGR

100% vesting at 12% CAGR

Pro-rata vesting in between 8% and 12%

0% vesting if less than 8% CAGR

30% vesting at 6% CAGR

100% vesting at 10% CAGR

Pro-rata vesting in between 6% and 10%

0% vesting if less than 6% CAGR

30% vesting at 10% ROIC

100% vesting at 12% ROIC

Pro-rata vesting in between 10% and 12% 
ROIC

0% vesting if less than 10% ROIC

First testing / 
vesting date

February 2018

Performance  
target at  
grant date

Retesting  
of unvested  
rights

Vesting  
outcome 
%

No retesting is 
required

49.7 cents b 

First test in 2019 

Retest in 2020

First test in 2020

First test in 2019

Retest in 2020

Retest in 2021

First test in 2020 

Retest in 2021

First test in 2021

100

0

100

100

0

0

0

0

0

0

0

65.4 cents b

February 2020

February 2021

February 2021

First test in 2021

57.8 cents c

February 2022

N/A

N/A

February 2022

N/A

N/A

35.9 cents c

February 2023

N/A

N/A

March 2023

46.9 cents c

N/A

N/A

March 2023

N/A

N/A

a   The performance targets are annual compound normalised EPS growth (CAGR) and/or return on invested capital (ROIC) from 1 January of grant year.

b   Including financial performance on funds under management on pre-paid contracts.

c   Excluding financial performance on funds under management on pre-paid contracts.

InvoCare            Annual Report 2020  | 53

Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report

Remuneration report – audited 
Executive KMP remuneration continued

d.  Fair value and maximum value for LTI grants

Table 11 provides the fair value and the maximum potential value of all outstanding LTI grants at grant date for the Executive KMP.  

If the performance conditions are not met, the minimum value of the LTI will be nil.

Table 11 – Fair value and maximum value for LTI grants

Grant 

Executive KMP 

Grant date 

Number  
of LTI  
granted 

Fair value  
per LTI  
$

Performance  
period 

Maximum value  
to be recognised 
from grant date  
$

Shares granted 
under DESP

Martin Earp

31/03/2015

13.74

17,410

1 January 2015 to 31 December 2019

01/01/2016

01/01/2017

Martin Earp

01/01/2018

Options 
granted under 
LTIP a

Damien MacRae

01/01/2019

01/01/2020

01/01/2018

01/01/2019

2.40

2.93

2.78

2.51

0.58

2.78

2.51

160,313

1 January 2016 to 31 December 2020

133,284

1 January 2017 to 31 December 2021

203,982

1 January 2018 to 31 December 2022

225,923

1 January 2019 to 31 December 2023

272,934

1 January 2020 to 31 December 2022

66,772

1 January 2018 to 31 December 2022

73,954

1 January 2019 to 31 December 2023

Former Executive KMP ceased during the financial year

Josée Lemoine c

01/01/2016

01/01/2017

01/01/2018

01/01/2019

01/01/2016

01/01/2017

Martin Earp

01/01/2018

01/01/2019

01/01/2020

01/01/2018

Performance 
rights granted 
under LTIP b

Damien MacRae

01/01/2019

01/01/2020

Adrian Gratwicke d

15/06/2020

2.40

2.93

2.78

2.51

12.08

14.06

13.91

12.96

9.70

13.91

12.96

9.70

9.70

14,754

1 January 2016 to 31 December 2020

46,075

1 January 2017 to 31 December 2021

49,532

1 January 2018 to 31 December 2022

54,860

1 January 2019 to 31 December 2023

10,617

1 January 2016 to 31 December 2020

9,258

1 January 2017 to 31 December 2021

13,589

1 January 2018 to 31 December 2022

13,072

1 January 2019 to 31 December 2023

14,098

1 January 2020 to 31 December 2022

4,448

1 January 2018 to 31 December 2022

4,279

1 January 2019 to 31 December 2023

26,336

1 January 2020 to 31 December 2022

17,107

15 June 2020 to 3 August 2023

Former Executive KMP ceased during the financial year

Josée Lemoine c

01/01/2016

01/01/2017

01/01/2018

01/01/2019

12.08

14.06

13.91

12.96

2,931

1 January 2016 to 31 December 2020

3,201

1 January 2017 to 31 December 2021

3,300

1 January 2018 to 31 December 2022

3,174

1 January 2019 to 31 December 2023

239,200

384,750

390,521

567,069

567,067

158,302

185,625

185,625

35,410

135,000

137,699

137,699

128,250

130,174

189,023

169,413

136,751

61,875

55,456

255,459

165,938

35,410

45,000

45,900

41,135

Footnotes to Table 11

a   The grant date fair value of the options granted under LTIP was 

c    No LTI was granted to Josée Lemoine for the financial year ended  

determined using Black-Scholes valuation methodology.

31 December 2020.

b   The grant date fair value of the performance rights granted for 2016 to 
2018 under LTIP equalled the ten-day VWAP starting from the first day 
of the trading window immediately following the announcement of the 
full year result. From 2019 grants onwards, the grant date fair value 
of the performance rights granted under LTIP was determined using 
Black-Scholes valuation methodology.

d    The performance period for the 2020 grant to Adrian Gratwicke is 

from 15 June 2020 (i.e., the signing date of the employment condition 
which is deemed to be the commencement date of performance 
period as per AASB 2) instead of 3 August 2020. The performance 
targets are the same as the 2020 grant for other Executive KMP, ie 
50% CAGR on EPS and 50% on ROIC from 1 January 2020.

InvoCare            Annual Report 2020  | 54

e.  Movements in LTI grants

Table 12 provides the movement of all outstanding LTI grants for the Executive KMP during 2020.

Table 12 – Movement of LTI grants

Grant

Executive KMP

Number 
 of LTI held at  
1 January  
2020

Number  
of LTI  
granted  
during 2020

Number of LTI 
vested and 
exercised  
during 2020

Number  
of LTI  
lapsed  
during 2020

Number of  
LTI held at  
31 December 
2020

Shares granted 
under DESP

Options 
granted  
under LTIP

Performance 
rights granted 
under LTIP

Martin Earp

Adrian Gratwicke

Martin Earp a

Damien MacRae

5,804

-

723,502

140,726

Former Executive KMP ceased during the financial year

Josée Lemoine b

Martin Earp

Damien MacRae

Adrian Gratwicke

165,221

42,997

8,727

-

-

(5,804)

30,000

272,934

-

-

14,098

26,336

17,107

-

-

-

-

(7,078)

-

-

Former Executive KMP ceased during the financial year

Josée Lemoine

11,629

-

(1,954)

-

-

-

-

-

-

-

-

-

-

30,000

996,436

140,726

165,221

50,017

35,063

17,107

9,675

Footnotes to Table 12

a  At 1 January 2020 and 31 December 2020, Martin Earp held 53,438 and 160,313 vested and exercisable options, respectively.

b  At 1 January 2020 and 31 December 2020, Josée Lemoine held 4,918 and 14,754 vested and exercisable options, respectively.

VII. Loans to Executive KMP

There were no loans at the beginning or at the end of the financial year ended 31 December 2020 to the Executive KMP. No loans were made available 

to the Executive KMP during 2020.

VIII. The year ahead – What can we expect in 2021?

a.  STI 2021

The Executive KMP 2021 STI opportunity will be subject to key performance conditions and weightings as listed in Table 13.

Table 13 – 2021 STI performance targets

Component

2021 performance targets

CEO – 
weight

CFO – 
weight Why this was chosen?

Financial 

performance

Group EBITDA

30% 

30%  The Company’s key performance metric

Group case volume 

10% 

10%  Case volume is an indicator of revenue growth

Personal financial objective

10%

10% Alignment of KMP’s STI reward with key objectives for the year

Our customer

Net Promoter Score

10%

10% Customer feedback and satisfaction remains core to the service offering

Our people

Employee turnover  

< 12 months tenure

10%

10%

People are the Company’s greatest asset. This encourages greater 

involvement and consideration around all recruitment activity in the regions

Our safety

culture in the workplace. The safety components reflect both a lead and a  

LTIFR

15%

15% The Company continues to reinforce its commitment to a strong safety  

Workplace inspections

5%

5%

lag measure.

Personal

Project objective

10%

10% Alignment of KMP’s STI reward with key objectives for the year

InvoCare            Annual Report 2020  | 55

Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report

Remuneration report – audited 
Executive KMP remuneration continued

b.  2021 Executive KMP changes announced

i.  

 Olivier Chretien – Managing Director and Chief Executive 
Officer, effective 1 January 2021

ii 

 Martin Earp – Former Chief Executive Officer ceasing 31 
March 2021

Mr Olivier Chretien has been appointed to the position of Chief 

The following provides an overview of final payments upon conclusion 

Executive Officer effective 1 January 2021, and Managing Director 

of Mr Earp’s six year contract in 2021:

effective 4 January 2021.

TFR of $1,025,000 per annum.

Total fixed 
remuneration 
(TFR)

Short term 
incentive (STI)

• •  Fixed remuneration until 31 March 2021

• •  Payment for completion of agreed handover arrangements

• •  Grant of 2021 LTI pro-rated for the period ended 31 March 2021

Target STI of $717,500 (70% of TFR).

• •  Unused accrued annual leave entitlements until 31 March 2021

The STI is based on Mr Chretien’s achievement of 

iii.    Damien MacRae – Former Deputy Chief Executive Officer 

key performance indicators prescribed by InvoCare 

ceasing 5 February 2021

for the relevant financial year.

If Mr Chretien’s STI award exceeds $150,000, 

50% of the value that exceeds this amount will be 

The following provides an overview of final payments upon 

redundancy of Mr MacRae. They included all items in accordance to 

the statutory requirements for his redundancy:

deferred and paid into the Company’s shares held in 

• •  Fixed remuneration until 5 February 2021

trust. There is a one year deferral period from grant. 

The Board retains a discretion to deliver deferred STI 

in cash.

Long term 
incentive (LTI)

Target LTI of $717,500 (70% of TFR).

• •  Remaining contractual notice period from 6 February to 30 June 

2021

• •  Redundancy payments in accordance with statutory requirements

• •  Unused accrued annual leave entitlements until 5 February 2021

Mr Chretien will be eligible to participate in the 

Company’s Long Term Incentive Plan, under 

which he may be granted performance rights and/

or options (subject to shareholders’ approval). 

For the financial year ending 31 December 

2021, the maximum value of Mr Chretien’s LTI 

will be $717,500. Vesting of the LTI is subject 

to performance and continuous employment 

conditions.

Sign-on incentive: Mr Chretien will receive a one-off sign-on incentive 

to the value of $400,000, in the form of InvoCare shares (subject 

to shareholders’ approval). The shares will be allocated and held in 

trust and pursuant to the terms of the InvoCare Deferred Employee 

Share Plan (DESP). The shares will vest two years after Mr Chretien’s 

appointment date provided that he is still employed by InvoCare at 

that date and the applicable vesting conditions as described in the 

DESP rules and accompanying offer letter have been satisfied.

InvoCare            Annual Report 2020  | 56

Directors’ Report

Remuneration report – audited 
Non-Executive Director remuneration

F.  Non-Executive Director remuneration

I.  Fee structure and policy

The following table outlines the Non-Executive Directors (NEDs) fee 

policy and any changes introduced for 2021.

Maximum 

Non-Executive Directors’ base fee for services 

Additional or 

The base fees exclude any remuneration determined 

aggregate 

as Directors is determined within an aggregate 

special duties

by the Directors where a Director performs additional 

fees 

Directors’ fee pool cap, which is periodically 

approved by 

approved by shareholders. At the date of this report, 

shareholders

the pool cap is $1,250,000, being the amount 

approved by shareholders at the AGM held on  

22 May 2015.

Contracts

Upon appointment to the Board, all NEDs receive a 

letter of appointment which summarises the Board 

policies and terms, including compensation, relevant 

to the office of Director.

Non-

The Board reviews NED fees on an annual basis in 

Executive 

line with general industry practice. This ensures fees 

Director fee 

are appropriately positioned in the market to attract 

reviews

and retain high calibre individuals.

or special duties for the Company. If a NED performs 

additional or special duties for the Company, they 

may be remunerated as determined by the Board 

and that remuneration can be in addition to the limit 

mentioned above.

Whilst all Directors have contributed actively to the 

board and special projects beyond the board room 

during the year, these contributions have been made 

as directors and as such have not resulted in any 

additional payments.

Superan-

The fees set out above include superannuation 

nuation

contributions in accordance with relevant statutory 

requirements.

NEDs are entitled to be reimbursed for all reasonable 

Equity 

NEDs may receive options as part of their 

costs and expenses incurred by them in performing 

participation

remuneration, subject only to shareholder approval. 

No options are held by any NED at the date of this 

report.

NEDs of InvoCare Limited are encouraged to acquire 

a minimum equity interest in the Company equivalent 

in value to 50% of their annual Director’s fee applying 

at the time of their appointment as a director of the 

Company, and NEDs are allowed up to three years to 

accumulate the required shareholding.

NEDs equity holdings are set out in Table 16  

in Section G.

Post 

NEDs are not entitled to any compensation on 

employment 

cessation of employment.

benefits

their duties.

NED fee changes 2020

To maintain market equity, the Board determined an 

increase of 3% to the base fee from 1 January 2020 

to the Chairman and the NED roles.

No change to the Chair of the Audit, Risk & 

Committee fee was made in 2020.

Following the half year financial results with the 

impact of COVID-19, it was agreed that NEDs would 

take a 25% reduction to their fees for four months 

from 1 August to 30 November 2020. This reflects 

the continued alignment with all our stakeholders.

NED fee changes 2021

There are no changes to the Board base fees in 

2021. In recognition of the additional workloads for 

Chairs of committees and alignment, the decision 

was made to extend the current Chair fee of $11,560 

for the Audit, Risk & Compliance Committee to the 

Chairs of both the Investment Committee and the 

People, Culture & Remuneration Committee.

Refer to Table 14 for details of 2020 fees including 

reduced NED fees from 1 August to 30 November 

2020 as well as 2021 fees. The aggregation of all 

Board and committee fees for 2020 and 2021, 

respectively, remains below the current pool limit.

InvoCare            Annual Report 2020  | 57

Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report

Remuneration report – audited 
Non-Executive Director remuneration continued

Table 14 – Non-Executive Director fees (inclusive of superannuation)

Board/Committee 

Role 

Per role 
$

2020

Total * 
$

From 1 January 2021

Per role 
$

Total 
$

Board base fee

Chairman

285,691

261,883

285,691

285,691

Non-Executive Directors

142,840

654,683

142,840

714,200

Audit, Risk & Compliance Committee

Chairman

11,560

10,597

Investment Committee

Chairman

People, Culture & Remuneration Committee Chairman

-

-

-

-

11,560

11,560

11,560

11,560

11,560

11,560

Total

927,163

1,034,571

* 

 Following the half year financial results with the impact of COVID-19 the NEDs took a 25% reduction to their fees for four months from 1 August to  
30 November. Therefore, the total annual Board base fee in 2020 column was less than the annual amount per role.

II.  Non-Executive Director’s remuneration details

Table 15 provides the remuneration details for the Non-Executive Directors on the Company’s Board. For any Directors appointed during the  

financial year, their remuneration has been pro-rated from the date of appointment to the end of the financial year. During the financial year ended  

31 December 2020, the Non-Executive Directors took a reduced Board base fee received during the period from 1 August to 30 November 2020. 

Therefore, total remuneration for the financial year ended 31 December 2020 was lower than that for the prior financial year.

Table 15 – Total Non-Executive Director’s remuneration

Short-term 
 employee benefits 

Post- employment 
benefits 

Board and  
committee fees 
$

Superannuation 
$

240,535

253,306

119,577

126,648

119,577

126,648

119,577

126,648

129,254

137,205

119,577

126,648

21,348

24,064

11,420

12,032

11,420

12,032

11,420

12,032

12,279

13,035

11,420

12,032

2020

2019

2020

2019

2020

2019

2020

2019

2020

2019

2020

2019

Total

$

261,883

277,370

130,997

138,680

130,997

138,680

130,997

138,680

141,533

150,240

130,997

138,680

Bart Vogel

Richard Davis

Jackie McArthur

Megan Quinn

Keith Skinner

Robyn Stubbs

InvoCare            Annual Report 2020  | 58

G. Additional information

Table 16 summarises the movement in holdings of InvoCare ordinary shares during the year and the balance at the end of the financial year, both in total 

and held indirectly by related parties of the KMP.

Table 16 – Movement of shareholding interests of Directors in accordance with  
section 205G of the Corporations Act 2001 and the other Executive KMP

Balance as at  
1 January  
2020 
Number

Grant as 
compensation 
Number

Exercise of LTI 
vested during 
2020 
Number

Net other 
changes during 
2020 
Number

Non-
Executive 
Directors

Bart Vogel

Richard Davis

Jackie McArthur

Megan Quinn

Keith Skinner

Robyn Stubbs

Martin Earp

Damien MacRae

Adrian Gratwicke b

Executive 
KMP

16,129

200,000

4,000

-

1,084

7,905

22,671

1,000

-

Former Executive KMP ceased during the financial year

Josée Lemoine

977

Footnotes to Table 16

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12,882

-

-

1,954

3,214

(40,000)

480

-

2,884

-

(17,119)

3,884

-

-

Total shares 
held directly and 
indirectly as at  
31 December 
2020 a 
Number

19,343

160,000

4,480

-

3,968

7,905

18,434

4,884

-

2,931

a    Shares held indirectly are included in the column headed Total shares held at 31 December 2020. Total shares are held directly by the KMP and indirectly 
by the KMP’s related parties, inclusive of domestic partner, dependants and entities controlled, jointly controlled or significantly influenced by the KMP.

b   Adrian Gratwicke commenced as Executive KMP from 3 August 2020 and therefore there were no shares held as at 1 January 2020.

This concludes the Remuneration Report which has been audited.

InvoCare            Annual Report 2020  | 59

Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report

Other statutory matters

Directors

The directors of InvoCare Limited at any time during or since the end of the financial year are as follows. Directors were in office for the entire period until 

otherwise stated.

Name

Bart Vogel

Martin Earp

Richard Davis

Jackie McArthur

Megan Quinn

Keith Skinner

Robyn Stubbs

Role

Chairman

Date of appointment/resignation

Chief Executive Officer and Managing Director

Resigned 4 January 2021

Independent Non-Executive Director

Independent Non-Executive Director

Independent Non-Executive Director

Independent Non-Executive Director

Independent Non-Executive Director

Resigned 1 February 2021

Directors appointed subsequent to balance sheet date

Olivier Chretien

Chief Executive Officer and Managing Director

Appointed 4 January 2021

Directorship of other listed companies

Directorship of other listed companies held by the directors in the three years preceding the end of the financial year are as follows.

Name

Company

Period of directorship

Bart Vogel

Martin Earp

Richard Davis

Jackie McArthur

Megan Quinn

Macquarie Telecom Limited

Infomedia Ltd

Salmat Limited

None

Australian Vintage Ltd

Monash IVF Group Limited

Inghams Group Limited

Tassal Group Limited

Blackmores Limited

Qube Holdings Limited

City Chic Collective Limited (formerly known as Specialty Fashion 
Group Limited)

Reece Limited

Keith Skinner

Emeco Holdings Limited

Since 2014

Since 2015

From May 2017 to November 2019

Since 2009

Since 2014

Since 2017

Since 2018

From April 2018 to August 2019

Since 2020

Since 2012

Since 2017

Since 2017

Robyn Stubbs

Aventus Group – Aventus Retail Property Fund and its subsidiaries

Since 2015

Brickworks Limited

Since 2020

Directors appointed subsequent to balance sheet date

Olivier Chretien

None

InvoCare            Annual Report 2020  | 60

Directors’ profiles

Bart Vogel BCom (Hons), FCA, FAICD

Richard Davis BEc

Independent Non-Executive Chairman

Independent Non-Executive Director

Bart Vogel was appointed to the InvoCare Board of Directors  

Richard Davis was appointed to the InvoCare Board of Directors  

on 1 October 2017, and as Chairman of the Board  

on 21 February 2012.

from 1 October 2018.

Richard is the Chair of Investment Committee and serves on the 

Bart serves on the Audit, Risk & Compliance Committee, People, 

People, Culture & Remuneration Committee and Nomination 

Culture & Remuneration Committee and Nomination Committee.

Committee.

Bart’s career includes 20 years in the management consulting 

Richard previously retired as InvoCare’s Chief Executive Officer 

industry, as a partner with Deloitte Consulting, A.T. Kearney and 

and Managing Director on 31 December 2008 after 20 years with 

Bain & Company, focused on the technology and services sectors. 

InvoCare. For the majority of that time, he held the position of Chief 

In his consulting roles, Bart has spent extensive time working in 

Executive Officer and successfully initiated and managed the growth 

global markets with multinational corporates and government 

of the business through a number of ownership changes and over  

bodies. He also spent 13 years in senior executive roles at Asurion 

20 acquisitions, including Singapore Casket Company (Private) 

Australia, Spherion Limited and as the Asia Pacific leader of Lucent 

Limited, the Company’s first international acquisition.

Technologies.

Richard is the Chairman of Australian Vintage Limited and Monash 

Bart is a director of listed companies Infomedia Ltd (serves as 

IVF Group Limited. Richard is also serving as Chairman of Singapore 

Chairman) and Macquarie Telecom Limited. He is also a Director of 

Casket Company (Private) Limited.

BAI Communications and of the Children’s Cancer Institute Australia 

and was a Director of Salmat Limited (delisted on 3 September 2020).

InvoCare            Annual Report 2020  | 61

Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report

Other statutory matters continued

Jackie McArthur BEng MAICD

Megan Quinn GAICD

Independent Non-Executive Director

Independent Non-Executive Director

Jackie McArthur was appointed to the InvoCare Board of Directors  

Megan Quinn was appointed to the InvoCare Board of Directors  

on 1 October 2018.

on 1 October 2018.

Jackie serves on the Audit, Risk & Compliance Committee, 

Megan serves on the Audit, Risk & Compliance Committee, People, 

Investment Committee and Nomination Committee.

Culture & Remuneration Committee and Nomination Committee.

Jackie has over 20 years experience at board and executive levels 

Megan is internationally regarded as a transformation, marketing, 

in strategic planning processes, organisational design, operations, 

retail and business expert and is invited to speak and consult on 

franchising systems, retail, supply chain, logistics, transport, food 

service, innovation, creativity, strategy, building a global brand, 

processing and manufacturing, emerging brand issues and crisis 

business excellence and customer experience for companies, 

management, risk management, corporate social responsibility and 

conferences and media outlets around the world. Named a global 

compliance issues, as well as governance at a global level, across 

game changer and one of Australia’s most powerful women in retail, 

Australia, Asia and globally.

Megan was a co-founder of the world’s premier online luxury fashion 

Most recently she was managing director, Australia and New Zealand, 

retailer, NET-A-PORTER.

of Martin-Brower ANZ, the exclusive distributor to McDonald’s 

Megan is a Director of listed companies City Chic Collective Limited 

restaurants across Australia and New Zealand. Previously, for more 

and Reece Limited. Having previously served on the Board and 

than 13 years, she held various senior executive positions with 

national committee of UNICEF Australia, she is an advocate for the 

McDonalds, both in Australia and overseas, including vice president 

Rights of the Child,and is a passionate ambassador of Fitted For 

of supply chain for Asia Pacific, Middle East and Africa and, in 

Work.

McDonalds Australia, as senior vice president chief restaurant support 

officer and vice president supply chain director.

Jackie is a Director of listed companies Inghams Group Limited, 

Tassal Group Limited and Qube Holdings Limited.

Jackie was the 2016 Telstra NSW Business Woman of the Year and 

overall 2016 Telstra Business Women’s Awards - Corporate and 

Private National Winner. She has completed the INSEAD International 

Executive Program.

InvoCare            Annual Report 2020  | 62

Keith Skinner BCom, FCA, GAICD

Olivier Chretien MEng, MBA, GAICD

Independent Non-Executive Director

Managing Director and Chief Executive Officer

Keith Skinner was appointed to the InvoCare Board of Directors 

Olivier Chretien was appointed as Managing Director and Chief 

 on 1 September 2018.

Keith is the Chair of Audit, Risk & Compliance Committee and serves 

Executive Officer effective from 1 January 2021. Mr Chretien was 

appointed to the InvoCare Board of Directors on 4 January 2021.

on the Investment Committee and Nomination Committee.

Olivier was recently Group Chief Strategy Officer with Ramsay Health 

Keith has a strong record in business management, restructuring, 

finance, accounting, risk and governance. He commenced his career 

as an auditor with Deloitte Australia in 1974, later moving to the firm’s 

Care, where he was in charge of Group Strategy, M&A and Ventures, 

the Australian Pharmacy business, and a Director of the European and 

Asian JV Boards.

Restructuring Services division, and was appointed a partner in 1986. 

Prior to this, Olivier spent 12 years with Wesfarmers. His last role was 

He was a leading practitioner for company turnarounds for over a 

Managing Director, Business Development for the Group, where he 

decade, before becoming Chief Operating Officer of Deloitte Australia 

was also a Director of retail divisional Boards for Coles, Bunnings, 

in 2001.

Since retirement in 2015, Keith has been a Director of a number of 

public and private organisations including Emeco Holdings Limited, 

North Sydney Local Health Board and not for profit organisation 

Kmart and Officeworks. He was previously the Managing Director 

of the Wesfarmers Industrial & Safety division for seven years, with 

more than 4,000 employees and 250 locations across Australia, New 

Zealand, China, Indonesia and the United Kingdom.

Lysicrates Foundation. He has also been Independent Chair of 

Prior to Wesfarmers, he spent nine years with Boston Consulting 

the Audit and Risk Committee of the Australian Digital and Health 

Group in France and Australia, consulting to clients in the 

Agency and has consulted to a number of organisations on strategy 

pharmaceuticals and travel and tourism services industries. He 

execution, restructuring and operational improvement.

started his career in engineering.

Olivier holds an Executive MBA (AMP) from Harvard Business School 

(Boston USA), an MBA from INSEAD (France), and a Master of 

Engineering from Ecole Centrale de Paris (France).

InvoCare            Annual Report 2020  | 63

Performance Review12Directors’ Report3Financial Report4Other InformationDirectors’ Report

Other statutory matters continued

Meetings of Directors

The number of meetings of the Company’s Board of Directors (the Board) and each Board committee held during the financial year ended  

31 December 2020, and the number of meetings attended by each director were as follows.

Board

Audit, Risk & 
Compliance  
Committee

Investment  
Committee

People, Culture 
& Remuneration 
Committee

Nomination  
Committee

Name

Held

Attended

Held

Attended

Held

Attended

Held

Attended

Held

Attended

Bart Vogel

Martin Earp

Richard Davis

Jackie McArthur

Megan Quinn

Keith Skinner

Robyn Stubbs

19

19

19

19

19

19

19

19

19

19

19

19

19

19

4

-

-

4

4

4

-

4

-

-

4

4

4

-

-

-

5

5

-

5

5

-

-

5

5

-

5

5

5

-

5

-

5

-

5

5

-

5

-

5

-

5

8

-

8

8

8

8

8

8

-

8

8

8

8

8

In addition to the formal meetings of directors there were numerous informal meetings of the non-executive directors during the year. Those meetings 

were concerned, for the most part, with succession planning, environmental, social and governance and customer strategy and site visits.

The composition of the Board and Board committees is a minimum of three directors. Board committees consist entirely of independent  

non-executive directors.

Company secretary

Significant changes in the state of affairs

The significant changes in the state of affairs during the financial year 

were as follows:

• •  During April 2020, the Company undertook a fully underwritten 

institutional placement and a Share Purchase Plan which raised 

a total of $270,862,000 in capital net of costs. Part of the capital 

raised was used to reduce borrowings, continue growth projects 

and increase liquidity during the COVID-19 pandemic

• •  During the financial year, the Group acquired the following business 

assets and companies. Further details of these acquisitions are 

provided in Note 18 Business combinations:

•  The business assets of Galaxy Funerals based in Sydney, New 

South Wales. Galaxy Funerals is a specialist business providing 

funeral care to the Chinese community, with religious and  

non-religious backgrounds

•  Family Pet Care Pty Limited which is the provider of pet 

cremation services and has a presence in Western Australia, 

South Australia, Victoria and Southern New South Wales

•  The pet cremation business assets of Pets in Peace which is 

based in Queensland

Other than the matters as stated above, there were no other 

Heidi Aldred BEcon, LLB

Heidi Aldred was appointed as Company Secretary on 15 March 2019. 

significant changes in the state of affairs of the Company during the 

Heidi, a qualified lawyer, has over 20 years experience in secretarial 

financial year.

and general counsel roles in a wide variety of areas with both listed 

and unlisted companies. Her early career included working with 

legal firms Arnold Bloch Leibler and Allens Linklaters (formerly Arthur 

Robinson & Hedderwicks).

InvoCare            Annual Report 2020  | 64

Dividends 

Non-audit services 

Details of dividends paid or determined by the Company during the 

Details of the amounts paid or payable to the auditor for non-audit 

financial year ended 31 December 2020 are set out in Note 4. 

services provided during the financial year by the auditor are outlined 

Subsequent events 

Refer to Note 17 for details of a property sale in January 2021. Other 

than this transaction and the Board’s determination of a final dividend 

of 7.0 cents per share, fully franked, there have been no other matter 

in Note 25 to the financial statements. 

The directors are satisfied that the provision of non-audit services 

during the financial year, by the auditor (or by another person or firm 

on the auditor’s behalf), is compatible with the general standard of 

independence for auditors imposed by the Corporations Act 2001. 

or circumstance arising since 31 December 2020 that has significantly 

The Directors are of the opinion that the services as disclosed in 

affected the Company’s operations, results or state of affairs, or may 

Note 25 to the financial statements do not compromise the external 

do so in future financial years.

auditor’s independence requirements of the Corporations Act 2001 

Indemnification and insurance of officers 

To the extent permitted by law, the Company has indemnified the 

directors and executives of the Company for liability, damages and 

expenses incurred, in their capacity as a director or an executive, for 

which they may be held personally liable, except where there is a lack 

of good faith. 

During the financial year, the Company paid a premium in respect of 

an insurance policy to insure directors and officers of the Company 

against a liability to the extent permitted by the Corporations Act 

2001. The insurance policy specifically prohibits disclosure of the 

nature and liability covered and the amount of the premium paid. 

Environmental regulation and performance 

The Company is committed to the protection of the environment, 

the health and safety of its employees, customers and the general 

public, as well as compliance with all applicable environmental 

laws, rules and regulations in the jurisdictions in which the Company 

operates. The Group is subject to environmental regulation in respect 

of its operations, including some regulations covering the disposal 

of mortuary and pathological waste and the storage of hazardous 

materials. The Company has appropriate risk management systems 

in place at its locations. 

There have been no claims during the year and the directors believe 

the Company has complied with all relevant environmental regulations 

and holds all relevant licences. 

Corporate governance 

The Company and the Board of Directors are committed to achieving 

and demonstrating the highest standards of corporate governance. 

The Board adopts a continuance improvement approach and 

regularly reviews corporate governance and reporting practices. For 

2020, InvoCare’s Corporate Governance Statement reports against 

the 4th Edition ASX Principles and will be published at the time of 

publication of the 2020 Annual Report. 

The 2020 InvoCare Corporate Governance Statement is available on 

the InvoCare website at:  

www.invocare.com.au/investor-relations/corporate-governance 

for the following reasons:

• •  All non-audit services have been reviewed and approved to ensure 

that they do not impact the integrity and objectivity of the auditor

• •  None of the services undermine the general principles relating to 

auditor independence as set out in APES 110 Code of Ethics for 

Professional Accountants issued by the Accounting Professional 

and Ethical Standards Board, including reviewing or auditing the 

auditor’s own work, acting in a management or decision-making 

capacity for the Company, acting as advocate for the Company or 

jointly sharing economic risks and rewards

Auditor’s independence declaration 

A copy of the auditor’s independence declaration as required under 

section 307C of the Corporations Act 2001 is set out immediately 

after the Directors’ Report.

Rounding of amounts

The Company is of a kind referred to in ASIC Corporations (Rounding 

in Financial/Directors’ Reports) Instrument 2016/191, issued by 

the Australian Securities and Investments Commission, relating to 

the “rounding off” of amounts in the directors’ report and financial 

report. Amounts in the reports have been rounded off to the nearest 

thousand dollars (where rounding is applicable) in accordance with 

that instrument.

This report is made in accordance with a resolution of Directors, 

pursuant to section 298(2)(a) of the Corporations Act 2001.

On behalf of the Directors on 24 February 2021.

Bart Vogel Chairman 

Sydney

InvoCare            Annual Report 2020  | 65

Performance Review12Directors’ Report3Financial Report4Other Information 
PricewaterhouseCoopers, ABN 52 780 433 757 One International Towers Sydney, Watermans Quay, Barangaroo, GPO BOX 2650, SYDNEY  NSW  2001 T: +61 2 8266 0000, F: +61 2 8266 9999, www.pwc.com.au Level 11, 1PSQ, 169 Macquarie Street, Parramatta NSW 2150, PO Box 1155 Parramatta NSW 2124 T: +61 2 9659 2476, F: +61 2 8266 9999, www.pwc.com.au   Liability limited by a scheme approved under Professional Standards Legislation. 66Auditor’s Independence Declaration As lead auditor for the audit of InvoCare Limited for the year ended 31 December 2020, I declare that to the best of my knowledge and belief, there have been:  (a)no contraventions of the auditor independence requirements of the Corporations Act 2001 inrelation to the audit; and(b)no contraventions of any applicable code of professional conduct in relation to the audit.This declaration is in respect of InvoCare Limited and the entities it controlled during the period.MW Chiang Sydney Partner PricewaterhouseCoopers 24 February 2021 Financial Report

InvoCare            Annual Report 2020  | 67

Financial Report

Introduction

This is the financial report of InvoCare Limited (the Company) and its 

PAGE  CONTENT

subsidiaries (together referred to as InvoCare or the Group).

InvoCare Limited (ABN 42 096 437 393) is a listed public company 

limited by shares, incorporated and domiciled in Australia. Its 

registered office and principal place of business is:

Level 2, 40 Miller Street 

North Sydney NSW 2060

A description of the nature of the Group’s operations and its principal 

activities is included in the Directors’ Report.

The financial report was authorised for issue by the Directors on  

24 February 2021. The Directors have the power to amend and 

reissue the financial report.

About this report

This financial report’s disclosures are split into five distinct groups 

to enable better understanding of how the Group has performed. 

Accounting policies and critical accounting judgements applied in the 

preparation of the financial statements are shown together with the 

related accounting balance and where the financial statement matter 

is disclosed.

69 

69 

70 

71 

72 

73 

75 

75 

78 

80 

81 

82 

83 

86 

88 

88 

89 

90 

92 

96 

99 

99 

Consolidated financial statements

Consolidated statement of comprehensive income

Consolidated balance sheet

Consolidated statement of changes in equity

Consolidated statement of cash flows

Basis of preparation

Key performance metrics

Note 1. Operating segments

Note 2. Revenue

Note 3. Earnings per share

Note 4. Dividends

Note 5. Expenses

Note 6. Income tax

Note 7. Cash flow information

Significant assets and liabilities

Note 8. Trade receivables

Note 9. Deferred selling costs and revenue

Note 10. Pre-paid contracts

Note 11. Non-current operating assets

Note 12. Intangibles

Capital and risks

Note 13. Financial risk management

106  Note 14. Contributed equity

107  Note 15. Contingencies

108  Note 16. Commitments

108  Note 17. Events after reporting period

109  Business portfolios

109  Note 18. Business combinations

112  Note 19. Interests in subsidiaries

114  Other statutory disclosures

114  Note 20. Share-based remuneration

118  Note 21. Related party transactions

119  Note 22. Parent entity information

120  Note 23. Deed of cross guarantee

122  Note 24. Economic dependence

122  Note 25. Remuneration of auditors

123  Note 26. Other accounting policies

125  Directors declaration

InvoCare            Annual Report 2020  | 68

Financial Report

Consolidated financial statements  
Consolidated statement of comprehensive income

For the year ended 31 December 2020

Revenue from continuing operations

Finished goods, consumables and funeral disbursements

Employee benefits expense

Advertising and public relations expenses

Occupancy and facilities expenses

Motor vehicle expenses

Technology expenses

Other expenses

Depreciation and amortisation expenses

Impairment loss on intangibles

Impairment reversal on cemetery land

Gain on disposal of an associate

Finance costs

Interest income

Net (loss)/gain on undelivered pre-paid contracts

Acquisition related costs

Net gain on disposal of non-current assets

(Loss)/profit before income tax

Income tax expense 

Net (loss)/profit after income tax from continuing activities

Net (loss)/profit after income tax for the year

Other comprehensive income  
Items that may be reclassified to profit or loss

Changes in the fair value of cash flow hedges, net of tax

Total realised loss on early settlement of interest rate swaps reclassified to profit or loss

Net changes to cash flow hedges, net of tax

Changes in foreign currency translation reserve, net of tax

Other comprehensive income/(loss) for the year, net of tax

Total comprehensive (loss)/income for the year, net of tax

(Loss)/profit is attributable to:

Equity holders of InvoCare Limited

Non-controlling interests

Total comprehensive (loss)/income for the year is attributable to:

Equity holders of InvoCare Limited

Non-controlling interests

Notes

2

12

11

10

18

6

2020 
$’000

477,652

(120,514)

(174,764)

(17,725)

(22,533)

(9,473)

(12,736)

(22,289)

97,618

(44,292)

(25,500)

6,000

-

2019 
$’000

500,348

(125,066)

(166,204)

(16,810)

(20,937)

(8,480)

(10,795)

(14,966)

137,090

(36,986)

(24,404)

-

52

(24,929)

(25,671)

1,059

(16,618)

(1,918)

7,383

(1,197)

(7,878)

(9,075)

(9,075)

(320)

2,419

2,099

(1,091)

1,008

(8,067)

(9,242)

167

(9,075)

(8,234)

167

(8,067)

2020 
cents

1,211

45,550

(2,021)

2,352

97,173

(33,285)

63,888

63,888

(1,661)

-

(1,661)

(198)

(1,859)

62,029

63,752

136

63,888

61,893

136

62,029

2019 
cents

Earnings per share for (loss)/profit attributable to the ordinary equity holders of InvoCare 
Limited

Basic earnings per share 

Diluted earnings per share 

3

3

(6.9)

(6.9)

55.8

54.9

The above consolidated statement of comprehensive income should be read in conjunction with the accompanying notes.

InvoCare            Annual Report 2020  | 69

Performance Review12Directors’ Report3Financial Report4Other Information 
 
Financial Report

Consolidated financial statements  
Consolidated balance sheet

As at 31 December 2020

Assets

Current  
assets

Cash and cash equivalents

Trade receivables

Other receivables

Inventories

Pre-paid contract funds under management

Assets held for sale

Deferred selling costs

Deferred contract assets

Total current assets

Non-current 
assets

Trade receivables

Other receivables

Other financial assets

Property, plant and equipment

Right of use asset

Pre-paid contract funds under management

Liabilities Current  
liabilities

Non-current 
liabilities

Equity

Intangibles

Deferred selling costs

Deferred contract assets

Total non-current assets

Total assets

Trade and other payables

Contingent considerations

Lease liabilities

Derivative financial instruments

Current tax liabilities

Pre-paid contract liabilities

Deferred revenue

Provision for employee entitlements

Total current liabilities

Contingent considerations

Borrowings

Lease liabilities

Derivative financial instruments

Deferred tax liabilities

Pre-paid contract liabilities

Deferred revenue

Provision for employee entitlements

Total non-current liabilities

Total liabilities

Net assets

Contributed equity

Reserves

Retained profits

Parent entity interests

Non-controlling interests

Total equity

The above consolidated balance sheet should be read in conjunction with the accompanying notes.

InvoCare            Annual Report 2020  | 70

Notes

7

8

10

9

8

11

11

10

12

9

18

11

10

9

18

13

11

6

10

9

2020 
$’000

118,781

38,757

13,710

44,117

50,268

2,788

3,644

1,541

273,606

29,445

670

4

464,277

144,368

562,863

243,515

34,068

2,525

2019 
$’000

19,560

40,679

9,983

45,117

57,552

5,842

4,480

2,409

185,622

31,477

655

4

426,955

144,001

561,837

210,724

35,448

4,040

1,481,735

1,415,141

1,755,341

1,600,763

60,514

9,265

19,465

600

1,874

44,685

28,632

16,613

181,648

7,909

246,039

146,459

548

32,639

496,624

109,086

2,489

60,810

94

12,934

735

813

48,885

34,913

14,864

174,048

800

357,189

149,967

3,422

34,826

476,498

104,387

2,647

1,041,793

1,129,736

1,223,441

1,303,784

531,900

497,005

9,977

23,495

530,477

1,423

531,900

296,979

219,826

7,728

68,169

295,723

1,256

296,979

Financial Report

Consolidated financial statements  
Consolidated statement of changes in equity

For the year ended 31 December 2020

Attributable to equity holders of InvoCare Limited

2020

Contributed 
equity 
$’000

Share-based 
payment 
reserve 
$’000

Hedging 
reserve 
$’000

Foreign 
currency 
translation 
reserve 
$’000

Retained 
profits 
$’000

Non-
controlling 
interests 
$’000

Total  
equity 
$’000

Balance at 1 January 2020

219,826

2,055

(2,854)

8,527

68,169

1,256

296,979

Total comprehensive income/(loss)  
for the year

Transactions with owners in their  
capacity as owners:

Dividends paid (Note 4)

Employee share plan shares vested during 
the year

Issue of ordinary shares as part of dividend 
reinvestment plan (Note 4)

Issue of ordinary shares, net of transaction 
costs

Transfer of shares from the deferred plan to 
the InvoCare Exempt Share Plan Trust

Employee shares – value of services

Balance at 31 December 2020

497,005

2019

Balance at 1 January 2019

Change in accounting policy

124,140

-

Restated balance at the beginning of the year

124,140

Total comprehensive income for the year

Transactions with owners in their  
capacity as owners:

Dividends paid (Note 4)

Reclassification of equity settled share based 
payments

Employee share plan shares vested during 
the year

Issue of ordinary shares as part of dividend 
reinvestment plan (Note 4)

Issue of ordinary shares, net of transaction 
costs

-

-

-

-

48

(16)

5,918

270,862

351

-

-

-

-

-

-

-

1,257

3,296

246

-

246

-

-

2,353

450

(192)

9,137

85,787

-

-

2,099

(1,091)

(9,242)

167

(8,067)

-

-

-

-

-

-

-

-

-

-

-

-

(29,514)

-

(5,918)

-

-

-

-

-

-

-

-

-

(29,514)

32

-

270,862

351

1,257

(755)

7,436

23,495

1,423

531,900

(1,193)

8,725

58,138

1,241

191,297

-

(1,193)

(1,661)

-

(11,842)

-

(11,842)

8,725

46,296

1,241

179,455

(198)

63,752

136

62,029

-

-

-

-

-

-

-

-

-

-

-

-

(32,742)

(121)

(32,863)

-

-

(9,137)

-

-

-

-

-

-

-

2,353

258

-

85,787

(40)

Employee shares – value of services

312

(352)

Balance at 31 December 2019

219,826

2,055

(2,854)

8,527

68,169

1,256

296,979

The above consolidated statement of changes in equity should be read in conjunction with the accompanying notes.

InvoCare            Annual Report 2020  | 71

Performance Review12Directors’ Report3Financial Report4Other Information 
Financial Report

Consolidated financial statements  
Consolidated statement of cash flows

For the year ended 31 December 2020

Notes

Cash flows from 
operating activities

Receipts from customers (including GST)

Payments to suppliers and employees (including GST)

Other revenue

Interest received

Finance costs

Income tax paid

Cash flows from 
investing activities

Net cash flows from operating activities

Proceeds from sale of property, plant and equipment

Purchase of subsidiaries and other businesses including acquisition 
costs, net of cash acquired

Proceeds from sale of subsidiaries and other businesses, net of 
restructuring costs

Purchase of property, plant and equipment and intangibles

Payments to funds under management for pre-paid contract sales

Receipts from funds under management for pre-paid contracts 
performed

Cash flows from 
financing activities

Net cash flows from investing activities

Share capital issue, net of transaction costs

(Payments)/proceeds from share option vested and exercised

Proceeds from borrowings

Repayment of borrowings

Payment for early settlement of interest rate swaps

Proceeds from lease arrangements

Principal elements of lease payments

2020 
$’000

2019 
$’000

505,716

488,008

(421,870)

(393,541)

11,192

95,038

373

6,037

100,504

388

(17,419)

(21,191)

(14,424)

(20,631)

63,568

11,908

59,070

5,565

(40,581)

(15,187)

-

985

(68,136)

(65,289)

(32,169)

(24,976)

45,026

40,842

(83,952)

(58,060)

270,875

85,787

(69)

258

5,000

47,397

(111,761)

(100,500)

(3,115)

-

(11,599)

-

13,598

(9,973)

Dividends paid to InvoCare Limited equity holders

(29,514)

(32,742)

Dividends paid to non-controlling interests in subsidiaries

Net cash flows from financing activities

Net increase in cash and cash equivalents

Cash and cash equivalents at the beginning of the year

Effects of exchange rate changes on cash and cash equivalents

-

119,817

99,433

19,560

(212)

(121)

3,704

4,714

14,776

70

Cash and cash equivalents at the end of the year

7

118,781

19,560

The above consolidated statement of cash flows should be read in conjunction with the accompanying notes.

InvoCare            Annual Report 2020  | 72

Financial Report

Basis of preparation

This consolidated financial report is a general purpose financial report 

Critical accounting estimates and judgements

which:

• •  Has been prepared in accordance with the Corporations Act 2001, 

Australian Accounting Standards (AASBs) and Interpretations 

adopted by the Australian Accounting Standards Board, as 

appropriate for for-profit oriented entities and the Australian 

Securities Exchange (ASX) Listing Rules

• •  Complies with International Financial Reporting Standards (IFRS) 

The preparation of a financial report that complies with AASBs 

requires management to make judgements, estimates and 

assumptions.

This can affect the application of accounting policies and the reported 

amounts of assets, liabilities, income and expenses. Actual results 

may differ from these estimates.

adopted by the International Accounting Standards Board

Estimates and underlying assumptions are reviewed on an on-going 

• •  Is presented in Australian dollars ($) which is the functional currency 

basis. Revisions to estimates are recognised prospectively.

of InvoCare

• •  Is prepared under the historical cost basis except for the following 

assets and liabilities, which are stated at their fair value: derivative 

financial instruments; fair value through profit or loss funds 

under management; and liabilities for cash settled share-based 

compensation plans. Recognised assets and liabilities that are 

hedged are stated at fair value in respect of the risk that is hedged. 

Refer to the specific accounting policies within the notes to the 

financial statements for the basis of valuation of assets and 

liabilities measured at fair value

Significant accounting policies have been:

The significant accounting policies highlight information about 

accounting judgements made in applying accounting policies that 

have the most significant effects on reported amounts and further 

information about estimated uncertainties that have a significant risk 

of resulting in material adjustments within the next financial year.

The areas involving a higher degree of judgement or complexity, or 

areas where assumptions and estimates are significant to the financial 

statements are disclosed within the notes following the financial 

information of those transactions or activities.

The COVID-19 pandemic has not significantly increased the 

estimation uncertainty in the preparation of the consolidated financial 

• •  Included in the relevant notes to which the policies relate, while 

statements. A thorough consideration of potential COVID-19 impacts 

other significant accounting policies are discussed in Note 26 

on carrying values of assets and liabilities, contracts and potential 

Other accounting policies

• •  Consistently applied to all financial years presented in the 

consolidated financial statements and by all entities in the Group, 

except as explained in Note 26 Other accounting policies – New 

and revised accounting standards and interpretations not yet 

mandatory or early adopted

liabilities has been made, with no material impact to the financial 

statements, except as recognised in these consolidated financial 

statements.

Current and non-current split

The Group presents assets and liabilities in the consolidated balance 

sheet as current or non-current:

• •  Current assets include assets held primarily for trading purposes, 

cash and cash equivalents and assets expected to be realised in, 

or intended for sale or use in, the course of the Group’s operating 

cycle (that is 12 months). All other assets are classified as  

non-current

• •  Current liabilities include liabilities held primarily for trading 

purposes, liabilities expected to be settled in the course of the 

Group’s operating cycle and those liabilities due within one 

year from the reporting date. All other liabilities are classified as 

non-current where the Group has an unconditional right to defer 

settlement of the liability for at least 12 months after the reporting 

period

InvoCare            Annual Report 2020  | 73

Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report

Basis of preparation continued

Comparatives

Where necessary, comparatives have been reclassified and 

repositioned for consistency with current year disclosures.

The following balance sheet and cash flow items are reclassified 

during the current year:

• •  Deferred contract assets separated from inventories and 

presented on the face of the consolidated balance sheet

• •  Capitalised software reclassified from property, plant and 

equipment to intangibles

• •  Deferred considerations separated from trade and other payables 

and presented on the face of the consolidated balance sheet

• •  Interest paid on lease liabilities reclassified to finance costs on the 

face of consolidated statement of cash flows

Rounding

The Group is of the kind referred to in the ASIC Corporations 

(Rounding in Financial/Directors’ Reports) Instrument 2016/191 

issued by the Australian Securities & Investments Commission.  

In accordance with that instrument, amounts in the financial report 

have been rounded to the nearest thousand dollars, unless otherwise 

indicated.

Non-IFRS information

Some of the financial data in the notes to the financial statements 

as listed below are not disclosures in accordance with the current 

AASBs’ requirements:

• •  EBITDA (earnings before interest, tax, depreciation and 

amortisation) and EBIT (earnings before interest and tax) in  

Note 1 Operating segments

• •  Operating EBITDA and EBIT in key performance metrics section

• •  Voluntary tax transparency code disclosure in Note 6 Income tax

• •  Cash conversion ratio in Note 7 Cash flow information

However, all financial data is based on the information disclosed in the 

audited financial statements and notes to the financial statements of 

InvoCare and follow the recognition requirement of AASBs.

InvoCare            Annual Report 2020  | 74

Financial Report

Notes to the consolidated financial statements  
Key performance metrics

Operating earnings before interest, tax, 
depreciation and amortisation (Operating 
EBITDA) is a key measure used to assess 
the Group’s performance. This section of 
the Financial Report focuses on disclosure 
that enhances a user’s understanding of 
Operating EBITDA.

Operating segment provides a breakdown 
of revenue and profit by the operational 
activity. The key line items of the 
consolidated statement of comprehensive 
income along with their components 
provide detail behind the reported 
balances. Group performance will also 
impact the earnings per ordinary share 
capital and dividend payout.

Finally, the cash flows reflect the core 
results of the Group’s capital management 
strategy and therefore the disclosure 
on these items has been included in this 
section.

Note 1. Operating segments

A. Identification of reportable segments

The Group is organised into three reportable segments:

• •  Australia

• •  Singapore

• •  New Zealand

These reportable segments are based on the internal reports that 

are reviewed and used by the Chief Executive Officer & Managing 

Director (who is identified as the Chief Operating Decision Maker 

(CODM)) in assessing performance and in determining the allocation 

of resources. There is no aggregation of reportable segments.

The reportable segments are identified by management based on the 

countries in which the product is sold or service is provided. Discrete 

financial information about each of these operating segments is 

reported to the CODM and the Board of Directors regularly.

The CODM reviews operating earnings before interest, tax, 

depreciation and amortisation (Operating EBITDA) and operating 

earnings before interest and tax (Operating EBIT).

The accounting policies adopted for internal reporting to the CODM 

are consistent with those adopted in the financial statements.

InvoCare            Annual Report 2020  | 75

Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report

Notes to the consolidated financial statements  
Key performance metrics continued

B. Reportable segments information

2020

Australia 
$’000

Singapore 
$’000

New  
Zealand 
$’000

Other 
$’000

Revenue from external customers

397,756

18,593

50,174

Other revenue (excluding interest income)

8,501

812

1,816

Operating expenses

Adjustment to revenue - pre-paid redemptions*

Adjustment to other revenue - pre-paid redemptions*

Adjustment to operating expenses - pre-paid redemptions*

Operating EBITDA

Depreciation and amortisation

Business acquisition costs

Operating EBIT

Finance costs

Interest income

Non-operating activities (including pre-paid contracts funds under 
management)

Impairment loss on intangibles

Impairment reversal

Income tax expense

Non-controlling interest

Net profit/(loss) after income tax

Total goodwill

Total assets

Total liabilities

(326,809)

(10,013)

(43,212)

79,448

9,392

8,778

3,709

(5,113)

6,351

-

-

-

-

-

-

84,395

9,392

8,778

(37,731)

(1,187)

(5,362)

(1,918)

-

-

44,746

8,205

3,416

(18,445)

1,040

(1)

-

(3,097)

19

(18,040)

(19)

479

(6,176)

6,000

-

-

(6,490)

(1,352)

(167)

-

(19,324)

-

(36)

-

2,468

6,833

(18,543)

171,284

14,365

27,057

1,595,502

46,754

113,085

1,135,264

3,866

84,311

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total 
$’000

466,523

11,129

(380,034)

97,618

3,709

(5,113)

6,351

102,565

(44,280)

(1,918)

56,367

(21,543)

1,059

(17,580)

(25,500)

6,000

(7,878)

(167)

(9,242)

212,706

1,755,341

1,223,441

*  Adjustment to reclassify the non-operating impacts of performing pre-paid funerals, burial and cremation services to net gain/loss on pre-paid contracts.

InvoCare            Annual Report 2020  | 76

2019

Australia 
$’000

Singapore 
$’000

New  
Zealand 
$’000

Other 
$’000

Revenue from external customers

413,403

20,823

56,033

Other revenue (excluding interest income)

9,176

400

513

Operating expenses

Adjustment to revenue - pre-paid redemptions*

Adjustment to other revenue - pre-paid redemptions*

Adjustment to operating expenses - pre-paid redemptions*

(308,253)

(11,306)

(43,657)

114,326

9,917

12,889

3,855

(4,538)

8,026

-

-

-

-

-

-

-

-

(42)

(42)

-

-

-

Total 
$’000

490,259

10,089

(363,258)

137,090

3,855

(4,538)

8,026

Operating EBITDA

Depreciation and amortisation

Business acquisition costs 

Operating EBIT

Finance costs

Interest income

Non-operating activities (including pre-paid contracts funds under 
management)

Impairment loss on intangibles

Income tax expense

Non-controlling interest

121,669

9,917

12,889

(42)

144,433

(30,775)

(1,201)

(4,997)

(1,984)

-

(37)

88,910

8,716

7,855

(19,561)

(1,309)

(3,552)

1,301

40,739

-

(43)

(20)

-

(31,638)

(1,126)

(136)

-

(47)

(1,368)

(24,404)

(521)

-

-

-

(42)

(2)

-

-

-

-

-

(36,973)

(2,021)

105,439

(24,424)

1,211

39,351

(24,404)

(33,285)

(136)

Net profit/(loss) after income tax

79,615

6,218

(22,037)

(44)

63,752

Total goodwill

Total assets

Total liabilities

119,573

15,514

47,382

-

182,469

1,427,388

47,131

126,105

139

1,600,763

1,156,812

41,774

105,131

67

1,303,784

*  Adjustment to reclassify the non-operating impacts of performing pre-paid funerals, burial and cremation services to net gain/loss on pre-paid contracts.

C. Accounting policy for segment reporting

Operating EBITDA is reconciled to profit after tax as disclosed on the 

consolidated statement of comprehensive income.

Segment revenue, expenses, assets and liabilities are those that are 

directly attributable to a segment and the relevant portion that can 

be allocated to the segment on a reasonable basis. Segment assets 

include all assets used by a segment and consist primarily of operating 

cash, receivables, inventories, property, plant and equipment, right 

of use assets and goodwill and other intangible assets, net of related 

provisions. Segment liabilities consist primarily of trade and other 

creditors, lease liabilities and employee benefits and, in the case of 

Singapore, include an allocation of the long-term borrowings raised 

in Australia to fund the investment in Singapore. New Zealand has 

long-term borrowings which are arranged in New Zealand but with the 

support of Australia.

InvoCare            Annual Report 2020  | 77

Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report

Notes to the consolidated financial statements  
Key performance metrics continued

Note 2. Revenue

A.   Disaggregation of revenue from contracts with customers

The tables below provide detailed disaggregation of revenue derived by the Group.

2020

Funeral services

Memorial Parks

Pet cremations

Rent

Sundry revenue

Australia  
$’000

Singapore 
$’000

New  
Zealand 
$’000 

Total 
$’000

278,699

119,463

4,646

18,593

48,004

345,296

-

-

2,212

121,675

-

4,646

402,808

18,593

50,216

471,617

411

3,039

29

782

121

1,653

561

5,474

Total revenue from continuing operations

406,258

19,404

51,990

477,652

2019

Funeral services

Memorial Parks 

Pet cremations

Rent

Sundry revenue

298,868

117,973

816

20,823

53,576

373,267

-

-

2,528

120,501

-

816

417,657

20,823

56,104

494,584

307

4,616

65

335

13

428

385

5,379

Total revenue from continuing operations

422,580

21,223

56,545

500,348

InvoCare’s New Zealand and Singapore businesses were eligible for government subsidies. The government subsidies were recognised as sundry 

revenue during the financial year ended 31 December 2020.

B.  Critical accounting judgements, estimates and 

The 15 year period is based on a periodically updated actuarial 

assumptions

I.  Significant financing

The Group receives payment from customers for pre-paid funerals, 

burial and cremation services prior to the transfer of the promised 

goods or services to the customer. As the period between receipt of 

the consideration and transfer of the goods or services can exceed 

one year, the Group adjusts deferred revenue using a discount rate. 

The Group determines the discount rate that best reflects the at-need 

funerals price the customers would have paid (that is the cash selling 

assessment of the average period between a customer entering into a 

pre-paid funeral plan and the contract becoming at-need. The actual 

history of a pre-paid cemetery/crematorium contract may differ from 

the profile of a pre-paid funeral plan; however, in the absence of more 

specific data being available, the funeral data has been applied.

The average 15 year period is an assumption only and therefore 

subject to uncertainty. It is possible that there will remain unperformed 

contracts at the end of the 15 year amortisation period, yet all revenue 

will have been recognised. Offsetting this is the likelihood that 

contracts performed during the 15 year period will have unrecognised 

price as if the customer had paid the consideration at the time when 

revenue.

the services are performed or the goods delivered).

II.   Timing of recognition of deferred plaque and 

miscellaneous merchandise revenue

Pre-paid cemetery/crematorium plaque and miscellaneous 

merchandise sales are currently brought to account over an assumed 

15 year period. Unredeemed merchandise sales (included within 

deferred revenue on the balance sheet) total $57,663,000 at  

31 December 2020 (2019: $58,617,000).

Actual redemptions information has been collated for a sample of sites 

in order to determine a more accurate historical pattern of cemetery/

crematorium pre-paid sale redemptions. The information collated 

suggests there is no material misstatement of revenue using the 

assumed 15 years period. The impact of recognising revenue over 

five years less (or five years more) than 15 years would be to increase 

annual revenue by approximately $3,500,000 (2019: $3,300,000) or 

decrease by $1,700,000 (2019: $1,700,000).

InvoCare            Annual Report 2020  | 78

 
C. Accounting policy for revenue recognition

II.    Cemetery and crematorium memorial products 

The Group derives its revenue from the transfer of goods and services 

on delivery of the underlying good or service.

The Group predominately generates revenue through the following 

streams:

(‘memorial products’)

The Group’s deliverables under memorial contracts are:

• •  Interment right – An interment right is the right to be committed in a 

designated space in a cemetery. The specific site is allocated at the 

time of signing the contract. Revenue is recognised when control of 

I.    Funeral services, including pre-paid funerals, burial and 

the interment right and associated memorial passes to the customer.

crematorium services

II.   Cemetery and crematorium memorial products (‘memorial 

products’)

Each of the above goods and services delivered or to be delivered to 

the customers are considered separate performance obligations even 

though for some situations they may be governed by a single legal 

contract with the customer.

Revenue recognition for each of the above revenue streams are as 

follows:

I.    Funeral services, including pre-paid funerals, 

burial and crematorium services

The Group’s performance obligations under funeral services  

contracts are:

• •  At-need funeral services – Revenue is recognised when the 

funeral, burial, cremation and other services are performed or the 

goods supplied

• •  Pre-paid (Pre-need) funerals services – The Group enters 

into pre-paid contracts to provide funerals, burial and cremation 

services or other services in the future. For these contracts, the 

period between payment by the customer and transfer of the 

promised goods or services to the customer can exceed one year

The funds received are placed in trust and are not recognised as 

revenue until the service is performed. As a result, the Group adjusts 

the deferred revenue and pre-paid contract liabilities using a discount 

rate that results in revenue being recognised that approximates the 

cash selling price the customer would have paid if the consideration 

was paid at the same time as the services are provided.

On delivery of a pre-paid funeral service contract, the Group 

recognises the financing component as a component of revenue.

Pre-2018 memorial product contracts 

For memorial product contracts entered into with customers prior to  

1 January 2018, the customer gains control of the interment right on 

full and final settlement.

Post-2018 memorial product contracts 

For contracts entered into from 1 January 2018, the customer gains 

control of the interment right at contract inception, thereby allowing 

revenue to be recognised on delivery.

• •  Headstone/monument/gardens – In a memorial products contract, 

a customer purchases a memorial, such as headstone/heritage 

garden/monument, to be installed on the interment site.  

The memorial may be on site at the time of purchase or may be 

delivered at a future time. Typically, there is a considerable time lag 

between a contract being signed and the delivery of the memorial. 

These items are tracked on a contract by contract basis and 

recognised as revenue upon delivery of products.

• •  Plaques (and other associated smaller merchandise) – These 

products are delivered to the customer on an ‘at-need’ basis 

(generally when the beneficiary has passed away). The revenue 

recognised for plaques and other associated smaller merchandise 

such as ash containers, vases and photos, where actual deliveries are 

not individually tracked, are managed on a portfolio basis given the 

small value of the individual items. The revenue is recognised over a 

15 year period on a straight line basis. The 15 year period represents 

an actuarial estimate of when the contracts will be delivered.

Billing and collection of memorial products contracts can be immediate 

and in full upon contract signing. However, most memorial products 

contracts are paid via instalments over a period of up to five years 

(although the payment periods do vary). The interment right, memorial 

products and plaques are each considered to be distinct performance 

obligations under AASB 15 Revenue from Contracts with Customers 

(AASB 15) as a customer can use the site without a memorial and there 

is not a transformative or integrated relationship between the products. 

The transfer of control of these distinct performance obligations 

determines when revenue should be recognised.

Revenue is measured at the fair value of the consideration received 

or receivable. Amounts disclosed as revenue are net of returns, 

allowances, duties and taxes paid.

Revenue relating to undelivered memorials and merchandise are 

deferred until delivered or made ready for use.

Minor items such as plaques, ash containers and vases where  

actual deliveries are not individually tracked are released to revenue  

over 15 years.

InvoCare            Annual Report 2020  | 79

Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report

Notes to the consolidated financial statements  
Key performance metrics continued

Note 3. Earnings per share

A. Reported period value

Basic earnings per share

Diluted earnings per share

Operating earnings per share

2020 
cents

2019 
cents

(6.9)

(6.9)

20.4

55.8

54.9

51.7

C.  Weighted average number of shares used in 

calculating basic and diluted earnings per share

2020 
Number 
’000

2019 
Number 
’000

Weighted average number of shares used in 
calculating basic earnings per share

133,927

114,189

InvoCare determines the dividends to be paid for any financial periods 

from Operating earnings after tax. Operating earnings is derived from 

Adjustments for calculation of diluted 
earnings per share:

Share options and rights *

-

1,994

Weighted average number of shares used in 
calculating diluted earnings per share

133,927

116,183

*    For the year ended 31 December 2020, the potential ordinary shares 
issued under the Performance Long-Term Incentive Plan of the Group 
were excluded from the calculation because they are anti-dilutive.

D. Accounting policy for earnings per share

Basic earnings per share is calculated by dividing the profit 

attributable to the equity holders of InvoCare Limited by the weighted 

average number of ordinary shares outstanding during the financial 

year, adjusted for any bonus elements in ordinary shares issued during 

the financial year and excluding treasury shares.

Diluted earnings per share adjusts the figures used in the 

determination of basic earnings per share to take into account the 

after income tax effect of interest and other financing costs associated 

with dilutive potential ordinary shares and the weighted average 

number of shares assumed to have been issued at no consideration 

received in relation to dilutive potential ordinary shares.

basic earnings after excluding earnings generated from all non-

operating activities and the financial impacts of pre-paid contracts. 

This is a financial measure which is not prescribed by Australian 

Accounting Standards (AASBs) and represents the earnings under 

AASBs adjusted for specific items as per the table below from the 

statement of comprehensive income.

B.  Reconciliation of earnings used in calculating 

earnings per share

2020 
$’000

2019 
$’000

Net (loss)/profit after income tax

(9,075)

63,888

Less: Non-controlling interests

(167)

(136)

Net (loss)/profit after income tax attributable 
to InvoCare Limited’s equity holders for 
calculating statutory basic and diluted 
earnings per share

Less: Non-operating items 

(9,242)

63,752

Non-operating EBITDA

4,947

7,343

Net loss/(gain) on pre-paid contracts before 
income tax

16,618

(45,550)

Depreciation and amortisation

12

13

Net impairment loss on non-current assets

19,500

24,404

Asset sales gain before income tax

(7,383)

(2,404)

Net finance costs

3,386

1,247

Income tax on non-operating items

(527)

10,261

Operating earnings after income tax for 
calculating operating earnings per share

27,311

59,066

InvoCare            Annual Report 2020  | 80

Note 4. Dividends

A. Dividends paid

2020

Dividends on InvoCare Limited’s ordinary shares

2020 interim dividend

2019 final dividend

2019

2019 interim dividend

2018 final dividend

Cents  
per share 

Total  
amount  
$’000

Tax rate for  
franking credit  
%

Percentage  
franked  
%

5.5

23.5

17.5

19.5

7,894

27,538

35,432

20,428

21,451

41,879

30

30

30

30

100

100

100

100

B.  Dividends determined and not recognised at 

C. Franking credits

year end

On 24 February 2021, the Directors determined a final dividend of 

7.0 cents per share, fully franked, to be paid on 22 April 2021. As this 

occurred after the reporting date, the dividends determined have not 

been recognised in these financial statements and will be recognised 

in future financial statements.

The Company has a Dividend Reinvestment Plan (DRP) that allows 

equity holders to elect to receive their dividend entitlement in the 

form of the Company’s ordinary shares. The price of DRP shares 

is the average market price, less a discount if any (determined by 

2020 
$’000

2019 
$’000

Franking credits available for subsequent 
financial years based on a tax rate of 30%

35,133

39,256

Franking credits available for subsequent financial years include:

• •  Franking credits that will arise from the payment of the amount of 

the provision for income tax at the reporting date

• •  Any franking debits that will arise from the payment of dividends 

recognised as a liability at the reporting date

the directors) calculated over the pricing period (which is at least 

• •  Franking credits that will arise from the receipt of dividends 

five trading days) as determined by the directors for each dividend 

recognised as receivables at the reporting date

payment date.

The Company’s DRP operates by acquiring shares on market at no 

discount. Election notices for participation in the DRP in relation to this 

final dividend must be received by 5 March 2021.

D. Accounting policy for dividends

Dividends are recognised when declared during the financial year.

InvoCare            Annual Report 2020  | 81

Performance Review12Directors’ Report3Financial Report4Other Information 
Financial Report

Notes to the consolidated financial statements  
Key performance metrics continued

Note 5. Expenses

Profit before income tax includes the following specific expenses:

A.   Finance costs

C.  Impairment loss – financial assets

2020 
$’000

2019 
$’000

Interest paid and payable

11,122

14,882

Trade receivables

Interest expense on customer advance 
payments

3,232

4,114

D.  Leases expense

2020 
$’000

2019 
$’000

3,598

1,016

Interest expense on lease liabilities

5,297

4,760

Other finance costs

3,156

1,915

Realised loss on early settlement of interest 
rate swaps

2,122

-

24,929

25,671

Expense relating to short term leases

936

569

Expense relating to leases of low value assets 
not included in short term leases

905

1,841

145

714

Interest expense on pre-paid contracts

20,277

20,331

E.   Employee benefits expense

B.  Depreciation, amortisation and impairment of 

non-current assets

Buildings

5,927

4,646

Defined contribution superannuation expense

10,993

10,750

Share-based payments expense

1,192

(206)

Property, plant and equipment

13,723

14,474

F.   Accounting policies 

Right of use assets

Total depreciation

Cemetery land

Leasehold land and buildings

Leasehold improvements

Capitalised software

Brand names

16,384

11,406

The accounting policies on the above specified expenses are located 

36,034

30,526

445

141

384

170

2,642

1,962

3,574

2,508

1,457

1,436

in the notes where the assets or liabilities are disclosed other than 

defined contribution superannuation expense disclosed below. 

Defined contribution superannuation expense

Contributions to defined contribution superannuation plans are 

expensed in the period in which they are incurred.

Amortisation of non-current assets

8,259

6,460

Total depreciation and amortisation

44,293

36,986

Impairment loss on intangibles

25,500

24,404

Impairment reversal of cemetery land

(6,000)

-

Impairment of non-current assets

19,500

24,404

Total depreciation, amortisation and 
impairment

63,793

61,390

InvoCare            Annual Report 2020  | 82

 
 
 
Note 6. Income tax

A.   Income tax expense

D.  Deferred tax liability

Current tax

Deferred tax

2020 
$’000

2019 
$’000

7,232

19,816

(614)

14,326

Under/(over) provided in prior years

1,260

(857)

Income tax expense

7,878

33,285

2020 
$’000

2019 
$’000

The deferred tax liability balances comprised  
temporary differences attributable to:

Amounts recognised in profit and loss:

Cemetery land

30,750

26,626

Property, plant and equipment

2,410

9,013

B.  Reconciliation of income tax expense  

to prima facie tax payable

(Loss)/profit before income tax

(1,197)

97,713

Prima facie tax at 30% (2019: 30%) on (loss)/
profit before income tax

(359)

29,152

Tax effect of amounts which are not 
deductible/(taxable) in calculation of 
taxable income:

Deferred selling costs

Prepayments and other

Brand names

Pre-paid contracts

Provisions

Receivables

Accruals and other

Effect of foreign tax rate differences

(296)

(685)

Deferred revenue

Acquisition costs

465

203

Leased assets

Capital gains not subject to tax as offset 
against capital losses

(405)

(1,284)

Impairment loss on intangibles

5,850

6,833

Capital losses recognised

Amounts recognised directly in equity:

Cash flow hedge reserve

11,938

12,115

485

(947)

2,408

1,900

21,777

28,202

(6,480)

(5,444)

(1,923)

(618)

(2,483)

(2,044)

(19,318)

(26,302)

(6,593)

(5,628)

-

(826)

(332)

(1,221)

32,639

34,826

Non-deductible interest expense

Effect of interest rate swap settlement

Other items (net)

232

1,005

126

-

-

(77)

6,618

34,142

Under/(over) provision in prior years

1,260

(857)

Income tax expense attributable  
to continuing operations

7,878

33,285

C.  Tax expense relating to items of other 

comprehensive income

Cash flow hedges

880

-

The net movement in the deferred  
tax liability is as follows:

Balance at the beginning of the year

34,826

24,314

Net (credit)/charge to statement of 
comprehensive income – current period

(614)

14,326

Net credit to statement of comprehensive 
income – prior periods

(1,939)

(727)

Amounts recognised directly in equity

880

692

Amounts recognised directly in equity –
transition to AASB 16

-

(5,030)

Additions from business combinations

544

-

Effect of movements in exchange rates

(1,058)

1,251

Balance at the end of the year

32,639

34,826

InvoCare            Annual Report 2020  | 83

Performance Review12Directors’ Report3Financial Report4Other Information 
 
 
Financial Report

Notes to the consolidated financial statements  
Key performance metrics continued

E. Tax losses

The Australian Group has nil capital losses (2019: $2,750,000 gross) 

available to offset against capital gains in future years. The capital 

losses carried forward at 31 December 2019, for which a deferred tax 

asset was recognised, were fully utilised against capital gains made 

during 2020. Accordingly no deferred tax asset is recognised at  

31 December 2020 in respect of tax losses.

F. Voluntary tax transparency code disclosure

The Tax Transparency Code (TTC) is a set of principles and minimum 

standards to guide medium and large businesses on public disclosure 

of tax information. The TTC was developed by the Board of Taxation 

and endorsed by the government in the Federal Budget 2016–17.

Adoption of the TTC is voluntary and intended to complement 

Australia’s existing tax transparency measures. The TTC is designed 

to encourage greater transparency within the corporate sector, 

particularly by multinationals, and to enhance the community’s 

understanding of the corporate sector’s compliance with Australian’s 

tax laws.

Companies (including entities treated as companies for Australian 

tax purposes) that are medium or large businesses are encouraged 

to adopt the TTC. For the purpose of TTC, InvoCare is classified as a 

medium business and elected to adopt TTC.

Income tax expense on reported profit was $6,618,000  

(2019: $34,142,000), representing an effective rate of 28.0%  

(2019: 35.1%). An analysis of tax paid, based on tax residency  

status, for Australia and the Group is set out below.

Profit/(loss) before income tax

Tax at nominal rate in relevant country

Increase/(decrease) due to non-temporary differences

Non-deductible acquisition costs

Capital gains offset against capital losses or not subject to tax

Impairment loss on goodwill

Foreign exempt dividends

Non-deductible interest expense

Other items

Increase/(decrease) due to temporary differences

Unrealised pre-paid contract funds under management gains and losses

Impairment of capitalised software

Impairment of cemetery land

Property, plant and equipment temporary differences

Other items

Current income tax paid or payable

Current income tax paid rate *

Current year income tax expense

Effective tax rate

Prior period tax adjustments

Australia

Group

2020 
$’000

2019 
$’000

19,924

113,501

5,977

34,050

465

(517)

-

170

(946)

-

(2,478)

(1,026)

-

165

6,655

1,853

(1,800)

(3,422)

(1,118)

5,780

29.0%

5,060

25.4%

1,427

-

68

(12,128)

-

-

(2,017)

(785)

17,386

15.3%

32,017

28.2%

(771)

2020 
$’000

(1,197)

(1,000)

465

(405)

5,411

-

232

194

6,655

1,853

(1,800)

(3,529)

(844)

7,232

25.8%

6,618

28.0%

1,260

2019 
$’000

97,173

28,467

203

(1,284)

6,833

-

-

26

(12,128)

-

-

(1,834)

(467)

19,816

20.4%

34,142

35.1%

(857)

*  Calculated as the total amount of income tax paid divided by the profit before income tax.

InvoCare            Annual Report 2020  | 84

Governance of tax planning for the Group has been delegated by 

the Board to the Audit, Risk & Compliance Committee (Committee), 

which pursues a non-aggressive tax planning strategy which is 

principled, transparent and sustainable in the long term. It oversees 

the Group’s tax affairs in a pro-active manner that seeks to maximise 

shareholder value, while operating in accordance with the law, and not 

participating in any aggressive tax planning activities. The Committee 

G.  Accounting policy for income tax

The income tax expense or benefit for the period is the tax payable on 

that period’s taxable income based on the applicable income tax rate 

for each jurisdiction, adjusted by the changes in deferred tax assets 

and liabilities attributable to temporary differences, unused tax losses 

and the adjustment recognised for prior periods, where applicable.

receives a regular report on the Group’s tax compliance. Tax planning 

Deferred tax assets and liabilities are recognised for temporary 

initiatives are not implemented until they receive approval from the 

Committee. Tax risks and opportunities are rated according to their 

differences at the tax rates expected to be applied when the assets 

are recovered or liabilities are settled, based on those tax rates that are 

potential impact which determines whether management or the 

enacted or substantively enacted.

Committee has the delegated authority to resolve the matter.

During 2020, capital gains were realised on the sale of land and 

buildings. These capital gains were partially offset against capital 

Deferred tax assets are recognised for deductible temporary 

differences and unused tax losses only if it is probable that future 

taxable amounts will be available to utilise those temporary differences 

losses ($2,750,000 gross) carried forward from the year ended  

and losses.

31 December 2019.

The Group has a limited number of international related party 

arrangements in place. They are:

• •  An Australian subsidiary receives dividends from Singapore Casket 

Company, which is resident in Singapore

• •  The New Zealand group is charged management fees, based on 

time spent, for management, administration, accounting and other 

The carrying amount of recognised and unrecognised deferred tax 

assets are reviewed at each reporting date. Deferred tax assets 

recognised are reduced to the extent that it is no longer probable 

that future taxable profits will be available for the carrying amount 

to be recovered. Previously unrecognised deferred tax assets are 

recognised to the extent that it is probable that there are future taxable 

profits available to recover the asset.

services provided by the Australian operation

Deferred tax assets and liabilities are offset only where there is a 

legally enforceable right to offset; and they relate to the same taxable 

authority on either the same taxable entity or different taxable entities 

which intend to settle simultaneously. Deferred tax balances are 

presented as non-current assets/liabilities on the balance sheet.

Current and deferred tax balances attributable to amounts recognised 

directly in equity are also recognised in equity.

• •  Loans from the Australian group to subsidiaries outside Australia 

are made occasionally under documented loan agreements.  

A loan of NZ$25,000,000 was made by InvoCare Limited to 

InvoCare Holdings New Zealand Limited on 30 April 2020

In addition to income tax paid, the Australian group paid the following 

types of taxes and fees during 2020:

• •  Payroll tax of $6,779,000 (2019: $6,608,000)

• •  Fringe benefits tax of $1,791,000 (2019: $1,663,000)

• •  Land tax on owned buildings of $5,360,000 (2019: $5,246,000),  

to various state governments

• •  Council and water rates paid to various authorities of $3,330,000 

(2019: $3,162,000)

InvoCare            Annual Report 2020  | 85

Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report

Notes to the consolidated financial statements  
Key performance metrics continued

Note 7. Cash flow information

A.   Reconciliation of cash flows from operations 

B. Non-cash investing and financing activities

with net profit after income tax

2020 
$’000

2019 
$’000

Non-cash investing and financing activities for the current and prior 

financial years are:

• •  Acquisition of right of use assets through the changes in 

accounting treatments in accordance with AASB 16 Leases  

(refer to Note 11.B for further details)

• •  Dividends satisfied by the issue of shares under the dividend 

reinvestment plan of $5,918,000 (2019: $9,137,000)

• •  Performance rights and shares issued to employees under the 

Employee Share Trusts Plan and employee share scheme for no 

cash consideration

Net (loss)/profit from ordinary activities after 
income tax

(9,242)

63,752

Adjustments for non-cash items in  
(loss)/profit from ordinary activities

Depreciation and amortisation

44,292

36,986

Impairment loss on intangibles

25,500

24,404

Impairment reversal on cemetery land

Share-based payments expense

Loan establishment costs

Net gain on disposal of property, plant and 
equipment

(6,000)

1,192

890

-

(206)

679

(7,383)

(2,352)

Unrealised loss/(gain) on pre-paid contracts

16,618

(45,550)

Other pre-paid contract movements

15,749

13,909

Interest expense: customer advance 
payments

3,232

4,114

Other non-cash deferred revenue/deferred 
selling costs movements

(26,003)

(19,251)

Business acquisition costs classified in 
investing activities

1,918

2,021

Changes in assets and liabilities, net of the  
effects of purchase and disposal of 
subsidiaries

(Increase)/decrease in trade and other 
receivables

(1,117)

(20,210)

(Increase)/decrease in inventories

(11)

(7,544)

(Increase)/decrease in deferred contract 
assets

(Increase)/decrease in deferred selling 
expenses

Increase/(decrease) in trade and other 
payables

2,383

1,905

2,217

2,222

(896)

(6,075)

Increase/(decrease) in deferred revenue

(1,583)

Increase/(decrease) in income taxes payable

1,061

538

(673)

Increase/(decrease) in deferred taxes

(1,642)

8,847

Increase/(decrease) in provisions

2,393

1,554

Net cash flows from operating activities

63,568

59,070

InvoCare            Annual Report 2020  | 86

C. Net debt reconciliation

D. Cash conversion ratio

The tables set out below provide an analysis of net debt and the 

The cash conversion ratio is one of the key cash performance metrics 

movements in net debt for the current and last financial year.

of the Group, refer to the table below for detail calculation.

Cash 
and cash 
equiv-
alents 
$’000

Borrow-
ings 
$’000

Lease 
liabilities 
$’000

Net  
debts 
$’000

The conversion ratio calculation and the line items as shown in the 

table below are all non-IFRS information. However, all financial data is 

based on the information disclosed in the audited financial statements 

and notes to the financial statements of InvoCare and follow the 

recognition requirements of Australian Accounting Standards. 

19,560

(357,189)

(162,901)

(500,530)

Although the adoption of AASB 15 and AASB 16 have significant 

2020

Net debt as at  
1 January 2020

Cash flows

99,433

106,761

11,599

217,793

financial impacts on the Group, they have had no cash impact.

Additions/variations

Interest expense on 
lease liabilities

Foreign exchange 
adjustments

Net debt as at  
31 December 2020

2019

Net debt as at  
1 January 2019

Recognised due to 
adoption of AASB16

-

-

-

-

(9,631)

(9,631)

(5,297)

(5,297)

Operating cash flows

2020 
$’000

2019 
$’000

63,568

59,070

(212)

4,389

306

4,483

118,781

(246,039)

(165,924)

(293,182)

14,776

(408,245)

-

(393,469)

-

-

(135,629)

(135,629)

Add back: Net finance costs paid

17,046

20,803

Add back: Tax paid

14,424

20,631

Net funds from pre-paid contracts

12,857

15,866

Other cash flows related to pre-paid contracts

1,429

2,406

Ungeared, tax free operating cash flows

109,324

118,776

Operating EBITDA

Cash conversion %

102,565

144,433

107%

82%

Cash flows

4,714

53,103

14,733

72,550

Additions/variations

Interest expense on 
lease liabilities

Foreign exchange 
adjustments

Net debt as at  
31 December 2019

-

-

-

-

(37,245)

(37,245)

E. Cash and cash equivalents

(4,760)

(4,760)

Cash on hand

70

(2,047)

-

(1,977)

Cash at bank

19,560

(357,189)

(162,901)

(500,530)

2020 
$’000

2019 
$’000

126

119

118,655

19,441

118,781

19,560

Cash at bank is non-interest bearing as at 31 December 2019 and 

2020. Therefore, the weighted average interest rate for cash at bank is 

rounded to zero for both 2019 and 2020.

InvoCare            Annual Report 2020  | 87

Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report

Notes to the consolidated financial statements  
Significant assets and liabilities

This section contains the key assets and liabilities in relation to the three main streams 
of businesses, being funeral business (at-need and pre-need) and the cemetery and 
crematoria business. These assets and liabilities include:

• •  Trade and receivables, deferred selling costs and revenue

• •  Pre-paid contracts from the pre-need funeral business

• •  Non-current operating assets, being the land for cemetery, crematoria,  

plant and equipment for supporting the operations and right of use assets

• •  Intangibles recognised for acquired businesses

Note 8. Trade receivables

Current

Trade receivables

Less: loss allowance

Non-current

Trade receivables

Less: loss allowance

2020 
$’000

2019 
$’000

45,230

44,351

(6,473)

(3,672)

38,757

40,679

29,445

31,480

-

(3)

29,445

31,477

A. Loss allowance

The ageing of the impaired trade receivables provided for above are as follows:

Forward aged (12 - 60 months contracts)

Current

Over 30 days past due

Over 60 days past due

Over 90 days past due

Expected credit loss rate

Carrying amount

Allowance for expected  
credit losses

2020 
%

-

0.2

1.5

10.5

39.4

2019 
%

-

0.2

1.0

8.0

21.0

2020 
$’000

36,482

13,718

5,765

3,535

15,175

74,675

2019 
$’000

32,811

20,047

4,556

2,177

16,240

75,831

2020 
$’000

-

27

86

371

5,989

6,473

2019 
$’000

-

40

46

174

3,415

3,675

The movements of loss allowance of trade receivables are as follows:

As at 1 January

2020 
$’000

2019 
$’000

3,675

3,010

Loss allowance recognised during the year

3,667

1,057

Receivables written off as uncollectable

(869)

(392)

As at 31 December

6,473

3,675

InvoCare            Annual Report 2020  | 88

B. Accounting policies

I.  Trade receivables

Trade receivables are amounts due from customers for goods sold or 

services performed in the ordinary course of business. They are initially 

recognised at the amount of consideration that is unconditional. The 

Group holds the trade receivables with the objective to collect the 

contractual cash flows and therefore measures them subsequently at 

amortised cost using the effective interest method.

2020

Note 9. Deferred selling costs and revenue

This note provided details on the movements for the deferred 

selling costs and revenue arising from the sales of pre-paid funeral, 

cremation and burial contracts and undelivered memorials and 

merchandise for the current and prior financial year.

Deferred 
selling 
costs 
$’000

Deferred 
revenue 
$’000

Trade receivables are usually due for settlement no more than  

Balance as at 1 January 2020

39,928

139,300

30 days from the date of recognition, except where extended payment 

terms (up to a maximum of 60 months) have been made available on 

cemetery and crematorium memorial contracts for sale of interment 

rights and associated memorials and other merchandise.

Receivables arising from cemetery and crematorium memorial 

contracts, which are initially expected to be collected over a period 

exceeding twelve months, are recognised as non-current receivables 

and measured as the net present value of estimated future cash 

receipts, discounted at an imputed effective interest rate. Upon initial 

recognition of the contract receivables, any undelivered portion of the 

contracts is included in deferred revenue until delivery.

II.  Loss allowance on trade receivables

Add/(less): Changes during the year

Revenue deferred: Cash received from 
customer instalment payments

Revenue recognised related to transition 
adjustment and instalments received 
during the year:

Cemetery and crematorium memorial 
products

Revenue deferred during the year:

-

9,938

(2,605)

(20,256)

Recognition of significant financing on 
customer advance payments: Cemetery and 
crematoria memorial products

-

1,955

The Group has applied the simplified approach to measuring 

expected credit losses which uses a lifetime expected loss allowance 

Revenue deferred: Cemetery and crematorium 
memorial products

520

4,720

Revenue deferred: Administration fees pre-
paid funeral service contracts

(131)

371

Recognition of significant financing on 
customer advance payments: Administration 
fees pre-paid funeral service contracts

Other movements

-

-

1,277

413

Balance as at 31 December 2020

37,712

137,718

Current

Non-current

3,644

28,632

34,068

109,086

Balance as at 31 December 2020

37,712

137,718

for all trade receivables.

To measure the expected credit losses, trade receivables have been 

grouped based on shared credit risk characteristics and the days  

past due.

When a trade receivable is uncollectible, it is written off against the 

loss allowance account for trade receivables. Subsequent recoveries 

of amounts previously written off are credited against sundry revenue 

in the consolidated statement of comprehensive income.

The occurrence of the pandemic has changed the risk characteristics 

of the Group’s trade receivables. During the year, the Group 

experienced an increase in the number and amount of uncollectible 

trade receivables, due to both the age of the balances and certain 

customers’ financial circumstance. At 31 December 2020, the 

Group’s loss allowance on trade receivables has been increased 

with all of the increase related to the Australian and New Zealand 

Funerals businesses. The increase in provision reflects the Group’s 

assessment of the potential impact of customers’ inability to repay 

debts due to financial hardship caused by the pandemic. The 

Group has implemented a range of initiatives to mitigate any further 

deterioration in the risk characteristics of its trade receivables, 

including requiring the payment of up-front deposits and the 

introduction of key performance metrics focused on collecting 

outstanding trade receivables. These initiatives have resulted in the 

increase in the cash conversion ratio in 2020, however as collection 

of older trade receivables remains challenging, an increased provision 

was recognised.

InvoCare            Annual Report 2020  | 89

Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report

Notes to the consolidated financial statements  
Significant assets and liabilities continued

2019

Deferred 
selling 
costs 
$’000

Deferred 
revenue 
$’000

Balance as at 1 January 2020

42,150

138,754

Note 10. Pre-paid contracts

A.   Statement of comprehensive income impact of 

undelivered pre-paid contracts

2020 
$’000

2019 
$’000

-

11,953

under management

3,659

65,881

Gain on pre-paid contract funds  

Add/(less): Changes during the year

Revenue deferred: Cash received from 
customer instalment payments

Revenue recognised related to transition 
adjustment and instalments received 
during the year:

Cemetery and crematorium memorial 

products

(2,036)

(16,332)

Revenue deferred during the year:

Recognition of significant financing on 

customer advance payments: Cemetery and 

crematoria memorial products

-

2,867

Change in provision for pre-paid  

contract liabilities

(20,277)

(20,331)

Net (loss)/gain on undelivered  

pre-paid contracts

(16,618)

45,550

B.   Movements in pre-paid contract funds under 

management

2020 
$’000

2019 
$’000

619,389

563,587

Revenue deferred on cemetery and 

crematorium memorial products

(209)

(1,002)

Balance as at 1 January

Revenue deferred on administration fees  

Sale of new pre-paid contracts

32,169

24,976

pre-paid funeral service contracts

23

1,614

Recognition of significant financing on 

customer advance payments: Administration 

fees pre-paid funeral service contracts

Other movements

-

-

1,247

199

Initial recognition of contracts paid by 

instalment

3,908

2,494

Redemption of pre-paid contract funds 

following service delivery

(45,026)

(40,842)

Increase/(adjustment) due to business 

Balance as at 31 December 2019

39,928

139,300

combinations

(968)

3,293

Current

Non-current

4,480

34,913

Increase in fair value of contract funds under 

35,448

104,387

management

3,659

65,881

Balance as at 31 December 2019

39,928

139,300

Balance as at 31 December

613,131

619,389

Current

Non-current

50,268

57,552

562,863

561,837

Balance as at 31 December

613,131

619,389

Accounting policies

A.  Deferred selling costs

Direct selling costs applicable to deferred revenue on undelivered 

memorials and merchandise are deferred until the revenue is 

recognised. Direct selling costs applicable to sale of pre-paid funeral, 

cremation, and burial contracts are deferred until the underlying 

service is delivered.

B.  Deferred revenue

Revenue relating to undelivered memorials and merchandise are 

deferred until delivered or made ready for use.

InvoCare            Annual Report 2020  | 90

 
 
C. Movements in pre-paid contract liabilities

E.   Classification of pre-paid funds under 

2020 
$’000

2019 
$’000

management and liabilities

Balance as at 1 January

525,383

510,044

Sale of new pre-paid contracts

32,169

24,976

The current and non-current portions of the pre-paid contract 

assets and liabilities are disclosed separately to more clearly reflect 

the expected pattern of usage associated with the timing of actual 

Initial recognition of contracts paid by 
instalment

3,908

2,494

contract redemptions.

Decrease following delivery of services

(39,460)

(35,800)

F.   Critical accounting judgements, estimates and 

Increase/(adjustment) due to business 
combinations

(968)

3,338

Increase due to significant financing

20,277

20,331

Balance as at 31 December

541,309

525,383

assumptions

I. 

 Fair value measurements – Pre-paid contract 
funds under management

The fair values of the pre-paid contract funds under management are 

44,685

48,885

recognised and measured based on inputs that require judgements 

Current

Non current

496,624

476,498

Balance as at 31 December

541,309

525,383

D.   Nature of contracts under management and 

liabilities

Pre-paid contracts are tripartite agreements, currently entered into 

and performed in Australia, whereby InvoCare agrees to deliver a 

specified funeral service, cremation or burial at the time of need and 

the beneficiary invests the current price of the service to be delivered 

with a financial institution and conditionally assigns the benefit to 

InvoCare.

and estimates. To provide an indication about the reliability of the 

inputs used in determining fair value of the pre-paid contract funds 

under management, the Group has used Level 2 inputs as prescribed 

under the accounting standards. Level 2 input for fair value is 

described as observable inputs either directly (as prices) or indirectly 

(derived from prices) for the asset or liability, other than the unadjusted 

quoted prices in active markets.

II.  Current and non-current split

The Group determines the classification of current and non-current 

portions of pre-paid contract asset and liabilities based on the pattern 

of usage (based on an independent actuarial review) associated with 

the timing of actual contract redemptions. This pattern of usage is 

based on historical data, which is reviewed annually and has remained 

The assignment of the benefit of the invested funds to InvoCare only 

consistent over the past five years.

G. Accounting policies for pre-paid contracts

The Group records the value of the invested funds as an asset and 

revalue the invested funds to fair value at the end of each reporting 

period. The Group initially recognises a liability equal to the value 

of the undelivered service associated with pre-paid contracts and 

adjusts the deferred revenue using a discount rate that results in 

revenue being recognised that approximates the cash selling price the 

customer would have paid if the consideration is paid at the same time 

as the services are provided.

When the service is delivered, the liability is derecognised and 

included in revenue.

becomes unconditional when InvoCare demonstrates that it has 

delivered the service specified. InvoCare receives the investment 

returns as well as the initial investment when the service has been 

delivered.

InvoCare permits, on request, contracts to be paid by instalments 

over periods not exceeding three years. In some instances these 

contracts are never fully paid. If, during the three year period the 

contract becomes at-need, the family is given the option of either 

paying outstanding instalments and receiving the contracted 

services at the original fixed price or using the amount paid as a part 

payment of the at-need service. If the contract is not fully paid after 

three years InvoCare only permits the family to use the amounts paid 

as a partial payment of the at-need services. At the end of the year, 

the total balance of amounts received from instalment payments for 

incomplete contracts was $6,519,397 (2019: $6,863,000).

During the year, the non-cash fair value movements (i.e. investment 

earnings) of $3,659,000 in pre-paid contract funds under 

management (2019: $65,881,000) was less than the non-cash 

growth due to interest expense increases of $20,277,000 in the 

liability for future service delivery obligations (2019: $20,331,000) due 

to lower returns on equities and property revaluations.

InvoCare            Annual Report 2020  | 91

Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report

Notes to the consolidated financial statements  
Significant assets and liabilities continued

Note 11. Non-current operating assets

This note includes the information for the following two categories of non-current operating assets:

• •  Property, plant and equipment

• •  Right of use assets and the related lease liability

A. Property, plant and equipment

2020

Composition as at 31 December 2020

Cemetery 
land 
$’000

Freehold  
land 
$’000

Buildings 
$’000

Leasehold 
land and 
buildings 
$’000

Leasehold 
Improve-
ments 
$’000

Plant and 
equipment 
$’000

Total 
$’000

Cost

122,579

100,478

246,480

4,534

33,574

160,000

667,645

Accumulated depreciation/amortisation

Accumulated impairment

(9,568)

(9,299)

-

-

Net book value

103,712

100,478

172,959

Movement for the year ended 31 December 2020

(73,521)

(3,832)

(9,188)

(97,960)

(194,069)

-

702

-

-

(9,299)

24,386

62,040

464,277

Opening net book value

97,094

102,503

148,459

843

20,187

57,868

426,954

Additions

Additions through business combinations

Disposals

Depreciation/amortisation charge

Impairment reversal

Effect of movement in exchange rates

Transfers from held for sale

1,146

-

-

(445)

6,000

(83)

-

515

-

32,478

-

(2,670)

(2,090)

-

-

-

6,310

15,939

56,388

668

(102)

1,697

2,365

408

(4,454)

(5,927)

(141)

(2,642)

(13,723)

(22,878)

-

-

(1,671)

(1,177)

1,801

1,216

-

-

-

-

(35)

-

-

6,000

(149)

(3,115)

-

3,017

Closing net book value

103,712

100,478

172,959

702

24,386

62,040

464,277

2019

Composition as at 31 December 2019

Cost

121,519

102,503

216,309

4,534

27,166

142,229

614,260

Accumulated depreciation/amortisation

Accumulated impairment

(9,126)

(15,299)

-

-

Net book value

97,094

102,503

148,459

Movement for the year ended 31 December 2019

(67,850)

(3,691)

(6,979)

(84,361)

(172,007)

-

843

-

-

(15,299)

20,187

57,868

426,954

Opening net book value

92,386

101,965

130,825

1,013

14,289

66,723

407,201

Additions

Business combinations

Disposals

Depreciation/amortisation charge

Effect of movement in exchange rates

Transfers to held for sale

Closing net book value

2,037

3,000

-

(384)

30

25

-

21,899

1,390

2,229

(625)

(820)

-

-

-

7,180

21,044

52,160

-

209

6,828

(56)

(15,997)

(17,498)

-

(4,646)

(170)

(1,962)

(14,474)

(21,636)

504

(731)

334

(1,362)

-

-

11

725

137

226

1,016

(1,117)

97,094

102,503

148,459

843

20,187

57,868

426,954

InvoCare            Annual Report 2020  | 92

-

-

-

 
I.  Assets in the course of construction

III. Asset held for sale

The carrying amounts of assets disclosed above include the following 

Asset held for sale represents property identified as surplus to the 

expenditure recognised in relation to property, plant and equipment 

Group’s requirement pursuant to the Network & Brand Optimisation 

which is in the course of construction.

review carried out as part of the Protect & Grow Plan.

Cemetery land improvements

Freehold buildings

Leasehold improvements

Plant and equipment

2020 
$’000

2019 
$’000

31

5,571

6,945

22,262

574

2,164

5,141

19,716

Total assets in the course of construction

12,691

49,713

II.  Impairment

All cemetery and crematorium sites were assessed during the year 

using consistently applied methodology and no changes to the 

impairment provision were deemed necessary except as noted below.

B. Right of use assets and lease liabilities

The Group leases various properties, cemeteries, equipment and 

motor vehicles. Rental contracts are typically made for fixed periods of 

5 to 10 years, with some leases for periods of 30 years.

Extension and termination options are included in a number of 

property leases across the Group. These terms are used to maximise 

operational flexibility in terms of managing contracts. The majority of 

extension and termination options held are exercisable only by the 

Group and not by the respective lessor.

Lease terms are negotiated on an individual basis and contain a wide 

range of different terms and conditions. The lease agreements do 

not impose any covenants, and leased assets may not be used as 

In 2017, the Allambe Gardens Memorial Park was impaired due to a 

security for borrowing purposes.

This section provides information for leases where the Group is a 

lessee. The consolidated balance sheet shows the following types of 

assets and liabilities related to leases:

• •  Right of use assets

• •  Lease liabilities

reassessment of the land available for memorialisation plots. In 2018, 

remediation of the residual land at the Memorial Park commenced. 

The remediation of the residual land was completed in January 

2020, with sales of burial sites in the new Lakeside development 

commencing in 2020. Once all phases of the monumental 

developments are complete, the Lakeside development will ultimately 

result in over 3,000 burial spaces, increasing the lifespan of the park 

by a further 40 years. As a result, a reversal of $6,000,000 of the 

previous impairment has been recognised at 31 December 2020 

(2019: Nil).

The recoverable amount of cash-generating units is based on  

value-in-use calculations. These calculations use cash flow 

projections based on financial estimates approved by management 

based on past performance and future expectations. The cash flows 

cover an initial five-year period and are then extrapolated beyond 

five years using estimated growth rates of 2.5% (2019: 3%) in 

revenue and 2% (2019: 3%) in expenses which are not inconsistent 

with historical trends and forecasts included in reports prepared by 

market analysts. A sensitivity analysis has been conducted on the 

impaired sites by moving the underlying assumptions both up and 

down 10%, considered to be within the reasonably possible range of 

long-term outcomes. This analysis demonstrates that changing the 

assumptions is unlikely to result in a material change in the currently 

recognised impairment losses. The pre-tax discount rate used was 

9.2% (2019: 9.2%), reflecting the risk estimates for the business as  

a whole.

InvoCare            Annual Report 2020  | 93

Performance Review12Directors’ Report3Financial Report4Other InformationProperties 
$’000

Equipment 
$’000

Motor vehicles 
$’000

Financial Report

Notes to the consolidated financial statements  
Significant assets and liabilities continued

I.  Right of use assets

2020

Composition as at 31 December 2020

Cost

Accumulated depreciation

Net book value

Movement for the year ended 31 December 2020

Opening net book value

Additions

Additions through business combinations

Depreciation

Effect of movement in exchange rates

Closing net book value

2019

Composition as at 31 December 2019

Cost

Accumulated depreciation

Net book value

Movement for the year ended 31 December 2019

Opening net book value

Additions

Depreciation

Effect of movement in exchange rates

Closing net book value

II. Lease liabilities on related right of use assets

Current

Non-current

Balance as at 31 December

156,103

(22,924)

133,179

129,359

9,309

6,978

(12,774)

307

133,179

140,536

(11,177)

129,359

121,641

18,895

(11,012)

(165)

129,359

2020 
$’000

19,465

146,459

165,924

721

(365)

356

425

27

-

(96)

-

356

694

(269)

425

590

104

(262)

(7)

425

2019 
$’000

12,934

149,967

162,901

Total 
$’000

171,304

(26,936)

144,368

14,480

(3,647)

10,833

14,217

144,001

130

-

(3,514)

-

10,833

14,350

(133)

14,217

22

14,328

(132)

(1)

9,466

6,978

(16,384)

307

144,368

155,580

(11,579)

144,001

122,253

33,327

(11,406)

(173)

14,217

144,001

InvoCare            Annual Report 2020  | 94

 
 
 
C.  Critical accounting judgements, estimates and 

The cost of improvements to or on leasehold properties is amortised 

assumptions

I.  Estimated impairment of non-financial assets

The Group annually considers if events or changes in circumstances 

indicate that the carrying value of non-financial assets may not be 

recoverable. Similarly, at each reporting date, the non-financial assets 

that suffered a previous impairment are reviewed for possible reversals 

of the impairment. The recoverable amounts are determined based on 

value-in-use calculations which require the use of assumptions. Refer 

to section Note A.II above for details of these assumptions and the 

potential impact to changes to the assumptions.

II.  Determining the lease term

In determining the lease term, management considers all facts and 

circumstances that create an economic incentive to exercise an 

extension option, or not exercise a termination option. Extension 

options (or periods after termination options) are only included in the 

lease term if the lease is reasonably certain to be extended (or not 

over the unexpired period of the lease or the estimated useful life of the 

improvement to the Group, whichever is shorter. The assets’ residual 

values and useful lives are reviewed, and adjusted if appropriate, 

at each balance sheet date. Gains and losses on disposals are 

determined by comparing proceeds with the carrying amount. Gains 

and losses are included in the statement of comprehensive income.

II.  Right of use assets and lease liabilities

InvoCare recognises a right of use asset and a corresponding liability 

at the date at which the leased asset is available for use by the Group. 

Each lease payment is allocated between the liability and finance 

cost. The finance cost is charged to profit or loss over the lease 

period so as to produce a constant periodic rate of interest on the 

remaining balance of the liability for each period. The right of use asset 

is depreciated over the shorter of the asset’s useful life and the lease 

term on a straight line basis.

Assets and liabilities arising from a lease are initially measured on a 

present value basis. Lease liabilities include the net present value of 

terminated). The Group has assessed it is reasonably certain that it will 

the following lease payments:

exercise its option to renew all leases.

• •  Fixed payments (including in-substance fixed payments), less any 

The assessment is reviewed if a significant event or a significant 

lease incentives receivable

change in circumstances occurs which affects this assessment and 

that is within the control of the Group.

D. Accounting policies

I.  Property, plant and equipment

Property, plant and equipment are carried at historical cost less 

• •  Amounts expected to be payable by the Group under residual 

value guarantees

• •  Exercise price of a purchase option if the Group is reasonably 

certain to exercise that option

• •  Payments of penalties for terminating the lease, if the lease term 

reflects the Group exercising that option

depreciation or amortisation. Historical cost includes expenditure that 

The lease payments are discounted using the interest rate implicit in 

is directly attributable to the acquisition of the items.

the lease. If that rate cannot be determined, the Group’s incremental 

Subsequent costs are included in the asset’s carrying amount or 

recognised as a separate asset, as appropriate, only when it is 

probable that future economic benefits associated with the item 

borrowing rate is used, being the rate that the Group would have to 

pay to borrow the funds necessary to obtain an asset of similar value in 

a similar economic environment with similar terms and conditions.

will flow to the Group and the cost of the item can be measured 

Right of use assets are measured at cost comprising the following:

reliably. Repairs, maintenance and minor renewals are charged to 

the statement of comprehensive income during the financial period in 

which they are incurred.

Cemetery land is carried at cost less accumulated depreciation and 

impairment write-downs. The Group sells interment and inurnment 

rights while retaining title to the property. Cemetery land is amortised, 

as the right to each plot or space is sold, to write off the net cost of the 

land over the period in which it is utilised and an economic benefit has 

been received. Other freehold land is not depreciated or amortised.

Depreciation of other assets is calculated using the straight line 

method to allocate their cost or revalued amounts, net of their residual 

values, over their estimated useful lives, as follows:

• •  Buildings: 40 years

• •  Plant and equipment: 3-10 years

• •  Amount of the initial measurement of lease liability

• •  Any lease payments made at or before the commencement date 

less any lease incentives received

• •  Any initial direct costs

• •  Restoration costs

Payments associated with short term leases and leases of low-value 

assets (less than $10,000) are recognised on a straight line basis as 

an expense in profit or loss. Short term leases are leases with a lease 

term of 12 months or less. Low-value assets comprise information 

technology equipment and small items of office equipment.

InvoCare            Annual Report 2020  | 95

Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report

Notes to the consolidated financial statements  
Significant assets and liabilities continued

Note 12. Intangibles

2020

Composition as at 31 December 2020

Cost

Accumulated amortisation

Impairment

Net book value

Movement for the year ended 31 December 2020

Opening net book value

Additions

Goodwill 
$’000

Brand  
name 
$’000

Capitalised 
software 
$’000

Total 
$’000

256,066

19,748

45,351

321,165

-

(13,349)

(14,765)

(28,114)

(43,360)

-

(6,176)

(49,536)

212,706

6,399

24,410

243,515

182,469

6,465

21,790

210,724

-

-

12,011

12,011

Additions through business combinations

51,676

1,491

366

53,533

Amortisation charge

Impairment loss

Effect of movement in exchange rates

Closing net book value

2019

Composition as at 31 December 2019

Cost

Accumulated amortisation

Impairment

Net book value

Movement for the year ended 31 December 2019

Opening net book value

Additions

Additions through business combinations

Finalisation of prior period acquisitions

Disposals

Amortisation charge

Impairment loss

Effect of movement in exchange rates

Closing net book value

-

(1,457)

(3,574)

(5,031)

(19,324)

-

(6,176)

(25,500)

(2,115)

(100)

(7)

(2,222)

212,706

6,399

24,410

243,515

206,949

18,549

32,897

258,395

-

(12,084)

(11,107)

(23,191)

(24,480)

-

-

(24,480)

182,469

6,465

21,790

210,724

197,541

7,258

18,377

223,176

-

7,210

1,550

(275)

-

629

-

(9)

5,921

-

-

-

5,921

7,839

1,550

(284)

-

(1,436)

(2,508)

(3,944)

(24,404)

847

-

23

-

-

(24,404)

870

182,469

6,465

21,790

210,724

InvoCare            Annual Report 2020  | 96

 
A. Impairment test for goodwill

B. Goodwill

Impairment tests are performed annually, or more frequently if events 

or circumstances indicate that the carrying amount may not be 

recoverable.

For the Group’s Australian-based operations, goodwill cannot be 

allocated on a non-arbitrary basis to individual cash generating 

unit (CGU) due to the significant history of numerous acquisitions, 

especially during the years 1993 to 1999, 2018 to 2020, and resulting 

post-acquisition business integration activities and operational 

changes over many years. New Zealand and Singapore operations 

are separate CGU and the associated goodwill arising from their 

acquisition have been allocated to the individual New Zealand or 

Singapore CGU. As a result, the lowest level within the Group at which 

goodwill is monitored for management purposes comprises the 

grouping of all CGUs within a country of operation. The recoverable 

amounts of the total of Australia, New Zealand and Singapore CGUs 

I. 

Impairment of New Zealand CGU

Recoverable amount testing for the period ended 31 December 2020 

has identified the New Zealand CGU as being impaired.

As at 31 December 2020, an impairment charge of $19,324,000 

of goodwill has been applied as the carrying amount of goodwill, 

property, plant & equipment, right of use assets and brand names 

exceeded its recoverable amount within the New Zealand business 

CGU. The disruption caused by COVID-19 and the subsequent 

restrictions imposed by the New Zealand government have hampered 

the Group’s ability to operate to planned expectations previously 

used to assess the recoverable amount of this business. While some 

progress had been made to improve the business, the reassessment 

of recoverable value has resulted in a further impairment charge of 

$19,324,000 of goodwill for the year ended 31 December 2020.

are based on value-in-use calculations. These calculations use cash 

New Zealand is a very traditional market that is fragmenting on price 

flow projections based on approved financial estimates covering a 

as customer demand has shifted to lower value packages rather 

five year period. Cash flows beyond the five year period have been 

than larger traditional funeral services. This change in consumer 

extrapolated using estimated growth rates. The assessment also 

behaviour was previously experienced in Australia prompting the 

considered the reasonable possible long term shift in key assumptions 

NBO strategy and it was mitigated by the Group’s ability to leverage 

which may potentially cause an impairment to arise.

brands such as Simplicity and Value Cremations. The pandemic has 

accelerated the change in New Zealand, as restrictions on the number 

of funeral attendees and economic pressure on household incomes 

has contributed to customers choosing a simpler funeral service for 

their loved ones. The Simplicity brand provides some mitigation to 

the impact of this change on customer preference. Notwithstanding 

the impairment, the Group remains confident that the quality of our 

frontline team in New Zealand will continue to provide excellent service 

to our client families.

The remaining goodwill acquired through business combinations or 

territory acquisitions has been allocated to a reportable segment for 

impairment testing (refer Note 1).

II.  Sensitivity – New Zealand CGU

Each of the sensitivities below assumes that a specific assumption 

moves in isolation, while other assumptions are held constant.  

A change in one of the key assumptions could be accompanied by 

a change in another assumption, which may increase or decrease 

the net impact. A reasonable possible shift in these key assumptions 

would result in the following outcomes:

• •  Terminal growth rate decreased by 0.5%: $4,800,000  

(2019: $6,007,000) additional impairment

• •  Post-tax weighted average cost of capital increase by 0.3%: 

$3,789,000 (2019: $4,713,000) additional impairment

InvoCare            Annual Report 2020  | 97

Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report

Notes to the consolidated financial statements  
Significant assets and liabilities continued

C.  Key assumptions used for value-in-use 

E.   Critical accounting judgements, estimates and 

calculations

assumptions

Budgeted cash flows have been based on past performance and 

The Group annually considers if events or changes in circumstances 

expectations for the future. The growth rates of 2.5% (2019: 3%) in 

indicate that the carrying value of goodwill or cash-generating units 

revenue, 2% (2019: 3%) in expense and 1% (2019: 1%) in volume 

may not be recoverable. Similarly, at each reporting date, cash-

growth projections are not inconsistent with historical trends and 

generating units that suffered a previous impairment are reviewed 

forecasts included in reports prepared by market analysts. In the 

for possible reversals of the impairment. The recoverable amounts 

calculation of the terminal value, the long term annual growth rate 

are determined based on value-in-use calculations which require the 

of the real gross domestic product (GDP) of the country is used as a 

use of assumptions. Refer to section C. above for details of these 

basis for the terminal growth rate. For goodwill, these assumptions are 

assumptions and the potential impact to changes to the assumptions.

based on the CGU to which the goodwill is attributed.

The pre-tax discount rate used for assessing the carrying value of 

F.  Accounting policies

goodwill in each CGU was as follows:

Australian operations

Singapore operations

New Zealand operations

2020 
%

2019 
%

9.2

9.2

9.2

9.2

10.0

10.0

I.  Goodwill

Goodwill arises on acquisition of business/subsidiary. Goodwill 

acquired in business combinations is not amortised. Instead, goodwill 

is tested for impairment annually or more frequently if events or 

changes in circumstances indicate that it might be impaired, and 

is carried at cost less accumulated impairment losses. Impairment 

losses on goodwill are taken to profit or loss and are not subsequently 

These discount rates reflect the risk estimates for each business as  

reversed if the related assets subsequently increases in value.

a whole.

Sensitivity analysis indicates significant headroom exists in the  

value-in-use calculations for Australia and Singapore CGUs 

compared to the carrying value of goodwill. There is no reasonable 

possible long term shift in key assumptions considered likely which 

will cause impairment of either of these two CGUs.

D. Capitalised software

I. 

Impairment of Oracle cloud ERP (Compass)

The Group has been on a three year enterprise resource planning 

(ERP) and digital transformation journey, with the journey set to 

continue with a second phase of enhancements and transitioning 

the Memorial Parks business onto the Oracle cloud ERP platform 

(referred to as Compass), including providing a digital interface for 

our customers and suppliers. The Group remains committed to 

Compass. There have been some challenges through the journey 

with some lessons learnt from the early phases of the implementation. 

The Group has continued to enhance and update functionality 

of Compass in 2020. These enhancements have resulted in the 

replacement of certain functionality and significant improvements 

in certain modules to ensure the asset is operating as intended. 

A detailed analysis of the modules, integrations and functionality 

of Compass has identified some modules as having indicators of 

impairment at 31 December 2020. As a result, an impairment charge 

of $6,176,000 of capitalised software has been recognised.

II.  Trademarks and brand names

Trademarks and brand names recognised through business 

acquisitions have a finite useful life and are carried at cost less 

accumulated amortisation and impairment losses. Amortisation 

is calculated using the straight line method to allocate the cost of 

trademarks and brand names over their estimated useful lives of ten 

years.

III. Capitalised software

Capitalised software is carried at historical cost less accumulated 

amortisation and impairment write-downs. Historical cost includes 

expenditure that is directly attributable to the acquisition of the 

software. Amortisation is calculated using the straight line method to 

allocate the cost of software over its estimated useful life of ten years.

IV.  Impairment of assets

Assets that have an indefinite useful life are not subject to amortisation 

and are tested annually for impairment or half yearly only if events 

or changes in circumstances indicate that the carrying amount 

may not be recoverable. Assets that are subject to depreciation or 

amortisation are reviewed for impairment indicators every six months. 

An impairment loss is recognised for the amount by which the asset’s 

carrying amount exceeds its recoverable amount. The recoverable 

amount is the higher of an asset’s fair value less costs to sell and 

value-in-use. For the purposes of assessing impairment, assets are 

grouped at the lowest levels for which there are separately identifiable 

cash flows (cash-generating units).

InvoCare            Annual Report 2020  | 98

Financial Report

Notes to the consolidated financial statements  
Capital and risks

The Group’s activities expose it to a variety of financial risks. The Group’s overall financial 
risk management strategy focuses on the unpredictability of financial markets and seeks 
to minimise adverse effects on the Group’s financial performance. This section contains 
disclosures of financial risks the Group is exposed to and how the Group manages those risks.

The capital management, impact of contingencies, commitments, and events subsequent to 
reporting period are also considered in this section.

Note 13. Financial risk management

The Group operates in different jurisdictions and markets. Strategic risk management is carried out by the Board of Directors. The Audit, Risk & 

Compliance Committee, which operates under policies approved by the Board, is responsible for operational and financial risk management. These 

policies provide written principles for overall risk management, as well as policies covering specific areas such as interest rate risk and currency risk.

The table below summarises the key risks identified, exposures, and management of exposures.

Risk identified

Definition

Exposures

Management of exposures

Market risk –  

The risk that the value of a 

• •  Financial assets: mainly cash at bank

• •  Fixed interest rate borrowings

interest rate

financial asset or liability or 

cash flow associated with the 

financial asset or liability will 

fluctuate due to changes in 

market interest rates

• •  Financial liabilities: mainly borrowings, pre-
paid contract liabilities, lease liabilities

• •  Derivative financial instruments, mainly 

interest rate swaps

• •  Further information for interest rate risk 
exposure and hedging effectiveness is 
provided in section A below 

• •  Managing to the hedge limits in respect of 
the policies as approved by the Board

• •  Speculative trading is not permitted

Market risk – 

The risk in local currency 

• •  Foreign currency earnings

• •  Physical financial instruments, including 

foreign currency

terms that the value of a 

• •  Net investments in foreign operations

financial commitment or a 

recognised asset or liability, 

will fluctuate due to changes 

in foreign currency exchange 

rates

• •  Foreign currency borrowings

• •  Further information on foreign currency risk 
exposures is provided in section B below

Market risk – 

The risk that the investment 

price

returns of funds under 

• •  Investment returns of the funds under 
management of pre-paid contracts

management on pre-paid 

contracts impact future 

income

• •  Majority of the funds under management is 
placed with the Over Fifty Guardian Friendly 
Society (OFGFS)

• •  Further information on pricing risk exposures 

is provided in section C below

natural hedges from matching foreign assets 
and liabilities

• •  Speculative trading is not permitted

• •  Maintain Board representation in OFGFS

• •  Monitor the investment strategy of OFGFS 

and the investment assets mix

Credit risk

The risk that a counterparty 

• •  Recoverability of receivables

• •  The Group’s policy is to only deal with banks 

will not be able to meet its 

• •  Recoverability of other financial assets and 

obligations in respect of a 

cash deposits

financial instrument, resulting 

in a financial loss to the Group

• •  Further information on credit risk exposures 

is detailed in section D below

and financial institutions with minimum 
independent credit ratings

• •  Operations of the Group results in no 

concentration of customers in any particular 
region or sector enhanced

• •  Enhanced alternative payment methods for 

customers in regional areas

Liquidity risk

The risk of having insufficient 

• •  Insufficient levels of committed credit 

• •  Maintaining sufficient levels of cash 

funds to settle financial 

facilities

liabilities as and when they 

• •  Settlement of financial liabilities

fall due

• •  Further information on liquidity risk 

exposures is detailed in section E below

and committed credit facilities to meet 
financial commitments and working capital 
requirements

• •  Timely review and renewal of credit facilities

InvoCare            Annual Report 2020  | 99

Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report

Notes to the consolidated financial statements  
Capital and risks continued

The Group holds the following financial assets and liabilities.

The interest rate swaps position and the coverage on outstanding 

2020 
$’000

2019 
$’000

bank borrowings as at end of the financial years are set out in the table 

below.

Financial assets

Cash and cash equivalents

118,781

19,560

Trade receivables

68,202

72,149

Pre-paid contract funds under management

613,131

619,389

Other financial assets

Financial liabilities

Trade and other payables

Contingent considerations

Borrowings

Lease Liabilities

4

4

800,118

711,102

60,514

60,810

17,174

894

246,039

357,189

165,923

162,901

Derivative financial instruments

1,148

4,157

Bank borrowings a

Effective average interest rate as at  

31 December

Interest rate swaps position as at  
31 December

2020 
%

2019 
%

3

4

Weighted average fixed interest rate payable

2.49

2.34

Weighted average variable interest rate 

receivable

0.12

1.03

Interest rate swaps coverage on outstanding bank borrowings

Australia

New Zealand

Singapore b

490,798

585,951

Combined Australia and New Zealand

39

40

Nil

30

93

87

Nil

91

A.   Interest rate risk exposure  
(cash flow and fair value)

The Group’s main interest rate risk arises from long term borrowings. 

All bank borrowings are initially at variable interest rates determined by 

a margin over the reference rate based on the Group’s leverage ratio. 

Borrowings issued at variable rates expose the Group to cash flow 

interest rate risk. The Group’s policy is to keep 75% of debt, measured 

by individual currency, on fixed interest rates over the next 12 months 

by entering into interest rate swap contracts. The policy, however, 

provides flexibility to reduce the level of coverage in low interest rate 

currency or when the interest rate outlook is relatively benign. The 

Group has entered into interest rate swap contracts under which it 

receives interest at variable rates and pays interest at fixed rates.

In addition to bank borrowings, the Group also entered into a note 

purchase agreement in February 2018 that is denominated in 

Australian dollars at a fixed interest rate. This assists in minimising the 

Group’s overall interest rate risk.

a    The effective average interest rate includes swaps and margins but 

excluding establishment fees.

b    Due to the relative stability of Singapore interest rates, Singapore 
denominated debt has been allowed to stay at floating rates.

Hedging for interest rate risk exposure

Hedge effectiveness is determined at the inception of the hedge 

relationship, and through periodic prospective effectiveness 

assessments to ensure that an economic relationship exists between 

the hedged item and hedging instrument.

The Group enters into interest rate swaps that have similar critical 

terms as the hedged item, such as reference rate, reset dates, 

payment dates, maturities and notional amount. The Group does not 

hedge 100% of its loans; therefore the hedged item is identified as a 

proportion of the outstanding loans up to the notional amount of the 

swaps. As all critical terms matched during the year, the economic 

relationship was 100% effective.

Hedge ineffectiveness for interest rate swaps is assessed by 

performing a qualitative assessment of effectiveness. If changes 

in circumstances affect the terms of the hedged item such that the 

critical terms no longer match exactly with the critical terms of the 

hedging instrument, the Group uses the hypothetical derivative 

method to assess effectiveness.

Hedge ineffectiveness may occur due to:

• •  The credit value/debit value adjustments on the interest rate swaps 

which is not matched by the loans

• •  Differences in critical terms between the interest rate swaps and 

loans

InvoCare            Annual Report 2020  | 100

 
The following variable rate bank borrowings and interest rate swap contracts are outstanding at the reporting date.

Variable borrowings

Interest rate swaps (notional principal)

Net exposure to cash flow interest rate risk

2020

2019

Weighted average 
interest rate  
%

2.71

2.49

Weighted average 
interest rate  
%

3.94

2.34

Balance  
$’000

114,308

(44,723)

69,585

The notional principal amounts and swap liability periods of expiry of the interest rate swap contracts are as follows.

Less than one year

One to two years

Two to three years

Three to four years

Nominal value

Swap liability

2020 
$’000

30,681

14,042

-

-

2019 
$’000

74,400

54,000

49,000

25,000

2020 
$’000

600

548

-

-

44,723

202,400

1,148

Balance  
$’000

259,600

(202,400)

57,200

2019 
$’000

984

1,340

1,143

690

4,157

These contracts require settlement of net interest receivable or 

payable each 90 days. The settlement dates coincide with the dates 

on which interest is payable on the underlying debt.

As a consequence, the Group is exposed to interest rate risks on that 

B.  Foreign currency risk exposure

The Group rarely undertakes significant commercial transactions 

in currencies other than in the functional currency of the operating 

subsidiaries in New Zealand and Singapore.

portion of total borrowings not swapped to fixed rates and to potential 

Foreign currency risks arise from recognised assets and liabilities 

movements in the margin due to changes in the Group’s leverage 

ratio. Where possible, borrowings are made in the same country 

as the operation being funded to provide a natural hedge against 

currency volatility. Where this is not possible, other techniques, such 

as foreign currency bank accounts, are used to mitigate the profit and 

loss volatility due to currency movements.

Due to the use of floating to fixed interest rate swaps, the Group has 

fixed interest commitments and the changes in the fair value of the 

that are denominated in a currency other than the Group’s functional 

currency, the Australian dollar. The major foreign currency risk relates 

to the investments in subsidiaries in New Zealand and Singapore. This 

exposes the Group to foreign currency risk on the assets and liabilities.

Borrowings have been made by the New Zealand subsidiary and by 

the Group in Singapore dollars to provide a natural hedge against the 

risk of changes in exchange rates in New Zealand and Singapore. 

The borrowings in Singapore dollars are therefore a hedge of a net 

future cash flows of these derivatives are recognised in equity to the 

investment in a foreign subsidiary.

extent that the derivative remains effective in accordance with AASB 9 

Financial Instruments.

The interest rate swap contracts were all judged to be effective at 

31 December 2020 and the movements in the fair value of these 

instruments have been quarantined in equity.

The overall impact and sensitivities of the interest bearing assets and 

liabilities and related derivatives of the Group has been summarised in 

section G Summarised sensitivity analysis in this note.

The Group has no significant unhedged foreign exchange exposures 

at 31 December 2020. Therefore, there was no ineffectiveness to be 

recorded from net investments in foreign entity hedges.

The Group’s exposure to foreign currency risk at the end of the 

reporting period, expressed in Australian dollars, was as follows.

New Zealand dollars

Singapore dollars

2020 
$’000

2019 
$’000

2020 
$’000

2019 
$’000

Borrowings

50,000

72,000

35,000

37,100

Derivatives

678

1,334

-

-

InvoCare            Annual Report 2020  | 101

Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report

Notes to the consolidated financial statements  
Capital and risks continued

C. Price risk exposure

The Group is the ultimate beneficiary of pre-paid contract funds under 

management (Invested Funds) invested in various pre-paid contract 

trusts, as described in Note 10.D. There are a significant number of 

trusts in existence with various investment profiles.

Other than disclosed above, the Group does not hold any investments 

in equities or commodities and is therefore not subject to price risk.

Based on the asset allocation as at 31 December 2020 and  

31 December 2019 the following changes in investment returns are 

Accordingly, the Group’s future income is sensitive to the price risk 

reasonably probable.

relating to the investment returns of these funds under management. 

These funds are invested in a range of asset classes with different 

price risk variables including cash, fixed interest, Australian and 

international equities, hybrids and direct and indirect property. The 

return on these funds (net of the increase in the liability to deliver the 

future services) are recognised in the statement of comprehensive 

income.

88% of the funds are managed by the Over Fifty Guardian Friendly 

Society (OFGFS) which is controlled by a five-member independent 

Board with two InvoCare representatives. Non OFGFS funds primarily 

invested in capital guaranteed funeral bonds managed by a range of 

APRA regulated institutions.

The OFGFS Board has appointed an Investment Committee (GIC) 

which is responsible for the management of the Invested Funds in 

accordance with an approved Investment Policy Statement (IPS). 

The IPS provides guidance on the ongoing prudent and efficient 

management of the investment arrangements. The principle objective 

of the Invested Funds is to maximise returns without exceeding risk 

levels specified in the Investment Guidelines. By pursuing these 

objectives, the Invested Funds are expected to provide a long-term 

rate of return sufficient to meet the original plus subsequent increases 

in retail prices of delivering the promised funeral services after 

considering all Invested Funds expenses and tax.

The GIC regularly sets a target asset allocation to ensure investment 

activity sits within the stated risk profile and to also ensure that other 

limits specified in the IPS are being met. External consultants are 

engaged to review the risk and return forecasts on a regular basis and 

recommend amendments to the target asset allocation if required.

Normally funds are invested for extended periods, with the median life 

of a pre-paid funeral contract being circa nine years. Liquidity risk is 

considered low with the flow of funds from the sale of new contracts 

exceeding redemptions in most years. The fund can therefore take 

a long-term view on its investment horizon and absorb short term 

fluctuations in returns caused by market volatility.

The asset allocation at year end of pre-paid contract funds under 

management is as follows.

Equities

Property

Cash and fixed interest (includes hybrid 

securities)

2020 
%

2019 
%

40

28

32

43

27

30

Asset class

Equities  
(plus or minus 10%)

Property  
(plus or minus 3%)

Cash and fixed 
interest (no price risk)

2020

2019

Increase 
$’000

Decrease 
$’000

Increase 
$’000

Decrease 
$’000

20,819

(20,819)

26,875

(26,875)

4,305

(4,305)

4,993

(4,993)

-

-

-

-

25,124

(25,124)

31,868

(31,868)

D. Credit risk exposure

Credit risk is managed on a Group basis. Credit risk arises from cash 

and deposits with banks and financial institutions, derivative financial 

instruments, as well as credit exposures to customers, including 

outstanding receivables and committed transactions. For banks and 

financial institutions, only independently rated parties with a minimum 

rating of AA- are accepted.

Credit risks in relation to customers are highly dispersed and without 

concentration on any particular region or sector. The trade receivables 

are non-interest bearing. Funeral homes attempt to collect deposits at 

the time the service is commissioned both as a sign of good faith and 

in order to cover out-of-pocket expenses. Cemetery and crematorium 

products are generally not delivered prior to the receipt of all or 

substantially all of the amounts due.

The Group applies the simplified approach to measuring expected 

credit losses which uses a lifetime expected loss allowance for all 

trade receivables.

To measure the expected credit losses, trade receivables have been 

grouped based on shared credit risk characteristics and the days past 

due. The expected loss rates are based on the payment profiles of 

sales over a period of rolling 24 months before the financial year end 

31 December 2020. Refer to Note 8 for details of loss allowance and 

movement for the financial year.

The Group’s own collection activity, which varies based on the 

nature and relative age of the debt, is routinely applied to all past due 

accounts. When these activities do not result in a successful recovery 

of the debt, it is referred to external debt collection agencies.

Trade receivables are written off when there is no reasonable 

expectation of recovery. Indicators which include amongst others, 

is the failure of the debtor to engage in a repayment plan with the 

InvoCare            Annual Report 2020  | 102

Group. Once all attempts to recover the debt have been exhausted, 

As at 31 December 2020, the details of the facilities available, drawn 

then a debt is considered to be in default and written off. Subsequent 

down, unused by facilities are disclosed in the table below.

recoveries of amounts previously written off are credited against 

sundry revenue in the consolidated income statement.

E.  Liquidity risk exposure

Prudent liquidity management implies maintaining sufficient cash and 

marketable securities, the availability of funding through an adequate 

amount of committed credit facilities and the ability to close out 

market positions. Due to the relatively stable nature of the Group’s 

business, management aims to maintain a large portion of committed 

Total facilities available

Working capital facility  

– expiring within one year

Unsecured loan facility  

– expiring in two to five years

credit lines on a long term basis.

Drawn down as at 31 December

On 19 June 2020, InvoCare completed the extension to February 2023 

of its $200,000,000 three-year revolving debt facility, which was due 

to expire in February 2021.

This $200,000,000 debt facility is currently undrawn.

Working capital facility  

– expiring within one year

Unsecured loan facility *  

– expiring in two to five years

During April and May 2020, the Group completed an Institutional 

Placement and a Share Purchase Plan and raised a total of 

Unused as at 31 December

$274,034,000, gross of transaction costs. The net proceeds of the 

capital raised are to be utilised to reduce net debt, increase liquidity 

and balance sheet flexibility to support the business during the current 

uncertain environment and to fund growth initiatives.

With the reduction in net debt post capital raised, the covenant ratios 

of the Group continued to be met as per the facilities agreements as at 

31 December 2020.

The facilities agreements covenants ratios are calculated on a rolling 

12-month basis and are:

Working capital facility  

– expiring within one year

Unsecured loan facility *  

– expiring in two to five years

2020 
$’000

2019 
$’000

7,440

9,638

448,702

450,000

456,142

459,638

-

3,297

248,717

359,600

248,717

362,897

7,440

6,341

199,985

90,400

207,425

96,741

* 

 As at 31 December, the balance of the long-term borrowings – 
unsecured loan facility outstanding after loan establishment costs is 
as set out in the table below.

• •  Net debt to bank adjusted operating EBITDA must be no greater 

Long-term borrowings outstanding as at 31 December

than 3.5 times

• •  EBITDA to net interest must be great than 3.0 times

Unsecured loan facility  

– expiring in two to five years

248,717

359,600

Less: Loan establishment costs

(2,678)

(2,411)

246,039

357,189

In order to comply with the Group’s Treasury Policy, the repayment of 

the $200,000,000 tranche resulted in the early settlement of several 

interest rate swaps to ensure the Group remained within its policy 

bands and was not ‘over hedged’. The early settlement of the interest 

rate swaps resulted in a loss of $2,122,000 recognised through profit 

and loss during the half year ended 31 December 2020. Refer to  

Note 5.A.

InvoCare            Annual Report 2020  | 103

Performance Review12Directors’ Report3Financial Report4Other Information 
Financial Report

Notes to the consolidated financial statements  
Capital and risks continued

The table below analyses the Group’s financial liabilities into the relevant maturity groupings based on their contractual terms as at the reporting date. 

Trade and other payables, lease liabilities and borrowings are non derivative liabilities.

2020

Trade and other payables

Contingent considerations

Lease liabilities

Borrowings

Derivatives

2019

Trade and other payables

Contingent considerations

Lease liabilities

Borrowings

Derivatives

Less than  
one year 
$’000

Two to  
three years 
$’000

More than  
three years 
$’000

60,514

9,265

19,465

-

600

60,810

500

12,934

-

984

-

7,909

36,486

146,039

548

-

394

28,639

257,189

2,483

-

-

109,973

100,000

-

-

-

121,328

100,000

690

Total 
$’000

60,514

17,174

165,924

246,039

1,148

60,810

894

162,901

357,189

4,157

F. Fair value measurement

The Group’s financial assets and liabilities are measured at fair value at the end of each reporting period. They are measured or disclosed at fair value, 

using a three level hierarchy, based on the lowest level of input that is significant to the entire fair value measurement, being:

• •  Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date

• •  Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly

• •  Level 3: Unobservable inputs for the asset or liability

The following table gives information about how the fair value of financial assets and liabilities are determined, including the valuation technique and 

inputs used. For the Group’s financial assets and liabilities not measured at fair value, their carrying amount provides a reasonable approximation of 

their fair values.

Financial assets 
or liabilities

Fair value 
hierarchy

Valuation technique

Significant 
unobservable 
inputs

Relationship of unobservable 
inputs to fair value

Pre-paid 

contract 

funds under 

management

Derivative 

financial 

instruments

Level 2

The fair value is calculated based on the number 

Not applicable

Not applicable

of units multiplied by the unit price of the funds 

which administers the invested funds. 

The unit price of the funds is based on the fair 

value of the underlying investments, which 

include equities, cash, fixed interest deposits and 

property.

Level 2

The fair value is calculated as the present value 

Not applicable

Not applicable

of the estimated future cash flows based on 

observable yield curves

Contingent 

Level 3

The fair value is calculated based on the 

Forecast 

The estimated fair value would 

consideration

contracted terms of performance measures,  

performance 

increase/decrease if the forecast 

eg revenue, EBITDA or net profit

measures per the 

performance measures per the 

contracts

contracts were higher/lower. Refer 

to Note 18. C for further details

There were no transfers between levels during the reporting period.

InvoCare            Annual Report 2020  | 104

 
G. Summarised sensitivity analysis

The following table summarises the sensitivity of the Group’s financial assets and financial liabilities to interest rate risk and foreign exchange risk net of 

applicable income tax.

2020

Financial assets

Interest rate risk

Foreign exchange risk

-100 basis point

+100 basis point

-10%

+10%

Carrying 
amount 
$’000

Profit/ 
(loss) 
$’000

Equity 
$’000

Profit/ 
(loss) 
$’000

Equity 
$’000

Profit/ 
(loss) 
$’000

Equity 
$’000

Profit/ 
(loss) 
$’000

Equity 
$’000

Cash and cash equivalents

118,781

(831)

Trade receivables

68,202

-

Pre-paid contract funds under 
management

613,131

(188)

Other financial assets

4

Financial liabilities

Trade and other payables

Contingent considerations

Lease liabilities

Borrowings

Derivatives

(60,514)

(17,175)

(165,924)

(246,039)

(888)

(1,148)

-

Total increase/ (decrease)

(1,907)

2019

Financial assets

Cash and cash equivalents

Trade receivables

19,560

72,149

(137)

-

Pre-paid contract funds under 
management

619,389

(4,567)

Other financial assets

4

Financial liabilities

Trade and other payables

Contingent considerations

Lease liabilities

Borrowings

Derivatives

(60,810)

(894)

(162,901)

(357,189)

(400)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

626

626

-

-

-

-

-

-

-

-

831

-

188

-

-

-

-

888

-

1,907

137

-

4,567

-

-

-

-

400

-

-

-

-

-

-

-

-

(626)

(626)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(179)

-

(179)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(520)

520

147

(1,114)

-

1,114

-

-

-

-

-

-

-

-

147

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(325)

-

(637)

637

266

(5,178)

-

5,178

(4,157)

-

1,424

-

(1,424)

Total increase/ (decrease)

-

(5,104)

1,424

5,104

(1,424)

(325)

-

266

-

InvoCare            Annual Report 2020  | 105

Performance Review12Directors’ Report3Financial Report4Other Information 
Financial Report

Notes to the consolidated financial statements  
Capital and risks continued

Note 14. Contributed equity 

Ordinary shares – fully paid

Treasury shares – fully paid

A. Ordinary shares

2020  
Number   
‘000

144,061

(1,175)

142,886

2019 
Number   
‘000

117,185

(1,225)

115,960

2020  
Number   
‘000

2019 
Number   
‘000

Movement during the financial year

Balance as at 1 January

117,185

110,256

Shares issued for Dividend Reinvestment Plan*

Shares issued for Institutional Placement and Share Purchase Plan

Balance as at reporting date

527

26,349

144,061

664

6,265

117,185

2020   

$‘000

511,293

(14,288)

497,005

2020   

$‘000

234,513

5,918

270,862

511,293

2019   

$‘000

234,513

(14,687)

219,826

2019 

$‘000

139,589

9,137

85,787

234,513

Ordinary shares entitle the holder to participate in dividends and the proceeds on winding up of the Company in proportion to the number of and 

amounts paid on the shares held. On a show of hands every holder of ordinary shares present at a meeting in person or by proxy, is entitled to one vote, 

and upon a poll each share is entitled to one vote.

*    Since 2006, the Company activated its Dividend Reinvestment Plan under which equity holders of ordinary shares may elect to have all or part of their 

dividend entitlements satisfied in ordinary shares rather than by being paid in cash.

B. Treasury shares

Movement during the financial year

Balance as at 1 January

Disposal of shares – vested share rights/options

Disposal of shares – transfer to EESP's members

2020  
Number   
‘000

2019 
Number   
‘000

2020 

$‘000

2019 

$‘000

(1,225)

(1,261)

(14,687)

(15,449)

19

31

12

24

48

351

450

312

Balance as at reporting date

(1,175)

(1,225)

(14,288)

(14,687)

Treasury shares are shares in InvoCare Limited that are held by the InvoCare Deferred Employee Share Plan Trust for the purpose of issuing shares 

under the InvoCare Deferred Employee Share Plan, as set out in Note 20.

InvoCare            Annual Report 2020  | 106

 
 
 
   
 
 
C. Capital management

The Group’s capital management objectives and strategies seek 

• •  Maintaining an optimal leverage ratio: The optimal capital structure, 

to maximise total shareholder returns, while maintaining a capital 

which has the lowest cost of capital, is indicatively at a leverage 

structure with acceptable debt and financial risk.

The capital management goals can be broadly described as:

• •  Manage the amount of equity and the expectation of returns – 

including dividend distribution policy, dividend reinvestment and 

share buy-back policies

ratio (i.e. Net debt/Adjusted operating EBITDA) of no higher 

than a range between 3.0 times and 3.5 times but preferably 

lower than 3.0 times with an interest cover ratio of greater than 

4.0 times. A liquidity buffer of at least $25 million should be 

maintained. Where the capacity exists, debt financing will be used 

for small acquisitions and capital expenditure. In the absence 

• •  Maintain debt and gearing that is prudent, cost effective, 

of opportunities to invest in growing the business, the Group 

supports operational needs and provides flexibility for growth and 

will consider applying excess debt capacity to make returns to 

development

shareholders

• •  Avoid excessive exposure to interest rate fluctuations and debt 

• •  Maintaining floating to fixed base interest rate swaps for at least 

refinancing risk

75% of debt principal in Australia and New Zealand

The goals are actively managed by the use of quantifiable measures. 

These measures and relevant comments are as follows:

• •  Maximising shareholder returns: Earnings per share (EPS)  

is a key measure and for 2020, basic EPS was (6.9 cents)  

• •  Managing refinancing risk: By spreading the tenor of the debt 

available to the Group minimises its exposure to the risks that all the 

debt will become due at a single point of time

(2019: 55.8 cents). Operating EPS, which excludes restructuring 

D. Accounting policy for ordinary shares

costs, gains and losses on the disposal or impairment of  

non-current assets and on undelivered pre-paid contracts and 

non-controlling interests and disposal of subsidiaries, was  

20.4 cents (2019: 51.7 cents). Importantly, senior management  

of the Group have long-term incentives linked to EPS growth, thus 

aligning employee and shareholder interests. Total compound 

annual shareholder return, being the sum of cash dividends and 

share price growth, has exceeded 15% per annum since the 

Company listed in December 2003, except for 2008 when global 

Ordinary shares are classified as equity. Incremental costs directly 

attributable to the issue of new shares are shown in equity as a 

deduction, net of tax, from the proceeds.

Note 15. Contingencies

There were no unrecognised contingent assets as at  

equity market values declined, although InvoCare’s share price did 

31 December 2020 and 31 December 2019.

not fall as significantly as the rest of the market

The Group had the following guarantee that are determined as 

• •  Maintaining a minimum ordinary dividend payout ratio of between 

contingent liabilities at 31 December 2020:

• •  Bank guarantees given for leased premises of subsidiaries to a 

maximum of $2,870,000 (2019: $3,261,000)

• •  Deed of cross guarantee by a number of the entities within the 

Group. Refer to Note 22 for further details of the bank guarantee

60% to 80% of operating earnings after tax. For each of the years 

since listing, the Group has distributed ordinary dividends in 

excess of this payout ratio. The aggregate of the interim and final 

2020 dividends represents a payout ratio of 61% (2019: 79%) of 

operating earnings after tax

• •  Confirming compliance with the debt covenant ratios, as defined in 

the facility agreements, through bi-annual calculations. The Group 

has complied with its banking covenants as follows:

•  Interest cover (EBITDA/Net interest expense) must be greater 

than 3.0 times

•  Leverage ratio (Net debt/Adjusted operating EBITDA) must not 

be greater than 3.5 times

InvoCare            Annual Report 2020  | 107

Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report

Notes to the consolidated financial statements  
Capital and risks continued

Note 16. Commitments

Note 17. Events after reporting period 

As at reporting date, the Group has the following capital and other 

On 27 January 2021, a property classified as held for sale at  

commitments which are not recognised as liabilities.

31 December 2020 was sold for $7.4 million resulting in a gain of  

A.   Capital commitments

$6.3 million. 

Other than the above transaction and the dividend determined as 

2020 
$’000

2019 
$’000

disclosed in Note 4, no other matter or circumstance has arisen since 

31 December 2020 that has significantly affected, or may significantly 

affect the Group’s operations, the results of those operations, or the 

Group’s state of affairs in future financial years.

Contracted and conditionally contracted - within one year

Building extensions and refurbishments

301

4,969

Leasehold improvements

Plant and equipment purchases

1,112

511

70

434

B.  Other commitments

Within one year

Documentary letters of credit

104

35

C.  Operating lease commitments

The Group leases premises, motor vehicles and sundry office 

equipment under non-cancellable operating leases with terms 

generally from one to five years. The Rookwood Crematorium lease 

expires in 2025. The Great Southern Garden of Remembrance lease 

expires in 2047 with an option to renew for a further 50 years.

From 1 January 2019, the Group has recognised right of use assets 

for these leases, except for short term and low value leases, see  

Note 11. B. Right of use assets for further information.

Contracted non-cancellable operating leases committed at reporting 

date but not recognised as liabilities or payable are provided in the 

table below.

Within one year

One to five years

2020 
$’000

669

137

806

2019 
$’000

1,723

711

2,434

InvoCare            Annual Report 2020  | 108

 
Financial Report

Notes to the consolidated financial statements  
Business portfolio

This section provides 
information on how the Group 
structure affects the financial 
position and performance of 
the Group as a whole. The 
disclosures detail the types 
of entities and transactions 
included in the consolidation 
and those excluded.

Note 18. Business combinations

A.   Acquisitions for the year ended 31 December 2020

I. 

 Summary of acquisitions

During the year ended 31 December 2020, the Group acquired three 

businesses. A summary of the purchase consideration, goodwill and identifiable 

assets and liabilities acquired for all the acquisitions are presented below.

The accounting for these acquisitions is provisional as at 31 December 2020.

Subsidiaries/businesses acquired are:

• •  Galaxy Funerals

• •  Family Pet Care Pty Limited

• •  Pets in Peace

The purchase consideration, fair value of identifiable net assets acquired,  

and goodwill are disclosed below.

a.  Total purchase consideration paid/payable

2020

Cash consideration

Contingent consideration

Deferred consideration

Total purchase consideration

b. 

Identifiable assets and liabilities acquired

2020

Cash and cash equivalents

Inventories

Other current assets

Property, plant and equipment

Right of use assets

Identifiable intangibles

Lease liabilities

Borrowings

Other liabilities

Deferred tax liability

Total net identifiable assets acquired

Goodwill

Galaxy Funerals  
$’000

Family Pet Care  
Pty Limited 
$’000

Pets in Peace 
$’000

591

5,333

-

5,924

32,806

8,465

438

41,709

5,130

2,982

-

8,112

Galaxy Funerals  
$’000

Family Pet Care  
Pty Limited 
$’000

Pets in Peace 
$’000

-

-

-

59

431

-

(431)

-

(18)

-

41

5,883

364

1,010

1,320

1,695

4,539

1,857

(4,470)

(17)

(1,876)

(544)

3,878

37,831

-

-

10

611

2,008

-

(2,301)

-

(178)

-

150

7,962

Total 
$’000

38,527

16,780

438

55,745

Total 
$’000

364

1,010

1,330

2,365

6,978

1,857

(7,202)

(17)

(2,072)

(544)

4,069

51,676

The goodwill recognised is attributable to the location, workforce and the profitability of the acquired businesses. It will not be deductible for tax 

purposes.

If new information obtained within one year from the acquisition date about facts and circumstances that existed at the acquisition date identifies 

adjustments to the above amounts, then the acquisition accounting will be revised.

InvoCare            Annual Report 2020  | 109

Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report

Notes to the consolidated financial statements  
Business portfolio continued

c. 

 Financial performance of acquired businesses

2020

Revenue

Net profit after income tax

Galaxy Funerals  
$’000

Family Pet Care  
Pty Limited 
$’000

Pets in Peace 
$’000

1,670

484

2,360

238

420

213

Total 
$’000

4,450

935

If all the acquisitions had occurred on 1 January 2020, consolidated revenue and profit after tax for the year ended 31 December 2020 would have 

increased by approximately $25,065,000 and $3,495,000, respectively.

d.  Total purchase consideration – cash flows

2020

Galaxy Funerals  
$’000

Family Pet Care  
Pty Limited 
$’000

Pets in Peace 
$’000

Outflow of cash to acquire subsidiary/businesses, net of cash acquired

Cash consideration

Less: Cash balances acquired

Add: Acquisition related costs *

Add: Payment of deferred consideration  
(Broulee Memorial Gardens)

Net cash outflows – investing activities

591

-

32,806

(364)

5,130

-

Total 
$’000

38,527

(364)

1,918

500

40,581

* 

 Acquisition-related costs totalling $1,918,000 (as shown on the consolidated statement of comprehensive income) are not able to be allocated to 
individual transactions as they include the costs of operating a Mergers and Acquisitions team in addition to costs arising directly attributable to the 
acquisitions.

B.  Acquisitions for the year ended  

31 December 2019

C.  Fair value measurement – contingent 

consideration

For all three acquisitions settled during the prior year ended 31 

December 2019, the accounting for all of them has been finalised 

during 2020. There have been no material changes to the financial 

information disclosed for each acquisition. Refer to 2019 Annual 

Report for further details of those acquisitions.

For some of the businesses acquired, consideration paid/

payable consists contingent component (classified as contingent 

consideration as shown on face of the consolidated balance sheet) 

pending for the achievement of the agreed financial performance of 

the acquired businesses. The contingent consideration are measured 

and disclosed at fair value. This section provided details on how fair 

value is determined, including the valuation technique (only Level 3: 

Unobservable inputs for the contingent consideration) and inputs 

used and the movement for the financial period.

Level 3

Contingent consideration – current

Contingent consideration – non-current

2020 
$’000

9,265

7,909

17,174

2019 
$’000

94

800

894

InvoCare            Annual Report 2020  | 110

I. 

 Valuation techniques for fair value measurements 
categorised within level 3

The contingent consideration arose on the business combination 

(refer to earlier sections within this note). The fair value was 

determined using an independent expert and is estimated based 

on a multiple of forecast earnings before interest, tax, depreciation 

and amortisation (EBITDA) of the acquired business over a two year 

period. Any settlement of contingent consideration will be in the form 

of cash. Any variation at the time of settlement will be recognised as 

income or expense in profit or loss.

II.    Critical accounting judgements, estimates 
and assumptions – fair value of contingent 
consideration

The Group’s contingent consideration liability is measured at fair 

D. Accounting policies for business combination

The purchase method of accounting is used to account for all 

acquisitions of assets (including business combinations) regardless 

of whether equity instruments or other assets are acquired. Cost 

is measured as the fair value of the assets given, shares issued or 

liabilities incurred or assumed at the date of exchange.

Identifiable assets acquired and liabilities and contingent liabilities 

assumed in a business combination are measured initially at their fair 

values at the acquisition date. The excess of the cost of acquisition 

over the fair value of the Group’s share of the identifiable net assets 

acquired is recorded as goodwill. If the cost of acquisition is less 

than the fair value of the net identifiable assets of the subsidiary 

acquired, the difference is recognised directly in the statement 

of comprehensive income, but only after a reassessment of the 

value at the end of each reporting period. The information provided 

identification and measurement of the net assets acquired.

below is about how the fair value of this financial liability is determined, 

including the valuation technique and inputs used.

• •  Fair value hierarchy: level 3

• •  Valuation technique: the fair value is calculated based on a multiple 

of forecast EBITDA of the business over a two year period

Where settlement of any part of cash consideration is deferred, the 

amounts payable in the future are discounted to their present value 

as at the date of acquisition. Any variations in the initial estimates of 

deferred consideration and the final amount payable are remeasured 

through the statement of comprehensive income.

• •  Significant unobservable inputs: forecast EBITDA of the business 

The present value of contingent consideration is classified as a 

and the discount rate

• •  Relationship of unobservable inputs to fair value: the estimated fair 

financial liability and is subsequently remeasured to fair value with 

changes in fair value recognised in profit or loss.

value would increase/decrease if the forecast EBITDA or discount 

The acquisition-related costs are recorded in the statement of 

rate were higher/lower

comprehensive income.

III.  Level 3 – Contingent consideration

Movements in level 3 – contingent consideration during the current 

and previous financial year are set out below.

Balance at 1 January

2020 
$’000

2019 
$’000

894

1,394

Contingent consideration relating to business 
combinations

16,780

500

Payments during the financial year

(500)

(1,000)

Balance at 31 December

17,174

894

The carrying value of contingent consideration might be impacted by 

the changes in discount rate or the forecast EBITDA of the businesses 

acquired during the financial year. The impact to the carrying value for 

the following unobservable inputs are as follows:

• •  Profitability adjustments to EBITDA: a 5% decrease in the 

profitability per year over the two year period would decrease the 

contingent consideration by $839,000

InvoCare            Annual Report 2020  | 111

Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report

Notes to the consolidated financial statements  
Business portfolio continued

Note 19. Interests in subsidiaries

A. Interests in subsidiaries

Set out below are the Group’s principal trading subsidiaries at 31 December 2020. Unless otherwise stated, the subsidiaries as listed below have 

share capital consisting solely of ordinary shares, which are held directly by the Group, and the proportion of ownership interests held equals to the 

voting rights held by the Group. The country of incorporation or registration is also their principal place of business. The principal activities of all these 

subsidiaries are funeral services provider.

Name of subsidiaries

InvoCare Australia Pty Limited

Bledisloe Australia Pty Limited

InvoCare PetCare Limited

Family Pet Care Pty Limited

InvoCare New Zealand Limited

William Morrison Funeral Director*

Singapore Casket Company (Private) Limited

Country of 
incorporation

Australia 

Australia 

Australia 

Australia 

New Zealand 

New Zealand 

Singapore 

Ownership interest held

2020 
%

100

100

100

100

100

-

100

2019 
%

100

100

-

-

100

100

100

*    On 31 December 2020, William Morrison Funeral Director was amalgamated into InvoCare New Zealand Limited.

Shares in subsidiaries are carried at cost and relate to InvoCare 

Limited’s ownership interest in InvoCare Australia Pty Limited, 

InvoCare PetCare Pty Limited, Family Pet Care Pty Limited, InvoCare 

(Singapore) Pty Limited, InvoCare New Zealand Limited and InvoCare 

Hong Kong Limited. All shares held are ordinary shares.

InvoCare Australia Pty Limited, InvoCare PetCare Pty Limited, 

Family Pet Care Pty Limited, InvoCare (Singapore) Pty Limited and 

Bledisloe Australia Pty Ltd have been granted relief from the necessity 

B. Significant restrictions

Other than those imposed by the legislative provisions in the 

respective country of incorporation, for the subsidiaries listed above, 

the Group has no significant restriction on its ability to access or use 

assets and settle liabilities.

C. Subsidiaries with non-controlling interests

to prepare financial reports in accordance with ASIC Corporations 

One subsidiary, Macquarie Memorial Park Pty Limited, has  

Instrument 2016/785 issued by the Australian Securities & 

Investments Commission. For further information refer to Note 23.

non-controlling interests of 16.86% (2019: 16.86%). During the  

year dividends totalling $Nil were paid to non-controlling interests  

(2019: $121,000).

D. Employee share trust

The Group has formed a trust to administer the InvoCare Exempt 

Employee Share Plan and the InvoCare Deferred Employee Share Plan.

InvoCare            Annual Report 2020  | 112

E.  Accounting policies

I.  Subsidiaries

Subsidiaries are all entities (including employee share trust) over which 

the Group has control. The Group controls an entity when the Group is 

exposed to, or has rights to, variable returns from its involvement with 

the entity and has the ability to affect those returns through its power 

to direct the activities of the entity.

II.  Consolidation of subsidiaries

Subsidiaries are fully consolidated from the date on which control 

is transferred to the Group. They are deconsolidated from the date 

that control ceases. The purchase method of accounting is used to 

account for the acquisition of subsidiaries by the Group (refer to  

Note 18.D).

Intercompany transactions, balances and unrealised gains on 

transactions between Group companies are eliminated. Unrealised 

losses are also eliminated unless the transaction provides evidence 

of the impairment of the asset transferred. Accounting policies 

of subsidiaries have been changed where necessary to ensure 

consistency with the policies adopted by the Group.

Non-controlling interests in the results and equity of non-wholly 

owned subsidiaries are shown separately in the consolidated 

statement of comprehensive income and balance sheet, respectively.

III. Employee share trust

The employee share trusts are consolidated, as the substance of the 

relationship is that the trusts are controlled by the Group. Shares held 

by the InvoCare Deferred Employee Share Plan Trust are disclosed as 

treasury shares and deducted from contributed equity.

IV.  Foreign currency translation on subsidiaries

The results and financial positions of all the Group entities (none of 

which has the currency of a hyperinflationary economy) that have 

a functional currency different from the presentation currency are 

translated into the presentation currency as follows:

• •  Assets and liabilities for each balance sheet presented are 

translated at the closing rate at the date of that balance sheet

• •  Income and expenses for each statement of comprehensive 

income are translated at average exchange rates

• •  All resulting exchange differences are recognised in other 

comprehensive income

On consolidation, exchange differences arising from the translation 

of any net investment in foreign subsidiaries, and of borrowings 

and other financial instruments designated as hedges of such 

investments, are recognised in other comprehensive income. When 

a foreign operation is sold or any borrowings forming part of the 

net investment are repaid, a proportionate share of such exchange 

differences will be recognised in the statement of comprehensive 

income, as part of the gain or loss on sale where applicable.

Goodwill and fair value adjustments arising on the acquisition of a 

foreign subsidiary are treated as assets and liabilities of the foreign 

subsidiaries and translated at the closing rate.

InvoCare            Annual Report 2020  | 113

Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report

Notes to the consolidated financial statements  
Other statutory disclosures

This section provides information on other 
disclosures which are required by various 
accounting standards and reporting 
requirements.

Note 20. Share-based remuneration

The ultimate objective of share-based remuneration is to align the 

participants with delivery of shareholder value. Long term incentives, 

with appropriate performance hurdles, align participants to the longer 

term strategies, goals and objectives of the Group, and provide 

greater incentive for senior employees to have broader involvement 

and participation in the Group beyond their immediate role. Equity 

participation also assists the Group to attract and retain skilled and 

experienced senior employees.

The obligations under share-based payment arrangements are 

settled by either issuing new ordinary shares in the Company or 

acquiring ordinary shares of the Company on market. Overseas 

participants receive cash equivalent to the value of the equity awarded 

that vests.

Trading in the Company’s ordinary shares awarded under the share-

based remuneration arrangements is governed by the Company’s 

Share Trading Policy. The policy restricts employees from trading in 

the Company’s shares when they are in a position to be aware, or 

are aware, of price sensitive information. The policy also implements 

blackout periods which prohibit trading in the Company’s shares in 

the lead up to the Group’s half year and annual result announcements, 

unless Board express approval is obtained.

The arrangements are governed by the terms of the Company’s three 

Plan Rules.

Four plans are currently in operation. They include:

• •  A plan which is available to eligible employees who meet the 

employment conditions:

•  Exempt Employee Share Plan (EESP) – in the form of shares to 

the maximum value of $1,000 instead of cash salary

• •  Three plans which are only available to nominated employees:

•  Long-term Incentive Plan (LTIP) – in the forms of options 

and performance rights or cash equivalent, they will vest if the 

performance and employment conditions are both met

•  Deferred Employee Share Plan (DESP) – in the form of shares 

or share appreciation rights (SARs) for overseas employees 

which will vest when employment condition is met

•  Service Based Equity Plan (SEP) – in the form of rights or cash 

equivalent, they will vest if the employment condition is met

InvoCare            Annual Report 2020  | 114

A. Exempt Employee Share Plan

• •  Performance hurdle(s):

Australian based permanent employees with more than six months 

service and a salary less than $180,000 per annum and casual staff 

with more than two years service routinely working at least 40% of 

a full time equivalent are annually offered the opportunity to acquire 

•  For 2016 to 2019 grants: only compound annual growth (EPS 

CAGR) target: Normalised EPS b growth above the base year. 

Vesting of options and performance rights is conditional on 

meeting a minimum level of return on invested capital (ROIC a)

$1,000 worth of InvoCare Limited shares through a salary sacrifice 

•  For grants from 2020 onwards: 50% grant on EPS CAGR target 

arrangement as permitted by Australian Taxation Legislation.  

and 50% grant on ROIC target

During 2020, 351 employees accepted the offer and at  

31 December 2020 a further $185,000 was remaining to be  

collected via payroll deductions.

• •  Vesting scale:

•  For 2016 and 2017 grants, only EPS CAGR target: Below 7% 

EPS CAGR: Nil; At 7%: 30%; Between 7% and 12%: straight 

line pro-rata vesting between 30%-100%; At or above 12%: 

B. Long-term Incentive Plan

100%

LTIP was introduced during 2016. The plan permits settlement in 

•  For 2018 and 2019 grants, only EPS CAGR target: Below 8% 

either equity or cash, at the Board’s discretion. The plan provides 

EPS CAGR: Nil; At 8%: 30%; Between 8% and 12%: straight 

options and performance rights to senior management team, so 

line pro-rata vesting between 30%-100%; At or above 12%: 

employees are incentivised to maximise shareholder value in the 

100%

longer term.

The key terms and conditions of this plan:

• •  In the form of options and performance rights to be granted as 

approved by the Board

• •  Both options and performance rights are granted for nil 

consideration

•  For grants from 2020 two performance target (50% EPS CAGR 

and 50% ROIC): Below 6% EPS CAGR: Nil; At 6% EPS CAGR: 

30%; Between 6% and 10% EPS CAGR: straight line pro-rata 

vesting between 30%-100%; At or above 10% EPS CAGR: 

100%; Below 10% ROIC: Nil; At 10% ROIC: 30%; Between 10% 

and 12% ROIC: straight line pro-rata vesting between  

30%-100%; At or above 12% ROIC: 100%

• •  Allocation between options and performance rights is:

• •  Dividend entitlement:

•  Set by the Board for senior management team in the ratio of 

75%:25% for options and performance rights, respectively

•  For other participants in the ratio of 50%:50% based on the 

contractual arrangement or election

•  From 2020 grant onwards, the ratio between options and 

performance rights are based on election by all participants

• •  Upon vesting:

•  For 2016 to 2019 grants: Not entitled to any dividends

•  For grants from 2020 onwards: performance rights entitled 

to dividends in the form of DRP and only become vested and 

exercisable into InvoCare shares should performance hurdles of 

performance rights vest at the performance testing time

• •  Not entitled to voting rights during the vesting period

• •  Upon termination of employment, all unvested options and 

•  For Australian participants, each option (after paying the options 

performance rights will be forfeited

price) and performance right entitle the participant to subscribe 

for one InvoCare ordinary share

•  For overseas participants, each option (after paying the options 

price) and performance right entitle the participant to receive 

• •  Clawback and malus: the Board, at its sole discretion, may 

determine that all or part of any vested and unvested options or 

performance rights may be forfeited in certain circumstances

a    ROIC means return on invested capital and is calculated by dividing 

cash equivalent value of one InvoCare ordinary share at the 

the operating earnings by the average invested capital

market value at date of vesting

• •  Performance testing timing:

•  For 2016 and 2017 grants, each grant is divided in three equal 

tranches and the first testing date of the three tranches are in 

the second, third and fourth year anniversary following the grant 

year with last retesting in the fifth year anniversary

•  For 2018 and 2019 grants, each grant is divided in two equal 

tranches and the first testing date of the two tranches are in the 

third and fourth year anniversary following the grant year

b    Normalised EPS means constant currency EPS adjusted to exclude 
the after tax impacts of funds under management movements, the 
gain or loss on the sale, disposal or impairment of non-current assets, 
non-cash movements in derivative financial instruments reported 
in profit before tax and impacts of changed accounting policies 
because of changes of accounting standards from the base year. For 
2020 grant onwards, EPS is calculated based on operating earnings 
(normalised for non-operating items)

The fair value of the options and performance rights at grant date is 

estimated using Black-Scholes Pricing model. The model takes into 

account the exercise price, the term of the option, the share price at 

•  For grants from 2020 onwards, the grant has only one test in the 

grant date and expected price volatility of the underlying share, the 

third year anniversary following the grant year

expected dividend yield and the risk-free interest rate for the term of 

the option.

InvoCare            Annual Report 2020  | 115

Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report

Notes to the consolidated financial statements  
Other statutory disclosures continued

The following information related to the options and performance rights issued under the LTIP.

Grant date 

Expiry date 

Options

1/01/2016

1/01/2026

22/02/2016

22/02/2026

1/01/2017

1/01/2027

22/02/2017

22/02/2027

1/01/2018

1/01/2028

1/01/2019

1/01/2029

1/03/2020

1/03/2028

Performance rights

1/01/2016

1/01/2026

22/02/2016

22/02/2026

1/01/2017

1/01/2027

22/02/2017

22/02/2027

1/01/2018

1/01/2028

1/01/2019

1/01/2029

1/03/2020

1/03/2035

3/08/2020

1/08/2035

Fair value at 
grant date 

Balance at the 
start of the year  
Number

Granted 
Number

Vested 
Number

Lapsed 
Number

Balance at the  
end of the year 
Number 

$2.40

$2.40

$2.93

$2.93

$2.78

$2.51

$0.58

$12.08

$12.08

$14.06

$14.06

$13.91

$12.96

$9.70

$9.70

363,842

20,946

384,779

16,221

605,974

795,028

-

2,186,790

34,904

2,983

37,321

3,380

55,494

70,089

-

-

-

-

-

-

-

-

513,820

513,820

-

-

-

-

-

-

105,068

17,107

(2,591)

-

-

-

-

-

-

-

-

-

-

-

(15,936)

-

361,251

20,946

384,779

16,221

605,974

779,092

513,820

(2,591)

(15,936)

2,682,083

(11,946)

(213)

-

-

-

-

-

-

-

-

-

-

-

(2,766)

-

-

22,958

2,770

37,321

3,380

55,494

67,323

105,068

17,107

311,421

The value of the options and performance rights exercised is based on the VWAP for the year ended 31 December 2020 and was $11.10  

(2019: $14.08).

204,171

122,175

(12,159)

(2,766)

InvoCare            Annual Report 2020  | 116

C. Deferred Employee Share Plan

D. Service Based Equity Plan

This plan, introduced in 2007, is settled by the transfer of InvoCare 

The Service Based Equity Plan (SEP) introduced in 2020 is settled by 

ordinary shares to participants upon vesting. The plan is used to 

the transfer of InvoCare ordinary shares to participants upon vesting. 

recognise, reward and retain key talent in critical roles at the middle 

The plan is used to recognise, reward and retain key talent in critical 

management level. Eligible employees participate in the plan based 

roles at the middle management level. Eligible employees participate 

on nomination only.

in the plan based on nomination only.

Prior to 2015, the senior management who participated in this plan 

The key terms and conditions of this plan include:

were required to meet both performance and employment conditions 

in order for the shares to vest. The last Tranche,  being Tranche 3 of the 

2015 grant fully vested as a result of performance testing performed 

• •  Granted in the form of rights as approved by the Board

• •  Rights are granted for nil consideration

at the end of February 2020. Unvested grants from 2016 onwards 

• •  To vest, the participant must meet ongoing employment conditions

remain in place with employment conditions only for vesting.

• •  Each grant of rights is divided into six equal tranches

Due to the impact of COVID-19, the Board determined there would be 

• •  The vesting date of the six tranches are every six months from the 

no grants under the DESP for 2020 other than the commitments due 

grant date

to employment contractual requirements.

• •  Entitled to receive any dividends that may become payable during 

The key terms and conditions of this plan include:

the vesting period and are payable as additional shares only on 

• •  Granted in the form of shares as approved by the Board

• •  Shares are granted for nil consideration

• •  To vest, the participant must meet ongoing employment conditions

• •  Each grant of shares is divided into three equal tranches

• •  The vesting date of the three tranches are:

date of vesting

• •  Dividend entitlement will be calculated and converted into the 

equivalent number of rights based on the Dividend Reinvestment 

Plan rules

• •  Upon vesting:

•  For Australian participants, each right entitles the participant to 

•  Tranche 1 – completion of 36 months employment from  

subscribe for one InvoCare ordinary share

grant date

•  For overseas participants, each right entitles the participant to 

•  Tranche 2 – completion of 48 months employment from  

receive cash equivalent value of one InvoCare ordinary share at 

grant date

the market value at date of vesting

•  Tranche 3 – completion of 60 months employment from  

• •  Upon termination of employment, all unvested rights and any 

grant date

cumulative dividend (in the form of rights) will be forfeited

• •  Entitled to receive any dividends that may become payable on the 

shares during the vesting period

• •  Entitled to voting rights of the shares during the vesting period

• •  Upon termination of employment, all unvested shares will be 

forfeited

InvoCare            Annual Report 2020  | 117

Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report

Notes to the consolidated financial statements  
Other statutory disclosures continued

The following information relates to the rights issued under the SEP and shares held in the share plan trust under DESP.

Grant date 

Expiry date 

Fair value at 
grant date 

Balance at the 
start of the year  
Number

Granted 
Number

Vested 
Number

Lapsed 
Number

Balance at the  
end of the year 
Number 

Rights - ongoing employment condition only

1/09/2020

1/09/2035

19/10/2020

1/09/2035

$9.70

$10.50

Shares - ongoing employment condition only

1/03/2015

1/03/2020

1/03/2016

1/03/2031

1/03/2017

1/03/2032

1/03/2018

1/03/2028

1/03/2019

21/02/2029

1/03/2020

1/03/2035

15/06/2020

1/07/2035

$13.74

$12.08

$14.06

$13.91

$14.46

$10.70

$11.10

Shares - performance and ongoing employment conditions

1/01/2015

1/01/2030

22/02/2015

22/02/2025

31/03/2015

31/03/2030

23/08/2018

23/08/2028

$13.74

$13.74

$13.74

$13.74

-

-

-

135,948

14,000

149,948

117

3,367

7,665

13,136

29,617

-

-

53,902

10,866

1,358

5,804

1,354

19,382

-

-

-

-

-

1,758

30,000

31,758

-

-

-

-

-

-

-

-

(117)

(3,367)

(3,888)

(4,277)

-

-

-

-

-

-

-

-

(115)

(574)

(553)

-

-

(11,649)

(1,242)

(10,864)

(1,358)

(5,804)

(1,354)

(19,380)

(2)

-

-

-

(2)

135,948

14,000

149,948

-

-

3,662

8,285

29,064

1,758

30,000

72,769

-

-

-

-

-

The value of the options and performance rights exercised is based on the VWAP for the year ended 31 December 2020 and was $11.10  

(2019: $14.08).

Note 21. Related party transactions

A. Key management personnel compensation

B. Parent entity

2020 
$

2019 
$

The ultimate parent entity within and for the Group is InvoCare Limited.

Short-term employee benefits

3,330,600 3,316,765

Post-employment benefits

156,079

160,227

Other long-term benefits

Termination benefits

Share based payments

(101,930)

29,108

428,909

-

C. Transactions with subsidiaries

All transactions that have occurred among the subsidiaries within the 

Group have been eliminated for consolidation purposes.

320,490

(455,602)

D. Transactions with other related parties

4,134,148 3,050,498

The contributions to superannuation funds on behalf of employees are 

disclosed in Note 5.E.

InvoCare            Annual Report 2020  | 118

 
 
Note 22. Parent entity information

A. Summary financial information

C. Contingent liabilities

The financial information provided in the table below is only for 

Other than the guarantees as disclosed in section B above, there were 

InvoCare Limited, the parent entity of the Group.

no unrecognised contingent liabilities as at 31 December 2020 and  

2020 
$’000

2019 
$’000

31 December 2019.

Statement of comprehensive income

D.  Capital commitment – property, plant and 

Profit after income tax

59,662

66,079

equipment

Total comprehensive income

61,279

65,024

The parent entity has no capital commitments for the acquisition  

Balance sheet

Current assets

Total assets

Current liabilities

Total liabilities

Equity

44,936

2,015

866,746

653,989

1,582

2,353

165,779

256,760

of property, plant or equipment at 31 December 2020 and  

31 December 2019.

E. Tax consolidation group

InvoCare Limited (the head entity) and its wholly-owned Australian 

subsidiaries implemented the tax consolidation legislation from  

1 January 2004.

Contributed equity

497,005

219,826

On adoption of the tax consolidation legislation, the entities in the tax 

Share-based payments reserve

3,296

2,055

Cash flow hedges reserve

(359)

(1,976)

consolidated group entered into a tax sharing and funding agreement 

which, in the opinion of the directors, limits the joint and several liability 

of the wholly-owned subsidiaries in the case of a default by the head 

Foreign currency reserve

1,080

1,080

entity.

Retained profits

Total equity

199,945

176,244

700,967

397,229

B. Guarantees entered into by the parent entity

The parent entity provided the following guarantees during the year 

ended 31 December 2020 and 31 December 2019:

This agreement was updated on 5 June 2007 and provides that the 

wholly-owned subsidiaries will continue to fully compensate InvoCare 

Limited for any current tax payable assumed and be compensated 

by InvoCare Limited for any current tax receivable and deferred tax 

assets relating to unused tax losses or unused tax credits that are 

transferred to InvoCare Limited under the tax consolidation legislation.

The amounts receivable or payable under the tax funding agreement 

are due upon receipt of the funding advice from the head entity, 

• •  Bank guarantees given for leased premises of subsidiaries to a 

which is issued as soon as practicable after the end of each financial 

maximum of $2,870,000 (2019: $3,261,000)

year. InvoCare Australia Pty Limited, as permitted by the tax funding 

• •  Under the terms of a General Security Trust Deed executed 

on 16 February 2018 the parent entity, InvoCare Limited, and 

its material wholly-owned subsidiaries (the Guarantors) have 

individually guaranteed to the financiers the due and punctual 

payment in full of any liabilities or obligations provided under the 

terms of the Syndicated Facility Agreement and the Note Purchase 

Agreement both dated 16 February 2018. The Guarantors have 

also indemnified the financiers against any loss or damage suffered 

by the financiers arising from any failure by a borrower or any 

Guarantor to satisfy the obligations

agreement, acts on behalf of InvoCare Limited for the purpose of 

meeting its obligations to make tax payments, or receive refunds, 

and reimburses, or is compensated by, that entity through the 

intercompany loan account for amounts of tax paid, or received, 

except for the tax allocated to that entity.

F.   Accounting policy applicable to parent entity

The accounting policies of the parent entity are consistent with those 

of the Group, except for the following:

• •  Investments in subsidiaries are accounted for at cost, less any 

impairment, in the parent entity

• •  Dividends received from subsidiaries are recognised as other 

income by the parent entity and its receipt may be an indicator of an 

impairment of the investment

InvoCare            Annual Report 2020  | 119

Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report

Notes to the consolidated financial statements  
Other statutory disclosures continued

Note 23. Deed of cross guarantee

A.  Consolidated statement of comprehensive 

InvoCare Limited, InvoCare Australia Pty Limited and InvoCare 

(Singapore) Pty Limited entered into a Deed of Cross Guarantee 

on 11 December 2006 under which each company guarantees the 

debts of the others. Effective from 15 June 2011, Bledone Pty Ltd 

and Bledisloe Australia Pty Ltd became parties to this Deed of Cross 

Guarantee. Effective from 19 February 2021, InvoCare PetCare Pty 

Limited and Family Pet Care Pty Limited became parties to this Deed 

of Cross Guarantee. By entering into the deed, the wholly-owned 

income of the Closed Group

2020 
$’000

2019 
$’000

Revenue from continuing operations

387,544

400,261

Finished goods, consumables and funeral 
disbursements

(96,351)

(95,930)

Employee benefits expense

(143,212)

(132,503)

subsidiaries have been relieved from the requirement to prepare a 

Advertising and public relations expenses

(11,921)

(9,106)

Occupancy and facilities expenses

(18,985)

(14,741)

Financial Report and Directors’ Report under ASIC Corporations 

Instrument 2016/785 issued by the Australian Securities & 

Investments Commission.

The above companies represent a “Closed Group” for the purposes of 

Motor vehicle expenses

Technology

the ASIC Corporations Instrument, and as there are no other parties to 

Other expenses

the Deed of Cross Guarantee that are controlled by InvoCare Limited, 

they also represent the “Extended Closed Group”.

Set out below is a consolidated statement of comprehensive 

income, summary of movements in consolidated retained profits and 

consolidated balance sheet for the year ended 31 December 2020 of 

the Closed Group.

Depreciation, impairment and amortisation 
expenses

Impairment of loss on intangibles

Impairment reversal of cemetery land

Finance costs

Interest income

(8,125)

(7,066)

(10,951)

(10,795)

(18,811)

(11,087)

79,188

119,033

(34,630)

(29,176)

(6,175)

6,000

-

-

(38,573)

(17,959)

1,539

1,092

Net gain on undelivered pre-paid contracts

2,691

45,550

Acquisition related costs

Inter-segment revenue

(1,918)

(1,984)

1,317

1,810

Net gain on disposal of non-current assets

7,520

2,189

Profit before income tax

Income tax expense

16,959

120,555

(7,296)

(29,827)

Net profit after income tax for the year

9,663

90,728

Other comprehensive income 
Items that may be reclassified to profit and loss

Changes in fair value of cash flow hedges,  
net of tax

(1,240)

(1,055)

Total realised loss on early settlement of 
interest rate swaps reclassified to profit or loss

1,611

(1,055)

Net changes to cash flow hedges, net of tax

371

(1,055)

Changes in foreign currency translation 
reserve, net of tax

(1,595)

(1,248)

Other comprehensive income for the year,  
net of tax

(1,224)

(2,303)

Total comprehensive income for the year,  
net of tax

8,439

88,425

InvoCare            Annual Report 2020  | 120

 
B.  Summary of movements in consolidated 
retained profits of the Closed Group 

2020 
$’000

2019 
$’000

Current liabilities

Trade and other payables

Retained profits as at 1 January

193,201

144,401

Contingent consideration

Profit after income tax for the year

9,663

90,728

Lease liabilities

Dividends paid

(35,432)

(41,928)

Derivative financial instruments

Retained profits as at 31 December

167,432

193,201

Pre-paid contract liabilities

Deferred revenue

2020 
$’000

2019 
$’000

51,482

52,865

9,171

-

16,786

11,418

512

735

44,532

48,715

28,627

34,909

C.  Consolidated balance sheet of the  

Provision for employee benefits

15,463

13,626

Closed Group

Current assets

Cash and cash equivalents

107,219

7,920

Trade receivables

Other receivables

Inventories

15,894

35,172

15,041

7,576

40,000

40,688

Total current liabilities

Non-current liabilities

Contingent consideration

Borrowings

Lease liabilities

166,573

162,268

7,909

800

199,285

295,228

121,252

114,632

Derivative financial instruments

-

2,088

Pre-paid contract funds under management

50,268

57,551

Deferred tax liabilities

35,951

35,766

Asset held for sale

Deferred selling costs

Deferred contract assets

Total current assets

Non-current assets

2,333

3,981

3,644

4,481

1,541

2,409

235,940

159,778

Pre-paid contract liabilities

496,624

476,498

Deferred revenue

69,391

69,579

Provision for employee entitlements

2,444

5,528

Total non-current liabilities

932,856 1,000,119

1,099,429 1,162,387

663,291

405,475

497,005

219,826

(1,146)

(7,552)

167,432

193,201

663,291

405,475

Total liabilities

Trade and other receivables

64,042

62,132

Net assets

Shares in subsidiaries

246,778

246,778

Property, plant and equipment

423,397

353,630

Right of use asset

118,667

121,784

Pre-paid contract funds under management

562,863

561,837

Intangible assets

Deferred selling costs

Deferred contract assets

95,357

43,682

13,151

14,201

2,525

4,040

Total non-current assets

1,526,780 1,408,084

Total assets

1,762,720 1,567,862

Equity

Contributed equity

Reserves

Retained profits

Total equity

InvoCare            Annual Report 2020  | 121

Performance Review12Directors’ Report3Financial Report4Other Information 
 
Financial Report

Notes to the consolidated financial statements  
Other statutory disclosures continued

Note 24. Economic dependence

Note 25. Remuneration of auditors

The parent entity depends on dividend and interest income from, and 

During the year the following fees were paid or payable for services 

management fees charged to, its subsidiaries to source the payment 

provided by the auditor of the parent entity, InvoCare Limited, its 

of future dividends and fund its operating costs and debt service 

related practices and non-related audit firms.

obligations as borrower under the bank loan facility agreements. The 

parent entity’s financial position is sound. Adequate cash resources 

are available to enable it to meet its obligations as and when they fall 

due, through either drawing on unused finance facilities, which at the 

reporting date amounted to $207,425,000 as outlined in Note 13.E., 

or by on-demand repayment of intercompany advances.

A. Audit services

PricewaterhouseCoopers  
– Australian firm

2020 
$

2019 
$

Audit and review of financial reports

525,121

450,621

PricewaterhouseCoopers  
– non-Australian firm

Audit and review of financial reports

22,443

24,788

Non-PricewaterhouseCoopers  
– Singaporean firm

Audit and review of financial reports

32,152

32,743

Total remuneration for audit services

579,716

508,152

B. Non-audit services

PricewaterhouseCoopers  
– Australian firm

Assurance services

Taxation services

Other Services

PricewaterhouseCoopers  
– non-Australian firm

Taxation services

Other services

Non-PricewaterhouseCoopers  
– Singaporean firm

22,400

29,050

11,500

58,500

-

7,250

49,033

35,687

1,633

-

Other services

11,476

12,389

Total remuneration for non-audit services

96,042

142,876

It is the Company’s policy to employ PricewaterhouseCoopers 

on assignments additional to their statutory audit duties where 

PricewaterhouseCoopers’ expertise and experience with the Group 

are important and auditor independence is not compromised. These 

assignments are principally tax advice and advisory services, or where 

PricewaterhouseCoopers is awarded assignments on a competitive 

basis. It is the Company’s policy to seek competitive tenders for any 

major consulting projects.

InvoCare            Annual Report 2020  | 122

 
Note 26. Other accounting policies

IV.  Trade and other payables

A.   New or amended accounting standards and 

interpretations adopted

Trade and other payables represent liabilities for goods and services 

provided to the Group prior to the end of the financial year which had 

not been settled at balance date. The amounts are unsecured and are 

usually paid within 60 days of recognition.

The Group has adopted all of the new or amended Accounting 

Standards and Interpretations issued by the Australian Accounting 

V.  Borrowings

Standards Board (AASB) that are mandatory for the current reporting 

Borrowings are initially recognised at fair value, net of transaction 

period.

• •  Conceptual Framework for Financial Reporting and AASB 2019-1 

Amendments to Australian Accounting Standards–References to 

the Conceptual Framework

B. Other accounting policies applicable

I.  Foreign currency translation

a.  Functional and presentation currency

Items included in the financial statements of each of the Group’s 

entities are measured using the currency of the primary economic 

environment in which the entity operates (the functional currency). The 

consolidated financial statements are presented in Australian dollars, 

which is InvoCare Limited’s functional and presentation currency.

b.  Transactions and balances

Foreign currency transactions are translated into the functional 

currency using the exchange rates prevailing at the dates of the 

transactions. Foreign exchange gains and losses resulting from the 

costs incurred. Borrowings are subsequently measured at amortised 

cost. Any difference between the proceeds (net of transaction 

costs) and the redemption amount is recognised in the statement of 

comprehensive income over the period of the borrowings using the 

effective interest rate method.

Borrowings are classified as current liabilities unless the Group has an 

unconditional right to defer settlement of the liability for at least twelve 

months after the balance sheet date.

VI. Derivative financial instruments

The Group uses derivative financial instruments, interest rate 

swaps, to hedge its risks associated with exchange and interest rate 

fluctuations. Derivatives are initially recognised at fair value on the  

date a derivative contract is entered into and are subsequently  

re-measured to their fair value at each reporting date. The accounting 

for subsequent changes in fair value depends on whether the 

derivative is designated as a hedging instrument, and if so, the nature 

of the item being hedged. The Group designates certain derivatives 

as either:

settlement of such transactions and from the translation at year end 

• •  Hedges of the risks associated with the cash flows of recognised 

exchange rates of monetary assets and liabilities denominated in 

assets and liabilities and highly probable forecast transactions 

foreign currencies are recognised in the income statement, except 

(cash flow hedges)

when they are deferred in equity as qualifying cash flow hedges and 

qualifying net investment hedges or are attributable to part of the net 

• •  Hedges of a net investment in a foreign operation

The Group documents at inception the relationship between hedging 

instruments and hedged items, as well as its risk management 

objective and strategy for undertaking various hedge transactions. 

The Group also documents its assessment of whether the derivatives 

that are used in hedging transactions have been, and will continue to 

be, highly effective in offsetting changes in fair values or cash flows or 

hedged items.

The fair value of interest rate swap contracts is calculated as the 

present value of the estimated future cash flows. The full fair value of a 

hedging derivative is classified as a non-current asset or liability when 

the remaining maturity of the hedged item is more than twelve months; 

it is classified as a current asset or liability when the remaining maturity 

of the hedged item is less than twelve months.

investment in a foreign operation.

II.  Inventories

Inventories comprising of funeral merchandise and memorialisation 

property items in the cemeteries and crematoria and pets cremations 

business, primarily held for the purpose of trading, are sold, 

consumed or realised as part of the normal operating cycle even when 

they are not expected to be realised within twelve months, and are 

classified as current.

Inventories are stated at the lower of cost and net realisable value. 

Cost comprises direct materials and, where appropriate, a proportion 

of variable and fixed overhead. Costs are assigned to individual items 

of inventory predominantly on the basis of weighted average cost. Net 

realisable value is the estimated selling price in the ordinary course of 

business less the estimated costs necessary to make the sale.

III. Deferred contract assets

Deferred contract assets represent items to be delivered related to the 

pre-2018 memorial product contracts. These contract assets will be 

unwind to cost of goods sold as the performance obligations of these 

contracts are met.

InvoCare            Annual Report 2020  | 123

Performance Review12Directors’ Report3Financial Report4Other InformationFinancial Report

Notes to the consolidated financial statements  
Other statutory disclosures continued

Hedges that meet the criteria for hedge accounting are accounted for 

VII. Employee benefits

as follows:

a.   Cash flow hedges

a.   Wages and salaries, annual leave and sick leave

Liabilities for wages and salaries, including non-monetary benefits and 

The effective portion of changes in the fair value of derivatives that are 

annual leave expected to be settled within 12-months of the reporting 

designated and qualify as cash flow hedges is recognised in equity in 

date are recognised in other payables and provision for employee 

the hedging reserve. The gain or loss relating to the ineffective portion 

benefits in respect of employees’ services up to the reporting date and 

is recognised immediately in the statement of comprehensive income 

are measured at the amounts expected to be paid when the liabilities 

within finance costs.

are settled, including appropriate on-costs.

Amounts accumulated in equity are recycled in the statement of 

b.   Long service leave

comprehensive income within finance costs in the periods when the 

hedged item affects profit or loss (for instance when the forecast sale 

that is hedged takes place).

When a hedging instrument expires, is sold or terminated, or when 

a hedge no longer meets the criteria for hedge accounting, any 

cumulative gain or loss existing in equity at that time remains in 

equity and is recognised when the forecast transaction is ultimately 

recognised in the statement of comprehensive income.

The liability for long service leave is recognised in the provision for 

employee benefits and is measured as the present value of expected 

future payments to be made in respect of services provided by 

employees up to the reporting date, including appropriate on-costs. 

Consideration is given to expected future wage and salary levels, 

experience of employee departures and periods of service. Expected 

future payments are discounted using market yields at the reporting 

date on corporate bonds with terms to maturity and currency that 

match, as closely as possible, the estimated future cash outflows.

When a forecast transaction is no longer expected to occur, the 

cumulative gain or loss that was reported in equity is immediately 

c.   Bonus plans

transferred to the statement of comprehensive income.

The Group recognises a liability in other payables and an expense 

b.   Hedges of a net investment

Hedges of a net investment in a foreign operation, including a hedge 

of a monetary item that is accounted for as part of the net investment, 

are accounted for in a similar way to cash flow hedges. Gains or losses 

for bonus plans when there is no realistic alternative but to settle the 

liability and at least one of the following conditions is met:

• •  There are formal terms in the plan for determining the amount  

of the benefit

on the hedging instrument relating to the effective portion of the hedge 

• •  The amounts to be paid are determined before the time of 

are recognised directly in equity while any gains or losses relating to 

completion of the financial report

the ineffective portion are recognised in the income statement. On 

disposal of the foreign operation, the cumulative value of any such 

gains or losses recognised directly in equity is transferred to the 

income statement.

• •  Past practices give clear evidence of a constructive obligation

VIII.   New Accounting Standards and Interpretations 

not yet mandatory or early adopted

There are no Australian Accounting Standards and Interpretations 

that have recently been issued or amended but are not yet mandatory, 

that have been early adopted by the Group for the annual reporting 

period ended 31 December 2020.

InvoCare            Annual Report 2020  | 124

 
Financial Report

Directors’ declaration

In the Directors’ opinion:

• •  The financial statements and Notes 1 to 26 are in accordance with 

the Corporations Act 2001, including:

•  Complying with Accounting Standards, the Corporations 

Regulations 2001 and other mandatory professional reporting 

requirements

•  Giving a true and fair view of the Company’s and the Group’s 

financial position as at 31 December 2020 and of their 

performance for the financial year ended on that date

• •  There are reasonable grounds to believe that the Company will be 

able to pay its debts as and when they become due and payable

• •  At the date of this declaration, there are reasonable grounds to 

believe that the members of the Extended Closed Group identified 

in Note 23 will be able to meet any obligations or liabilities to which 

they are, or may become, subject by virtue of the deed of cross 

guarantee described in Note 23

Basis of preparation on page 73 confirms that the financial statements 

also comply with International Financial Reporting Standards as 

issued by the International Accounting Standards Board.

The Directors have been given the declarations by the Chief Executive 

Officer and Chief Financial Officer required by section 295A of the 

Corporations Act 2001.

This declaration is made in accordance with a resolution of the 

Directors.

Bart Vogel Chairman 

Sydney  24 February 2021

InvoCare            Annual Report 2020  | 125

Performance Review12Directors’ Report3Financial Report4Other InformationPricewaterhouseCoopers, ABN 52 780 433 757 One International Towers Sydney, Watermans Quay, Barangaroo, GPO BOX 2650, SYDNEY  NSW  2001 T: +61 2 8266 0000, F: +61 2 8266 9999, www.pwc.com.au Level 11, 1PSQ, 169 Macquarie Street, Parramatta NSW 2150, PO Box 1155 Parramatta NSW 2124 T: +61 2 9659 2476, F: +61 2 8266 9999, www.pwc.com.au Liability limited by a scheme approved under Professional Standards Legislation. 126Independent auditor’s report To the members of InvoCare Limited Report on the audit of the financial report Our opinion In our opinion: The accompanying financial report of InvoCare Limited (the Company) and its controlled entities (together the Group) is in accordance with the Corporations Act 2001, including: (a)giving a true and fair view of the Group's financial position as at 31 December 2020 and of itsfinancial performance for the year then ended(b)complying with Australian Accounting Standards and the Corporations Regulations 2001.What we have audited The Group financial report comprises: ●the consolidated balance sheet as at 31 December 2020●the consolidated statement of comprehensive income for the year then ended●the consolidated statement of changes in equity for the year then ended●the consolidated statement of cash flows for the year then ended●the notes to the consolidated financial statements, which include significant accounting policiesand other explanatory information●the directors’ declaration.Basis for opinion We conducted our audit in accordance with Australian Auditing Standards. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial report section of our report. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. Independence We are independent of the Group in accordance with the auditor independence requirements of the Corporations Act 2001 and the ethical requirements of the Accounting Professional & Ethical Standards Board’s APES 110 Code of Ethics for Professional Accountants (including Independence Standards) (the Code) that are relevant to our audit of the financial report in Australia. We have also fulfilled our other ethical responsibilities in accordance with the Code. Performance Review12Directors’ Report3Financial Report4Other Information127 Our audit approach An audit is designed to provide reasonable assurance about whether the financial report is free from material misstatement. Misstatements may arise due to fraud or error. They are considered material if individually or in aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of the financial report. We tailored the scope of our audit to ensure that we performed enough work to be able to give an opinion on the financial report as a whole, taking into account the geographic and management structure of the Group, its accounting processes and controls and the industry in which it operates. Materiality Audit scope Key audit matters ●For the purpose of our auditwe used overall Group materiality of $3.3 million,which representsapproximately 5% of theGroup’s average profit beforetax of the past three yearsadjusted for impairment.●We applied this threshold,together with qualitative considerations, to determinethe scope of our audit and the nature, timing and extent ofour audit procedures and toevaluate the effect ofmisstatements on the financialreport as a whole.●We chose Group profit beforetax because, in our view, it isthe benchmark against whichthe performance of the Group is most commonly measured.Due to fluctuations in profitand loss from year to year, wechose a three year average.Impairment is adjusted as it isan infrequently occurring itemimpacting the consolidatedstatement of comprehensiveincome.●We selected 5% which iswithin the range of acceptablequantitative profit related materiality thresholds.●Our audit focused on wherethe Group made subjectivejudgements; for example,significant accountingestimates involvingassumptions and inherentlyuncertain future events.●The Group comprises businesses operatingpredominately in Australia, New Zealand and Singaporewith the most financiallysignificant operations beingAustralia.●We focused our audit on thefinancial information of theAustralian operations giventheir financial significance tothe Group.●We performed specific risk-focused audit procedures overthe Singapore and NewZealand operations.●Amongst other relevant topics,we communicated the followingkey audit matters to the Auditand Risk Committee:−Estimated recoverableamount of goodwill for theNew Zealand operations−Accounting for pre-paidfuneral contracts●These are further described inthe Key audit matters section of our report.128 Key audit matters Key audit matters are those matters that, in our professional judgement, were of most significance in our audit of the financial report for the current period. The key audit matters were addressed in the context of our audit of the financial report as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters. Further, any commentary on the outcomes of a particular audit procedure is made in that context.  Key audit matter How our audit addressed the key audit matter Estimated recoverable amount of goodwill for the New Zealand operations Refer to note 12 Under Australian Accounting Standards, the Group is required to test goodwill annually for impairment, irrespective of whether there are indications of impairment. This assessment is inherently complex and judgemental as the Group is required to:      ●forecast the operational cash flows of the cashgenerating units of the Group●determine discount rates and terminal growthrateswhich are used in the discounted cash flow model used to assess impairment (the model).      The Group recognised a $19.3 million goodwill impairment charge relating to New Zealand operations in the year ended 31 December 2020. We considered this a key audit matter because significant judgement is required by the Group in estimating the recoverable amount of goodwill relating to the New Zealand operations. We focused our efforts on developing an understanding and testing the overall calculation and methodology of the Group’s impairment assessment.      In obtaining sufficient audit evidence, our procedures included, amongst others: ●assessing whether the cash generating units(CGUs) to which goodwill is allocated areconsistent with our knowledge and understandingof New Zealand operations and internal reporting●developing an understanding of how the Groupidentified the relevant methods, assumptions orsources of data, and the need for changes in them,that are appropriate for determining therecoverable amount in the context of theAustralian Accounting Standards ●evaluating whether judgements made in selectingthe method, significant assumptions and data fordetermining the estimate give rise to indicators ofpossible bias by the Group●comparing the cash flow forecasts to the Group’smost up-to-date budgets●assessing the Group’s historical ability to forecastfuture cash flows by comparing budgets withreported actual results for the past year●testing the mathematical calculations within themodel●comparing the terminal growth rate applied in themodel to external information sources●evaluating the reasonableness of the disclosuresagainst the requirements of Australian AccountingStandards.PwC valuations experts assisted us in performing these procedures where appropriate. Performance Review12Directors’ Report3Financial Report4Other Information129 Key audit matter How our audit addressed the key audit matter Accounting for pre-paid funeral contracts Refer to note 10 The Group enters into pre-paid funeral contracts whereby it agrees to deliver a specified funeral, cremation or burial service at the time of need. The beneficiary invests the current price of the service to be delivered with a financial institution and conditionally assigns the benefit to the Group. For each pre-paid funeral contract, the Group records an asset for the value of the funds invested (funds under management) and a liability to deliver the services. As at 31 December 2020, the Group had recorded $613.1 million of funds under management and   $541.3 million of contract liabilities. We considered pre-paid funeral contracts to be a key audit matter due to the: ●size of the asset and liability balances●significant financing component within thecontracts, as a result of significant time differencesthat may arise between receipt of cash fromcustomers and the subsequent recognition ofrevenue on the delivery of services (redemptiondate).For the asset value invested, we performed the following procedures amongst others: ●agreeing a sample of balances recorded by theGroup to statements and confirmations receivedfrom independent custodians●testing the valuation of the invested funds undermanagement by comparing a sample of underlyinginvestments to relevant unit prices using marketpricing data and custodian confirmations. For the liability recognised, we performed the following procedures amongst others: ●comparing the date and value of a sample ofcontracts to that recorded by the Group●assessing the reasonableness of the significantfinancing component recognised during the yearby comparing the amount to our own calculations●selecting a sample of redeemed contracts(recognised revenue) to assess whether theGroup’s performance obligation under the pre-paid funeral contracts had been satisfied. Thisincluded comparing the relevant original contractsto service delivery documents and investmentreturns●evaluating the reasonableness of the disclosures against the requirements of Australian AccountingStandards.Other information The directors are responsible for the other information. The other information comprises the information included in the annual report for the year ended 31 December 2020, but does not include the financial report and our auditor’s report thereon. Prior to the date of this auditor's report, the other information we obtained included the director's report. We expect the remaining other information to be made available to us after the date of this auditor's report. Our opinion on the financial report does not cover the other information and we do not and will not express an opinion or any form of assurance conclusion thereon. In connection with our audit of the financial report, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial report or our knowledge obtained in the audit, or otherwise appears to be materially misstated. If, based on the work we have performed on the other information that we obtained prior to the date of this auditor’s report, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard. When we read the other information not yet received, if we conclude that there is a material misstatement therein, we are required to communicate the matter to the directors and use our professional judgement to determine the appropriate action to take. 130 Responsibilities of the directors for the financial report The directors of the Company are responsible for the preparation of the financial report that gives a true and fair view in accordance with Australian Accounting Standards and the Corporations Act 2001 and for such internal control as the directors determine is necessary to enable the preparation of the financial report that gives a true and fair view and is free from material misstatement, whether due to fraud or error. In preparing the financial report, the directors are responsible for assessing the ability of the Group to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the Group or to cease operations, or have no realistic alternative but to do so. Auditor’s responsibilities for the audit of the financial report Our objectives are to obtain reasonable assurance about whether the financial report as a whole is free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with the Australian Auditing Standards will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of the financial report. A further description of our responsibilities for the audit of the financial report is located at the Auditing and Assurance Standards Board website at: https://www.auasb.gov.au/admin/file/content102/c3/ar1_2020.pdf. This description forms part of our auditor's report. Report on the remuneration report Our opinion on the remuneration report We have audited the remuneration report included in pages 36 to 59 of the directors’ report for the year ended 31 December 2020. In our opinion, the remuneration report of InvoCare Limited for the year ended 31 December 2020 complies with section 300A of the Corporations Act 2001. Responsibilities The directors of the Company are responsible for the preparation and presentation of the remuneration report in accordance with section 300A of the Corporations Act 2001. Our responsibility is to express an opinion on the remuneration report, based on our audit conducted in accordance with Australian Auditing Standards.  PricewaterhouseCoopers Sydney Partner 24 February 2021 MW Chiang Other Information

Shareholder Information

As at 24 March 2021

The following information is presented in compliance with ASX Listing Rules 4.10  

(as relevant). The information is current as at 24 March 2021.

1.  Corporate Governance Statement

The 2020 Corporate Governance Statement can be found on the Company’s website at 

www.invocare.com.au/investor-relations/.

2.  Securities on issue

Shares and options as at 24 March 2021

Ordinary shares on issue

Unquoted options on issue

3.  Voting rights

Number

144,060,733

2,682,083

For fully paid ordinary shares – On a show of hands every member present at a meeting in 

person or by proxy shall have one vote and upon a poll shall have one vote for each share 

represented.

For unquoted options – No voting rights apply unless and until the unquoted options are 

converted to fully paid ordinary shares. 

4.  Distribution of quoted ordinary shares and small holdings 

Range

100,001 and over

10,001 to 100,000

5,001 to 10,000

1,001 to 5,000

1 to 1,000

Total

Unmarketable parcels

Fully paid ordinary shares

%

Number of holders

73,905,231

19,841,791

14,732,703

29,172,320

6,408,688

144,060,733

15,451

51.30

13.77

10.23

20.25

4.45

100.00

48

957

2,063

12,347

13,883

29,298

732

InvoCare            Annual Report 2020  | 132

 
     
5.  Top 20 registered shareholders 

Name

HSBC Custody Nominees (Australia) Limited  

J P Morgan Nominees Australia Pty Limited  

BNP Paribas Noms Pty Ltd  

Citicorp Nominees Pty Limited  

Australian Foundation Investment Company Limited  

Argo Investments Limited  

National Nominees Limited  

Milton Corporation Limited  

BKI Investment Company Limited  

Netwealth Investments Limited  

Australian Executor Trustees Limited  

Solium Nominees (Australia) Pty Ltd  

BNP Paribas Nominees Pty Ltd HUB24 Custodial Serv Ltd  

Mirrabooka Investments Limited  

Australian United Investment Company Limited  

BNP Paribas Nominees Pty Ltd  

Djerriwarrh Investments Limited  

Australian United Investment Company Limited  

UBS Nominees Pty Ltd  

Navigator Australia Ltd  

Total for top 20

Number of shares

18,193,048

15,222,974

Percentage  
%

12.63

10.57

7,009,124

5,895,094

3,512,442

2,743,277

2,081,872

2,050,914

1,638,974

1,165,234

1,091,141

1,051,113

1,021,855

1,020,000

784,193

625,458

616,000

507,136

500,333

489,913

4.87

4.09

2.44

1.90

1.45

1.42

1.14

0.81

0.76

0.73

0.71

0.71

0.54

0.43

0.43

0.35

0.35

0.34

67,220,095

46.67

6.  Substantial shareholders   

The share balances in this table are extracted from substantial shareholder notices received by the Company. 

Shareholders

Number of shares

Voting power

Date of last notice

Vanguard Group (The Vanguard Group, Inc. and its controlled entities)

7,194,935

5.01%

10 July 2020

InvoCare            Annual Report 2020  | 133

Performance Review12Directors’ Report3Financial Report4Other Information 
 
 
 
 
 
 
 
Glossary

Term

AASB

ABS

ACCC

ASX

Description

Australian Accounting Standards Board

Australian Bureau of Statistics

Australian Competition & Consumer Commission

Australian Securities Exchange which is the operating brand of ASX Limited

ASX Corporate 

The eight Corporate Governance Principles and best practice recommendations of the ASX Corporate Governance Council 

Governance 

Principles and 

Recommendations

4th Edition 2019

Cemetery

A place for burials and memorialisation

CGU

A cash generating unit which is the smallest identifiable group of assets that independently generates cash inflows

Constitution

The Constitution of the Company

Crematorium

A place for cremations and memorialisation

Crypts

DRP

EBIT

EBITDA

Above ground burial facilities

Dividend Reinvestment Plan

Earnings before interest and tax

Earnings before interest, tax, depreciation and amortisation

Funeral arrangement

The process in which the funeral service is planned and necessary documentation prepared

Funeral home

The InvoCare location where a funeral can be arranged and where some services can be conducted

Memorial or 

The physical marker or tribute to the life of the deceased

Memorialisation

Memorial park

An InvoCare location offering cremation, burial and memorialisation services

Non-operating 

Earnings from the net gain/(loss) on pre-paid contracts, asset sales gains/(losses), commissions received, less costs 

earnings before tax

associated with the administration pre-paid contracts, share of profits attributable to non-controlling interests and any other 

Volume

VWAP

unusual items as disclosed in the relevant reconciliations.

A term that refers to the number of funeral services, burials and cremations performed/undertaken

Volume Weighted Average Price a trading benchmark used to determine the face value of an InvoCare share. VWAP is 

calculated by adding up the dollars traded for every transaction (price multiplied by number of shares traded) and then 

dividing by the total shares traded for the day

In addition to the above terms and description, refer to the Glossary on page 34 to 35 in the Operating and financial review section for other terms used 

in that section.

InvoCare            Annual Report 2020  | 134

Corporate Directory

InvoCare Limited

ABN 42 096 437 393

Financiers 

Australia and New Zealand Banking 

Group Limited 

242 Pitt Street 

Sydney NSW 2000

ANZ Bank New Zealand Limited 

ANZ Centre 

23–29 Albert Street 

Auckland New Zealand

HSBC Bank Australia Limited 

Tower 1 - International Towers Sydney 

100 Barangaroo Avenue 

Sydney NSW 2000

The Hongkong and Shanghai Banking 

Corporation 

1 Queen Street 

Auckland New Zealand

MetLife Investment Advisors, LLC 

One MetLife Way 

Whippany, New Jersey 

USA 07981

Mizuho Bank, Ltd. 

60 Margaret Street 

Sydney NSW 2000

Sumitomo Mitsui Banking Corporation 

2 Chifley Square 

Sydney NSW 2000

Westpac Banking Corporation 

275 Kent Street 

Sydney NSW 2000

Westpac New Zealand Limited 

16 Takutai Square 

Auckland New Zealand

Directors 

Bart Vogel 

Chairman

Olivier Chretien 

 Managing Director and 

Chief Executive Officer

Richard Davis  

 Non-Executive Director

Jackie McArthur   Non-Executive Director

Megan Quinn  

 Non-Executive Director

Keith Skinner  

 Non-Executive Director

Company Secretary Heidi Aldred

Registered Office

Level 2, 40 Miller Street 

North Sydney NSW 2060

Telephone: 02 9978 5200 

Facsimile: 02 9978 5299

www.invocare.com.au

Share Registry

Link Market Services Limited 

Level 12, 680 George Street 

Sydney NSW 2000

Toll free: 1300 854 911 

Facsimile: 02 9287 0303

Stock Exchange  

InvoCare Limited is a company limited by 

Listing

shares that is incorporated and domiciled in 

Australia. 

InvoCare Limited’s shares are listed on the 

Australian Securities Exchange only.

  ASX code is IVC.

Auditors

PricewaterhouseCoopers 

One International Towers Sydney 

Watermans Quay, Barangaroo 

Sydney NSW 2000

Solicitors 

Addisons Lawyers 

Level 12, 60 Carrington Street 

Sydney NSW 2000

Anthony Harper Lawyers 

Level 6, Chorus House 

66 Wyndham Street 

Auckland New Zealand

InvoCare            Annual Report 2020  | 135

Performance Review12Directors’ Report3Financial Report4Other InformationInnovation Vocation Care

invocare.com.au